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Summary 
In many animals, a specialized cytoplasm forms within the oocyte that harbors all the 
molecular factors required for germ cell fate specification and is defined as the germ plasm. In 
Drosophila melanogaster, the germ plasm (or pole plasm), is assembled at the posterior pole 
of the oocyte in a stepwise process triggered by Oskar protein. oskar mRNA transcribed in the 
nuclei of nurse cells is actively transported into, and to the posterior pole of, the oocyte. At the 
posterior pole, oskar mRNA is translated into Oskar protein, which recruits the other pole plasm 
components required for germline specification and posterior patterning in the embryo. 
Recently, it was shown that Oskar binds polyadenylated mRNAs in vivo and that the C-
terminal domain of the protein binds RNA in vitro. In that study, by using UV crosslinking and 
immunoprecipitation experiments, I showed that Oskar associates in vivo with three mRNAs 
involved in posterior patterning and germ cell fate specification: nanos, polar granule 
component and germ cell-less. In order to identify Oskar’s binding site(s) on its target 
transcripts I applied the iCLIP method to early Drosophila embryos. To this end, I analyzed the 
efficiency of three key steps of the iCLIP protocol: RNAse digestion, 3’ end dephosphorylation, 
and adapter ligation. I found that, while the 3’ end dephosphorylation was generally efficient, 
the ligation of an adapter to RNA was a limiting step in the protocol. By performing a series of 
optimization experiments, I established new reaction conditions for adapter ligation that 
increased the efficiency of the reaction significantly. 
Even after optimization of the iCLIP protocol, the data produced in the Oskar iCLIP were 
inconclusive, due at least in part to the low affinity of Oskar for RNA. Hence, positional 
information regarding Oskar’s interaction with specific RNAs in vivo is still lacking. Such 
information would enable validation and further characterization of the RNA-binding activity of 
Oskar, providing important new insight into the molecular mechanisms underlying Oskar’s 
unique pole plasm inducing activity. 
The optimized iCLIP protocol I developed should be applicable to other RNA-binding 
proteins in Drosophila and in other model organisms. 
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Zusammenfassung 
In der Oozyte zahlreicher Tiere wird ein spezialisiertes Zytoplasma gebildet, das alle für 
die Spezifikation der Keimzellen benötigten molekularen Faktoren beherbergt und als 
Keimplasma definiert ist. In Drosophila melanogaster wird das Keimplasma (oder Polplasma) 
am posterioren Pol der Oozyte in einem durch Oskar-Protein ausgelösten schrittweisen 
Prozess assembliert. Oskar mRNA, die in den Kernen der sogenannten Nurse Zellen 
(Nährzellen) transkribiert wird, wird aktiv zu dem posterioren Pol der Oozyte transportiert. Am 
posterioren Pol wird oskar mRNA in Oskar-Protein translatiert, das die für die Spezifikation der 
Keimzellen und frühe embryonale Musterbildung erforderlichen Polplasmakomponenten 
rekrutiert. 
Vor kurzem wurde gezeigt, dass Oskar polyadenylierte mRNAs in vivo und seine C-
terminale Domäne RNA in vitro binden kann. In Rahmen dieser Arbeit wurde mit Hilfe der UV-
Crosslinking und Immunpräzipitationsexperimenten demonstriert, dass Oskar in vivo mit drei 
mRNAs, die an der embryonale Musterbildung und der Spezifikation der Keimzellen beteiligt 
sind, assoziiert: nanos, polar granule component and germ cell-less. Um Oskars 
Bindungsstelle(n) auf seinen Zieltranskripten zu identifizieren, wurde in dieser Studie die 
iCLIP-Methode auf frühe Drosophila-Embryonen angewendet. Dafür wurde die Effizienz von 
drei Schlüsselschritten des iCLIP-Protokolls analysiert: RNAse-Verdauung, 3'-End-
Dephosphorylierung und Adapter-Ligation. Es konnte gezeigt werden, dass, während die 3'-
End-Dephosphorylierung im Allgemeinen effizient war, die Adapter-Ligation ein limitierender 
Schritt in dem Protokoll war. Durch eine Reihe von Optimierungsexperimenten wurden neue 
Reaktionsbedingungen für die Adapter-Ligation etabliert, die die Effizienz der Reaktion 
signifikant erhöhten. 
Trotz der Optimierung des iCLIP-Protokolls war die RNA-Sequenzierung nach Oskar 
iCLIP ergebnislos, was, zumindest teilweise, auf die geringen Affinität von Oskar für RNA 
zurückzuführen ist. Demzufolge bleibt die Positionsinformation über Oskars in vivo Interaktion 
mit spezifischen RNAs unbekannt. Solche Informationen würden die Validierung und weitere 
Charakterisierung der RNA-bindenden Aktivität von Oskar ermöglichen und einen wichtigen 
neuen Einblick in die molekularen Mechanismen liefern, die der einzigartigen 
polplasmainduzierenden Aktivität von Oskar zugrunde liegen. 
Das in dieser Arbeit optimierte iCLIP-Protokoll sollte auf andere RNA-bindende Proteine 
in Drosophila und in anderen Modellorganismen anwendbar sein. 
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1. Introduction 
1.1. Drosophila melanogaster oogenesis and early embryogenesis 
An adult Drosophila melanogaster female possesses one pair of ovaries, in which the 
process of egg production, oogenesis, occurs. Each ovary is composed of approximately 16 
ovarioles, each of which can be considered as an egg production line. Indeed, a single ovariole 
consists of a sequence of progressively older egg chambers separated by a few somatic cells. 
At the anterior end of each ovariole is a structure called the germarium, in which germline stem 
cells are located and where the process of oogenesis is initiated. From the germarium, the 
newly formed egg chambers progressively move towards the distal (posterior) end of the 
ovariole as they develop into eggs competent for fertilization. The entire process, based on 
morphological criteria, has been divided into 14 stages, from the newly formed egg chamber 
(stage 1) to the mature egg (stage 14) (Fig. 1) [1] [2]. 
 
Figure 1: Drosophila oogenesis. A single Drosophila ovariole contains a series of egg chambers 
at different developmental stages. In the germarium (on the left), new egg chambers are formed. 
Asymmetric divisions of germline stem cells in the germarium produce a new stem cell and a cystoblast. 
The cystoblast divides four times with incomplete cytokinesis thus producing a cyst composed of 16 
germline cells interconnected by cytoplasmic bridges. This group of cells is surrounded by somatic 
follicular cells, together constituting an egg chamber. Inside the egg chamber, one cell is selected to 
become the oocyte, while the remaining 15 cells become nurse cells and provide metabolic support to 
the growing oocyte. The development of an egg chamber has been divided into 14 morphological stages 
and the newly formed egg chamber arising from the germarium is defined as stage 1. While moving 
toward the end of the ovariole, the egg chamber matures. The oocyte increases its volume thanks to 
the material produced by the nurse cells. At stage 11, the nurse cells dump their cytoplasm into the 
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oocyte and undergo apoptosis. Toward the end of oogenesis follicular cells surrounding the oocyte 
produce the egg shell and other specialized structures. Stage 14 egg chambers are mature eggs ready 
to be fertilized. 
Adapted from [3]. 
The germarium, the site of egg chamber production, contains two cell types: germline stem 
cells and somatic stem cells. At the beginning of oogenesis, a germline stem cell undergoes 
an asymmetric division, producing a new germline stem cell and its sibling daughter cell, the 
cystoblast. Subsequently, the cystoblast divides four times with incomplete cytokinesis, thus 
producing a cyst of 16 cells interconnected by cytoplasmic bridges called ring canals. As the 
cyst travels through the germarium, one of the 16 cells is specified as the oocyte, and the cyst 
is surrounded by a single layer of somatic follicle cells. At this point the fully formed egg 
chamber exits the germarium and continues to develop while moving to the posterior end of 
the ovariole. [1] [2]. 
The process of oocyte selection restricts the oocyte fate to a single of the 16 cells resulting 
from the four rounds of division of the cystoblast. At the beginning of the process, several cells 
display oocyte features, which become progressively restricted to one cell, the future oocyte; 
the remaining 15 cells develop into so-called nurse cells [4]. A key role in oocyte selection is 
played by the fusome, a vesicular organelle associated with microtubules that links the 16 cells 
in the cyst via the ring canals. During the cystoblast divisions, the fusome is unequally 
distributed among the cells, with one of the cells retaining more fusome material than the 
others. This particular cell will develop as the future oocyte [5]. The fusome is required for the 
organization of a polarized microtubule network that allows the transport of molecular 
components toward the single microtubule organizing center (MTOC) of the cyst, located in 
the future oocyte [6]. The microtubule-dependent transport of oocyte factors requires the 
molecular motor Dynein. Mutations in egalitarian (egl) and bicaudal-D (bicD), genes that 
encode an RNA-binding protein (RBP) and a Dynein cargo adapter, respectively, cause a 
failure to select the future oocyte [7] [8]. Shortly after its fate has been specified the oocyte 
14 
 
enters meiosis, but the process is arrested at Prophase I until the mature oocyte reaches the 
tip of the ovary [4] [9]. 
The nurse cells provide metabolic support to the growing oocyte. They are highly active in 
both transcription and translation, producing the materials required by the growing oocyte, 
which is transcriptionally quiescent during oogenesis, as well as by the young embryo whose 
first steps of development after fertilization, occur before activation of the zygotic genome. 
These “maternally provided components” include messenger RNAs (mRNA), proteins and 
ribosomes, as well as organelles such as mitochondria, all of which are transported along 
microtubules, through the ring canals and into the oocyte [4] [9]. Once in the oocyte, some of 
these mRNAs and proteins are actively transported to or otherwise accumulate at specific 
subcellular locations. The process of asymmetric protein and RNA localization is key for 
specification of the anterior-posterior and dorsal-ventral axes of the future embryo [4] [10]. 
The amount of material that is transported from nurse cells into the growing oocyte is also 
responsible for the increase in volume of the oocyte itself. During the first stages of oogenesis 
(1 to 10) the slow, active and regulated transport of mainly proteins and mRNAs from the nurse 
cells, together with uptake of yolk proteins produced by the follicle cells, cause a progressive 
increase in the size of the oocyte. At the beginning of stage 10, roughly half of the egg chamber 
is occupied by the oocyte. Toward the end of oogenesis (stage 11), the nurse cells dump their 
cytoplasmic content into the oocyte and undergo apoptosis. At the end of these processes the 
oocyte reached its final volume (Fig. 1) [3]. 
Follicle cells that envelop the egg chamber also play an important role during oogenesis. 
Interactions that occur between the oocyte and follicle cells are critical for body axis 
specification. As the mature egg chamber leaves the germarium, the oocyte has been already 
polarized by the action of Par-1 together with BicD, Egl and the microtubule minus end directed 
motor protein Dynein [11]. Outside the germarium two signaling events that involve Gurken 
are required for both anterior-posterior and dorsal-ventral axis specification. Gurken is an 
epidermal growth factor receptor (EGFR) ligand that is received by the EGFR expressing 
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follicle cells. During stage 6/7 the first Gurken signal induces the follicle cells at the posterior 
of the egg chamber to differentiate into posterior follicle cells. An unidentified signal is sent 
back to the oocyte by the posterior follicle cells and as a consequence the microtubule 
cytoskeleton of the oocyte is repolarized [12] [13]. This process involves the disassembly of 
the MTOC at the posterior of the oocyte and formation of new arrays of microtubules that now 
nucleate from the anterior and lateral cortex of the oocyte, as well as from the nuclear 
membrane [14] [15]. At stage 7, the nucleus migrates to the anterior lateral cortex of the oocyte. 
Once it reaches this position at stage 9, a second round of Gurken signaling induces dorsal-
ventral axis specification [12] [13] [16]. Finally, toward the end of oogenesis the follicle cells 
produce the chorion proteins forming the eggshell, as well as other specialized eggshell 
structures, such as the dorsal appendages, the operculum and the micropyle [17]. 
As previously mentioned, the meiosis begins shortly after the oocyte has been specified, 
then arrests in Prophase I. This arrest is relieved upon oocyte maturation, a process that takes 
place during stage 12/13 of oogenesis [9]. The process of oocyte maturation has been 
extensively studied in some animal species, but is much less well understood in Drosophila. 
In amphibians and other animals, high levels of Cyclin-dependent kinase 1 (Cdk1) and Cyclin 
B (CycB) activity are required for oocyte maturation. In addition, the phosphatase Cell division 
cycle 25 (Cdc25) is another important factor required during this process. By removing 
inhibitory phosphate groups from Cdk1, Cdc25 stimulates the maturation process. Cdk1 in 
complex with CycB forms the maturation promoting factor (MPF) that triggers nuclear envelope 
breakdown, chromosome condensation and spindle assembly [18]. Mutations in Cdk1 delay 
the oocyte maturation process in Drosophila [19]. Twine, the Drosophila homolog of Cdc25, is 
also required for proper oocyte maturation [20]. Another factor that plays an important role in 
this process is Polo kinase, which acts as an activator of Twine [21] [22]. At the end of the 
maturation process meiosis is arrested once again in Metaphase I, until egg activation occurs 
[9]. 
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The process of egg activation in Drosophila occurs during the passage of the mature 
oocyte (stage 14) from the ovary into the oviduct. During egg activation, the meiotic process is 
completed and the egg becomes ready for fertilization. The exact molecular mechanisms 
underlying the egg activation process are still not completely understood but specific factors 
act as initial triggers: the mechanical stress to which the oocyte is subjected in the oviduct and 
fluid uptake that lead to an increase of the intracellular levels of calcium [23] [24]. 
After completion of egg activation, the fertilization process occurs in the uterus, the egg is 
deposited in the environment and embryogenesis starts. The zygotic nucleus undergoes a 
series of 13 rapid and synchronous mitotic divisions without cytokinesis. This process happens 
in 2-2.5 hours and can be so rapid because it relies on maternally deposited gene products 
thus permitting to skip S-phases in the mitotic divisions [25]. At the end of this process the 
early embryo consists of a syncytium containing approximately 6000 nuclei that migrate to the 
periphery of the embryo, where cellularization occurs. This is the first developmental process 
that requires transcription of zygotic genes and marks the beginning of gastrulation [9] [26].  
 
1.2. Anterior-posterior axis specification 
Anterior-posterior or head to tail axis specification in Drosophila is one of the best 
understood examples of pattern formation in animals. This process is achieved through the 
asymmetric localization within the oocyte of three key regulators: bicoid (bcd) mRNA at the 
anterior pole, oskar (osk) and nanos (nos) mRNAs at the posterior pole (Fig. 2). The 
accumulation of these mRNAs at specific subcellular locations is required to establish proper 
morphogen gradients along the anterior-posterior axis thus leading to proper patterning of the 
embryo [4] [10]. 
bcd mRNA is transcribed in the nurse cells and transferred into the oocyte, where it can 
be detected already in early stages of oogenesis. Within the oocyte bcd mRNA localizes at the 
anterior end (Fig. 2) [27]. This process is an example of mRNA localization achieved through 
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active transport. The signal responsible for the anterior localization of bcd was first identified 
as a 625 nucleotide stretch in the 3’ untranslated region (3’UTR) of the mRNA [28]. This region 
contains shorter sequence elements, called bcd localization elements (BLE) that are 
necessary for different steps of bcd localization [28]. BLE1, a 50 nucleotide long sequence 
element able to form a stem loop structure, is required for transport of bcd mRNA from nurse 
cells to the oocyte [29]. Additional sequence elements are required during other steps of bcd 
mRNA localization. In the same manner as BLE1, these additional elements can also fold into 
stem loop structures. Mutations in the primary sequence that do not impair the secondary 
structure of BLEs still allow proper bcd mRNA localization [30] [31]. It has also been shown 
that bcd mRNA is able to dimerize both in vitro and in vivo, through a stem loop structure in 
the 3’UTR, and that the dimerization is crucial for the interaction with the protein Staufen (Stau) 
[31]. 
 
Figure 2: bcd, osk, nos and gurken mRNA localization during Drosophila oogenesis. All 
four mRNAs are transcribed in the nurse cells and transported into the oocyte by a microtubule- and 
Dynein-dependent process. (A). Maternal mRNA localization during mid oogenesis. Once in the oocyte, 
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gurken mRNA accumulates next to the oocyte nucleus, at an anterior-lateral position of the oocyte 
cortex. Once in the oocyte bcd mRNA accumulates at the anterior cortex. osk mRNA accumulation at 
the posterior pole is a microtubule- and Kinesin-dependent process. (B). mRNA localization during late 
oogenesis. During nurse cell cytoplasmic dumping into the oocyte, bcd is continuously transported to 
the anterior cortex by Dynein. nos mRNA accumulation at the posterior depends on cytoplasmic flows 
and Osk protein. When nurse cell dumping occurs, cytoplasmic streaming distributes nos RNPs 
throughout the ooplasm and those which reach the posterior pole are trapped by the pole plasm. Arrows 
represent the movement of mRNAs and other cytoplasmic components within the oocyte during 
streaming. A: anterior. P: posterior. 
Adapted from [3]. 
The anterior localization of bcd mRNA is a multi-step process during which redundant 
mechanisms act to ensure proper bcd localization. The initial transport of bcd mRNA into the 
oocyte is a microtubule- and Dynein-dependent process. bcd mRNAs travel through the nurse 
cell cytoplasm along microtubules towards the ring canals, transported by the microtubule 
motor Dynein [32] [33] [34]. During mid oogenesis accumulation of bcd mRNA at the anterior 
of the oocyte requires Exuperantia (Exu) protein activity [27] [32]. Exu and bcd mRNAs 
associate in large ribonucleoprotein particles (RNP) in the nurse cells and travel together into 
the oocyte (Fig. 2A). In Exu mutant egg chambers, bcd mRNA is able to reach the oocyte, but 
instead of accumulating at the anterior diffuses throughout the ooplasm [32]. It has been 
hypothesized that after entering into the oocyte bcd-Exu RNPs are remodeled in order to 
incorporate those factors that are required for anterior accumulation [33]. Exu is 
phosphorylated by the kinase Par-1 and this modification is required for anterior localization of 
bcd mRNA [35]. 
During the later stages of oogenesis, from nurse cell dumping onwards, bcd mRNAs 
continue to accumulate at the anterior of the oocyte. The process is microtubule- and Dynein-
dependent but appears to be mechanistically different from the one active during mid 
oogenesis [36]. Indeed, mutations in two genes: swallow and stau, specifically compromise 
this late stage in bcd mRNA localization [27] [36]. In particular, Stau, a double stranded RBP, 
colocalizes with bcd RNPs during late stages of oogenesis [36]. It has been hypothesized that 
in this process, bcd RNPs move on a particular subpopulation of microtubules nucleated from 
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the anterior cortex, different from the microtubules present on the rest of the oocyte cortex (Fig. 
2B) [36] [37]. 
Finally, at the end of oogenesis, bcd mRNAs become anchored at the anterior cortex 
through an actin-dependent mechanism [38]. This mechanism is important for maintaining bcd 
at the anterior in mature oocytes prior to fertilization, which might only occur several days later. 
Swallow protein plays an important role in anchoring bcd. Indeed, Swallow localizes near the 
oocyte plasma membrane, where it seems to have a role in regulating the actin cytoskeleton 
that is required for bcd mRNA anchoring at the anterior [39]. The final step of bcd localization 
is triggered by egg activation, as a consequence of which the actin cytoskeleton at the cortex 
of the egg undergoes a rapid rearrangement that releases bcd RNPs from the anterior cortex, 
thus generating an anterior to posterior gradient [38] [40]. 
bcd mRNA encodes  a transcription factor and is translated upon  egg fertilization. As a 
consequence of the graded distribution of bcd mRNA and of the movement of Bcd protein 
itself, Bcd forms a morphogen gradient that controls anterior-posterior patterning in a 
concentration-dependent fashion (Fig. 3A) [40] [41]. In early embryogenesis, during the 
blastoderm phase, following the 13 rapid nuclear divisions the majority of the nuclei move to 
the periphery of the embryo where cellularization occurs. As a consequence of the Bcd 
gradient, depending upon their position cells incorporate different amounts of Bcd protein, 
resulting in differential gene expression along the anterior-posterior axis [10].  
Bcd regulates the expression of different genes involved in the formation of the anterior 
structures of the future animal (head and thorax). Among these targets an important role is 
played by hunchback (hb). Bcd activates hb transcription at the anterior of the embryo directly 
binding regulatory DNA elements upstream of the hb gene [42]. Hb protein is also a 
transcription factor involved in the regulation of genes required for embryonic patterning and 
development. In addition to the zygotic expression of hb resulting from Bcd transcriptional 
activation, hb mRNA is produced maternally during oogenesis and is distributed uniformly in 
the oocyte [43]. Maternal hb mRNA is translated at the anterior of the embryo and repressed 
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towards the posterior by the activity of a complex formed by Nos, Pumilio (Pum) and Brain 
tumor (Brat), which restricts the activity of maternal hb anteriorly (Fig. 3C) [44]. Another gene 
activated by Bcd is orthodenticle (otd). Sequences upstream of the otd gene are recognized 
by Bcd, promoting otd transcription and thus formation of head structures [45]. 
 
Figure 3: Bcd, Cad, Hb and Nos morphogen gradients in Drosophila embryo. (A). bcd 
mRNA accumulates at the anterior pole. bcd translation generates an anterior to posterior gradient of 
Bcd morphogen. (B). cad mRNA is evenly distributed in the embryo. Bcd together with 4EHP blocks cad 
translation at the anterior, thus generating an opposing gradient of Cad protein. (C). hb mRNA is evenly 
distributed in the embryo. hb translation is repressed at the posterior by Nos acting in complex with Pum 
and Brat. (D). nos mRNA accumulates at the posterior pole, but is also present throughout the embryo. 
Only posteriorly localized nos mRNAs are translated. Unlocalized nos mRNA is translationally repressed 
by Smg, which recruits Cup and the CCR4/NOT complex. 
Adapted from [10]. 
In addition to acting as a transcription factor, Bcd also acts as a repressor of translation of 
specific mRNAs in the embryo, for example of caudal (cad) mRNA. Cad is a transcription factor 
involved in posterior patterning. cad mRNA is uniformly distributed in the embryo and its 
translation at the anterior is repressed by the binding of Bcd to the 3’UTR: Bcd binds the 4E 
homology protein (4EHP) and recruits it to the 5’ end of cad mRNA; 4EHP then interacts with 
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the mRNA cap structure directly, inhibiting the assembly of an active cap-binding complex and 
thus repressing translation. This mechanism results in a posterior to anterior Cad protein 
gradient opposite to the Bcd gradient (Fig. 3B) [10] [46]. In this way, by regulating different 
steps of gene expression during early embryogenesis, the Bcd morphogen orchestrates the 
patterning of anterior structures of the future animal. 
The posterior localization of osk and nos mRNAs is crucial for proper patterning of the 
posterior structures of Drosophila embryo. Posterior localization of osk mRNA restricts Osk 
protein activity to the posterior pole, where directs the assembly of a specialized cytoplasm 
called the pole plasm (Fig. 2) [47]. Here I will describe the mechanism of nos mRNA localization 
during oogenesis and the function of Nos protein in the embryo. The features of osk mRNA 
localization and Osk protein activity will be discussed in the next paragraphs. 
Nos protein is the major player in patterning the posterior structures of the Drosophila 
embryo [48]. nos mRNAs localize at the posterior pole of the oocyte during late oogenesis and, 
as opposed to bcd mRNA transport, this is a passive process. The process requires several 
factors, including the previous localization of Osk, Vasa (Vas) and Tudor (Tud) proteins at the 
posterior pole [49]. The localization of nos mRNA is an inefficient process. Indeed, at the end 
of the process the majority of nos mRNA remains spread throughout the ooplasm and only 4% 
of the mRNA localizes at the poster pole of the oocyte [50]. The mechanism that drives nos 
posterior localization is initiated when nurse cell dumping generates cytoplasmic flows in the 
oocyte. As a consequence of cytoplasmic streaming, nos particles move throughout the oocyte 
and those that reach the posterior pole are trapped and accumulate there [51]. It has been 
shown that nos RNPs that reach the posterior pole are incorporated into the pole plasm and 
anchored by the actin cytoskeleton (Fig. 2B) [51]. 
As in the case of bcd and other localizing mRNAs, nos transcripts contain the information 
required to achieve their ultimate posterior localization. In its 3’UTR, nos mRNA contains a 
large localization element that can be subdivided into four smaller localization elements [52]. 
These elements might be recognized by specific factors. It has been shown that the protein 
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Rumpelstiltskin (Rump), the Drosophila homolog of the heterogeneous nuclear 
ribonucleoprotein (hnRNP) M, binds to one of the localization elements in the nos 3’UTR. This 
interaction is required for achieving proper nos localization [53]. An additional protein that has 
been recently identified as nos mRNA interactor in vivo is Aubergine (Aub). Aub affects nos 
localization and interacts in vivo with nos 3’UTR. Moreover, Aub interacts in vivo with Rump in 
an RNA-dependent manner [54]. 
Since the mechanism underlying nos localization is inefficient and the majority of the 
mRNA remains unlocalized, restriction of the source of Nos protein to the posterior pole is 
crucial and this is achieved by repression of translation and possibly degradation of unlocalized 
transcripts (Fig. 3D). Different mechanisms act in nos translational repression during different 
developmental stages. The nos 3’UTR contains a 90 nucleotide long region that is involved in 
translational regulation. Defined as the translational control element (TCE), the TCE partially 
overlaps with some of the localization elements [55]. During late oogenesis, translation of 
unlocalized nos transcripts is repressed by the activity of Glorund (Glo) protein. Glo is the 
Drosophila homolog of hnRNP F/H proteins and, by interacting with the TCE, prevents 
translation of unlocalized nos mRNAs [56]. During early embryogenesis another mechanism 
of repression is active that involves the protein Smaug (Smg). The nos TCE contains two Smg 
recognition elements (SRE) that can be bound by Smg [57]. nos mRNA bound by Smg can be 
repressed in two different ways. On one hand Smg can recruit the protein Cup by direct 
interaction. Cup binds the cap-binding protein eIF4E and by doing so interferes with the 
recruitment of the scaffold protein eIF4G by eIF4E, thus inhibiting the assembly of the 48S pre-
initiation complex [58]. A second mechanism of Smg-mediated translational repression 
involves deadenylation. After binding the SRE in the nos 3’UTR Smg recruits the CCR4/NOT 
deadenylation complex, resulting in nos mRNA degradation (Fig. 3D) [59]. 
Only nos mRNAs localized at the posterior are translated and translational activation 
depends on Osk protein function. Osk can interact directly with Smg and relieve the 
CCR4/NOT-dependent deadenylation, allowing Nos protein to accumulate at the posterior pole 
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[59] [60]. Therefore nos RNPs that reach the posterior pole escape translational repression 
and degradation. Local nos translation at the posterior starts after fertilization and generates a 
gradient of Nos protein that mirrors the Bcd protein gradient (Fig. 3D) [61]. During early 
embryogenesis Nos (together with Pum and Brat proteins) controls abdomen formation by 
inhibiting hb translation at the posterior (Fig. 3C) [44]. This repressive mechanism allows the 
expression of genes required for abdomen formation. 
The opposing gradients of Bcd and Nos regulate anterior-posterior patterning of 
Drosophila by acting on hb at different levels. This process in turn affects the activation and 
repression of other patterning genes that control formation of the head and the abdomen of 
the future animal [62]. 
 
1.3. oskar mRNA localization during oogenesis 
osk mRNA localization at the posterior pole triggers the assembly of a specialized 
cytoplasm called pole plasm that contains all the molecular factors required for both abdomen 
and germ cell formation [47]. In the next paragraphs I will discuss the various aspects involved 
in osk mRNA localization and Osk protein function in the context of pole plasm assembly. 
During early stages of oogenesis, up to stages 6 and 7, osk mRNA is detected in all the 
cells of the germline cyst, but appears to be more concentrated in the oocyte. Initially osk 
mRNA is evenly distributed in the ooplasm. During stages 8 and 9 the mRNA shows a slight 
and transient accumulation at the anterior of the oocyte and starts to accumulate at the 
posterior pole. From stage 10 onward osk mRNA is restricted at the posterior pole and the 
localization pattern does not change until the end of oogenesis. During early embryogenesis 
osk is detected at the posterior pole and begins to disappear during nuclear division 6 and 7 
[63] [64]. Different mechanisms mediate the accumulation of osk mRNA at the posterior pole 
of the oocyte. 
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Figure 4: oskar pre-mRNA and mRNA sequences. (A). Structure of the osk pre-mRNA. osk pre-
mRNA contains 3 introns that are removed by the splicing machinery. Splicing of the first intron leads to 
formation of the SOLE element, otherwise split between the first (red line) and second (blue line) exons. 
The EJC is deposited upon splicing 20-24 nucleotides upstream of exon-exon junctions. (B). osk mRNA 
structure. osk mRNA contains two in-frame start codons (ATGs). The SOLE element is required for 
Kinesin-mediated transport of the mRNA towards the posterior pole of the oocyte. Several RNA 
regulatory elements are present in the 3’UTR. The OES (black line), a stem-loop structure, is required 
for Dynein-mediated transport of the mRNA from the nurse cells into the oocyte. Within the OES, the 
loop promotes osk mRNA dimerization (DD). The osk 3’UTR contains several BREs (blue lines) that 
mediate translational repression and activation by Bru protein. IBEs (red lines) are required for osk 
translation at the posterior pole. 
Adapted from [65]. 
osk mRNAs are transcribed in nurse cells, then transported into the oocyte -  the first step 
in osk localization. A 67 nucleotide long element in the osk 3’UTR, the osk oocyte entry signal 
(OES), mediates this transport process. The OES folds into a stem loop structure and mediates 
the Dynein- and microtubule-dependent transport of osk mRNAs from the nurse cells into the 
oocyte (Fig. 4B) [66]. Different protein factors are involved in this transport process, among 
them Egl and BicD. Egl does not possess a classical RNA-binding domain (RBD) yet is an 
RBP that has been shown to be able to recognize specific localization signals within RNAs 
[67]. Furthermore a recent study suggests that Egl directly interacts with osk mRNA in vivo 
[68]. Egl directly interacts with BicD and both proteins interact with components of the Dynein 
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motor complex [69] [70]. Altogether these data show that osk mRNA transport into the oocyte 
is mediated by a cis-acting element in the 3’UTR that mediates the recruitment of Egl-BicD 
complex and Dynein, thus promoting the active transport of osk RNPs into the oocyte. 
After osk mRNA transport into the oocyte during early oogenesis, a second mechanism of 
active transport mediated by Kinesin motor proteins is responsible for the posterior localization 
of osk mRNA during mid oogenesis (Fig. 2A). As previously mentioned, beginning from stage 
7 the oocyte microtubule cytoskeleton disassembles and new microtubules nucleate from the 
anterior and lateral cortex of the oocyte with their plus ends extending into the ooplasm [14]. 
At this stage osk mRNA transport to the posterior pole requires the activity of the microtubule 
plus end motor protein Kinesin-1 [71] [72]. By in vivo observation of osk RNPs movement, it 
has been shown that the posterior accumulation is achieved through a series of random walks 
on a poorly polarized cytoskeleton. These walks are only slightly biased toward the posterior 
pole but they nevertheless suffice to ensure efficient posterior localization of osk [72]. 
Several sequence elements in osk mRNA are required for the Kinesin-1-dependent 
localization step. One of these RNA elements is assembled upon splicing of the osk pre-mRNA 
in the nurse cell nuclei. Indeed, it has been shown that splicing of the first intron in osk pre-
mRNA is strictly required for posterior localization [73]. Upon removal of the first intron, the last 
18 nucleotides of exon 1 3’ end and the first 10 nucleotides of exon 2 5’ end form the spliced 
osk localization element (SOLE), which folds into a stem loop structure (Fig. 4A) [74] [75]. As 
a consequence of splicing, the exon junction complex (EJC) is loaded on mRNAs, including 
osk mRNA, 20-24 nucleotides upstream of the splice junction. EJCs mark exon-exon 
boundaries and the complex is involved in several processes of mRNA post-transcriptional 
regulation [76]. In Drosophila, the four core components of the EJC, eIF4AIII, Mago nashi 
(Mago), Y14 and Barentsz (Btz), are required for osk mRNA transport to the posterior of the 
oocyte [77] [78] [79] [80]. Although splicing of the first intron is crucial for posterior localization 
of osk mRNA, intron-less transcripts that contain the osk 3’UTR can still localize correctly in 
wild-type oocytes, as a result of “hitch-hiking” with endogenous, spliced osk transcripts. This 
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mechanism involves RNA-RNA interactions between the stem loop structure of the OES 
element of two osk 3’UTRs, reinforced by proteins that have the capacity to dimerize or 
oligomerize. By this mechanism RNAs that lack the SOLE element can localize to the posterior 
together with osk mRNAs that are fully competent for posterior localization (Fig. 4B) [81]. 
Therefore, RNA-RNA interaction appears to be an additional mechanism that contributes to 
osk mRNA accumulation at the posterior pole. 
After nuclear pre-mRNA processing occurs, osk is exported to the nurse cell cytoplasm 
where a Dynein-mediated mechanism transports osk RNPs into the oocyte, where a Kinesin-
1-mediated mechanism takes over and mediates posterior localization of the mRNAs. How osk 
RNPs switch between opposite microtubule polarity motors during the different stages of 
localization is not completely understood. A recent study sheds new light on this mechanism. 
It has been shown that osk mRNA is mislocalized in tropomyosin mutant flies [82] and that 
Kinesin-1 recruitment to osk RNPs is mediated by the Tropomyosin 1 (Tm1) I/C isoform, that 
is able to bind the osk mRNA 3’UTR [83].  Tm1-mediated recruitment of Kinesin-1 seems to 
occur right after nuclear export of mature osk mRNAs to the perinuclear cytoplasm of nurse 
cells. The process of recruitment appears to be inefficient, as only a fraction of osk RNPs are 
loaded with Kinesin-1. However, the recruitment of Kinesin-1 by Tm1 is dynamic and ultimately 
ensures the posterior localization of the bulk of osk mRNAs. In the model proposed, Tm1 
bound to the 3’UTR recruits inactive Kinesin-1, which once the RNPs are in the oocyte is 
activated by the SOLE element associated with the EJC on spliced osk mRNAs [83]. 
Two additional proteins that are involved in osk posterior localization are Hrp48 and Stau. 
Hrp48, the Drosophila homolog of hnRNP A/B, is required for osk localization, as in oocytes 
produced from hrp48 mutant females, osk mRNAs fail to accumulate at the posterior pole [84]. 
Hrp48 directly interacts with the 5’ region and 3’UTR of osk mRNA and regulates osk 
translation in addition to localization [84] [85]. osk mRNA also fails to localize at the posterior 
in stau mutants [63]. Stau protein contains five RBDs and specifically interacts with double 
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stranded RNA. It has been proposed that Stau RBD2 might be involved in regulating osk 
localization while RBD5 is required for osk translational activation [86]. 
During the late stages of oogenesis, when cytoplasmic streaming from the nurse cells 
occurs, an additional mechanism of osk posterior localization becomes active that involves the 
proteins Rump and Lost. Rump binds directly to the osk 3’UTR and recruits Lost by direct 
interaction. This mechanism specifically boosts the amount of osk mRNAs localized at the 
posterior pole, ensuring the accumulation of an amount of osk mRNA and protein sufficient for 
germ plasm assembly [87]. 
The anchoring of osk RNPs after they have been transported to the posterior pole is also 
a crucial step in germ plasm assembly. This mechanism requires the activity of Osk protein 
itself, as well as the endocytic pathway and rearrangements in the F-actin cytoskeleton. 
Posteriorly localized osk mRNAs are translated into two protein isoforms Long Osk and Short 
Osk (Fig. 5) [88]. The features of the two Osk isoforms will be discussed in detail in the next 
paragraphs, but a short introduction is required here in order to explain the mechanisms 
underlying osk mRNA anchoring at the posterior pole. The Long Osk isoform is required for 
anchoring both osk mRNA and Short Osk at the posterior pole during late oogenesis. In the 
absence of Long Osk, pole plasm components detach from the posterior, resulting in posterior 
patterning defects and absence of germ cells [89]. Osk protein somehow stimulates 
endocytosis, and the Long Osk isoform has been shown to recruit several endosomal proteins 
[90]. Stimulation of endocytosis by Osk is required for anchoring the pole plasm at the posterior 
pole. Moreover Osk promotes rearrangement of the F-actin cytoskeleton. Long F-actin 
filaments project from the posterior cortex into the ooplasm and similar structures are not 
observed in other parts of the oocyte cortex [90] [91] [92]. These processes appear to act 
cooperatively to stably anchor osk mRNA and Osk protein at the posterior pole, spatially 
restricting Osk activity during oogenesis and early embryogenesis. 
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1.4. oskar mRNA translational regulation 
Translation of unlocalized osk mRNAs leads to severe patterning defects [47] [93]. In order 
to block ectopic Osk synthesis and restrict Osk protein accumulation to the posterior pole, 
translation of osk mRNA must be strictly regulated.  
Several mechanisms are active during oogenesis that repress osk mRNA translation. 
Some data suggest that during early oogenesis osk translation is inhibited by the RNA 
interference (RNAi) pathway. Indeed, mutations in several genes involved in RNAi as armitage, 
aub, spindle-E and maelstrom, lead to premature osk mRNA translation [94] [95]. 
An important protein required for osk translational repression in the ooplasm is Bruno 
(Bru). Bru is an RBP containing three RNA recognition motifs (RRM) that recognize sequence 
elements, called Bru response elements (BRE), in the osk 3’UTR (Fig. 4B). The direct 
interaction of Bru with osk mRNA represses its translation [96] [97]. Experimental evidence 
indicates that different mechanisms mediate Bru-dependent repression of osk translation. One 
of these mechanisms requires Bru interaction with the protein Cup, an eIF4E-binding protein. 
By interacting with the 5’ cap-binding protein eIF4E, Cup prevents recruitment of eIF4G, and 
hence of the small ribosomal subunit to unlocalized osk mRNAs [98]. An additional Bru-
mediated mechanism that might be involved in osk translational regulation requires Cup 
activity and involves deadenylation. Indeed Cup might promote osk poly(A) tail shortening by 
the direct recruitment of the CCR4/NOT complex and at the same time inhibit decapping and 
decay processes thus maintaining the mRNA in a repressed state [99]. This mechanism is 
supported by data showing that osk translational activation at the posterior pole requires 
polyadenylation [100]. 
osk mRNA translation is repressed by an additional Bru-mediated mechanism that does 
not involve Cup. Bru alone can promote osk mRNA oligomerization into large silencing 
particles inaccessible to ribosomes [101]. Formation of these silent osk RNPs, coupled with 
active transport, might represent an efficient mechanism for localizing a large number of mRNA 
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molecules at the posterior pole in a translational repressed state. An additional protein involved 
in osk oligomerization is hnRNP I, also known as polypyrimidine tract binding protein (PTB). 
PTB is required for osk translational repression and binds directly to multiple binding sites in 
the 3’UTR of osk transcripts. PTB contains four RRMs and by binding to different RNA 
molecules can promote the formation of large osk RNPs [102]. 
Only those osk mRNAs that localize at the posterior pole are translated into Osk protein; 
hence, starting from mid oogenesis, Osk accumulates at the posterior pole of the oocyte where 
it promotes pole plasm formation. The mechanism required for osk translational activation is 
not fully understood but studies over the last 20 years provide some information regarding this 
process. 
Interestingly it has been shown that Bru, in addition to its activity as a translational 
repressor, is involved in the activation of osk translation. The osk 3’UTR contains two clusters 
of BREs, both of which promote transcriptional repression of unlocalized osk mRNAs (Fig. 4B). 
The BRE cluster located close to the 3’ end of the 3’UTR is additionally required to promote 
translation. Both repression and activation are mediated by the different BREs and can occur 
in trans on different mRNA molecules, such that mRNAs concentrated in the same RNP can 
be regulated in a coordinated manner [103]. Additional sequence elements in the osk 3’UTR 
are important for translational activation. These sequences are recognized by the insulin 
growth factor II mRNA-binding protein (IMP) and are referred to as IMP-binding elements (IBE). 
osk mRNA contains 13 IBEs that are required for translation at the posterior pole (Fig. 4B). 
Interestingly, IMP protein is not required for osk translation [104]. 
An important function in activating osk mRNA translation at the posterior pole is exerted 
by oo18 RNA-binding protein (Orb). Orb is the Drosophila homolog of the cytoplasmic 
polyadenylation element binding protein (CPEB), whose activity is involved in regulation of osk 
mRNA poly(A) tail length. Orb colocalizes with osk at the posterior pole, and if Orb is lacking 
osk mRNAs bear shorter poly(A) tails. This reduces osk translation and Osk protein 
accumulation, leading to patterning defects [100]. Orb’s effect on the length of the poly(A) tail 
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on osk transcripts is exerted through the direct interaction of Orb with two poly(A) polymerases 
(PAP), PAP and Wispy, the first being required during mid oogenesis and the second during 
late oogenesis [105] [106]. 
Finally, osk mRNA itself is endowed with a function as a regulatory RNA. This is a non-
coding function of osk mRNA and is linked to the presence of BREs in the 3’UTR. osk mutant 
alleles that strongly reduce or completely abolish osk mRNA synthesis cause oogenesis arrest 
much earlier than the classical osk mutant alleles, which impair Osk protein function or 
production, although many support accumulation of the mutant osk mRNA at the posterior 
pole. The osk 3’UTR alone is sufficient to rescue the early oogenesis arrest phenotype of the 
so-called RNA null alleles [107]. A model has been proposed to explain the non-coding function 
of osk mRNA. In this model osk mRNA, via one BRE cluster in the 3’UTR, sequesters Bru 
molecules reducing the likelihood of Bru binding to other targets. Supporting this model, 
reducing Bru levels genetically in the oocyte partially rescues the osk mRNA null phenotype 
[108]. 
 
1.5. Two Oskar protein isoforms accumulate at the posterior pole 
The osk mRNA contains two in-frame start codons, both of which are used for translational 
initiation (Fig. 4B), leading to production of two protein isoforms: Long Osk (606 amino acids) 
and Short Osk (467 amino acids). The sole difference between the isoforms is the N-terminal 
extension that is present in Long Osk and absent in Short Osk (Fig. 5) [88]. 
Both Osk isoforms contain two globular domains separated by an intrinsically disordered 
region; the crystal structures of the two domains have been solved [109] [110]. The domain at 
the N-terminus (residues 139 to 240 in Long Osk) is a so-called LOTUS (Limkain, Oskar and 
Tudor containing proteins 5 and 7) domain (Fig. 5). This particular domain was identified in 
bioinformatic studies and proposed to act as an RBD [111] [112]. However, in vitro the LOTUS 
domain of Osk shows no RNA-binding activity. On the other hand it was shown that the LOTUS 
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domain forms dimers and interacts with the DEAD-box helicase Vas, an important component 
of the pole plasm [109] [110]. In a recent study the crystal structure of Osk LOTUS domain in 
complex with the C-terminal moiety of Vas was solved [113]. This study further revealed that 
the RNA helicase activity of Vas is stimulated by the interaction with LOTUS domain. In 
addition, Vas mutations that abolish the interaction with the LOTUS domain in vitro impair the 
recruitment of Vas to the pole plasm. These data suggest that Osk-dependent recruitment of 
Vas to the pole plasm is mediated by the N-terminal LOTUS domain. 
 
Figure 5: Oskar protein isoforms. The presence of two in-frame start codons in osk mRNA results 
in its translation into two Osk protein isoforms: Long Osk and Short Osk. Long Osk contains an N-
terminal extension that is absent in the Short isoform. Osk contains two globular domains: a LOTUS 
domain at the N-terminus and an OSK domain at the C-terminus. The LOTUS domain is required for 
Osk dimerization and interacts with Vas. The OSK domain binds RNAs in vitro. 
The domain at the C-terminus (from residues 401 to 606 in the Long Osk) of Osk protein 
has named the OSK domain [109]. The crystal structure of the OSK domain revealed a folding 
similar to SGNH hydrolase enzymes. Nevertheless, the OSK domain lacks several residues 
required for the catalytic activity of the SGNH class of enzymes, suggesting that is catalytically 
inactive. In addition, it was shown that the OSK domain is able to bind RNAs in vitro [109] 
[110]. 
Despite the fact that the only difference between the two isoforms is the presence of the 
N-terminal extension, Short Osk and Long Osk possess different biological activities. The Short 
Osk protein isoform (the more abundant of the two isoforms) is the one possessing pole plasm 
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inducing activity, therefore its function is critical for both posterior patterning of the embryo and 
germ cell formation [88] [89] [114]. The pole plasm inducing activity of Short Osk relies on the 
ability of this specific isoform to recruit other pole plasm factors, such as Vas, Valois (Vls) 
(which is required to recruit Tud protein) and Lasp [115] [116] [117]. At the posterior pole, Short 
Osk induces formation of and localizes within polar granules, electron-dense and membrane-
less structures that are large RNPs containing other molecular components, both proteins and 
RNAs, of the pole plasm [89]. 
In contrast to Short Osk, the Long isoform is not required for abdomen and germ cell 
formation, but its activity is essential for anchoring the pole plasm to the posterior cortex of the 
oocyte and early embryo. As discussed above, in the absence of Long Osk protein, Short Osk 
detaches from the posterior cortex and disperses in the ooplasm together with other pole plasm 
components such as Vas, causing defective germ cell and abdomen formation [89]. At the 
posterior pole, Long Osk is associated with endosomes, and this isoform has been shown to 
stimulate endocytosis at the posterior pole of the oocyte. Nevertheless, oocytes that produce 
only the Long Osk isoform at the posterior pole form endocytic structures that are strikingly 
different from those in wild-type oocytes. Therefore, although Long Osk stimulates 
endocytosis, the activity of both isoforms is required for correctly regulating the endocytic 
pathway at the posterior pole [92]. A recent study has shown that Long Osk is required for the 
transmission of mitochondria to the germline. Mitochondria localize at the posterior pole during 
the late stages of oogenesis independently on germ plasm assembly. Long Osk function is 
required to maintain mitochondria at the posterior pole, thus promoting their transmission to 
the germline. In the absence of Long Osk fewer mitochondria are inherited by the germ cells, 
causing a reduction in the number of germ cells that form during embryogenesis [118]. 
It has been proposed that the different biological activity of the two Osk protein isoforms 
might be explained by an uncharacterized inhibitory effect of the N-terminal extension on the 
activity of the protein. According to this hypothesis, the presence of this extension in the Long 
Osk isoform blocks the pole plasm inducing activity of the rest of the protein. Another 
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hypothesis is that the differential biological activities of the two might be due to their different 
subcellular localization. Being localized in the polar granules or on the endosomes might 
expose the two isoforms to different arrays of interacting partners [109]. Gaining more 
knowledge regarding the isoform-specific interactors of Osk might help understand the 
molecular mechanisms underlying the pole plasm inducing activity of the protein. 
 
1.6. Oskar triggers pole plasm assembly 
Germline specification is a crucial event in embryonic development. The germline plays a 
special role compared to the soma, as germ cells transmit the genetic information of the 
organism from one generation to the next. In metazoans, the germline is specified early during 
embryonic development by one or the other of two distinct mechanisms, preformation and 
epigenesis. In the case of preformation, the germline is specified through the localization of 
factors within the oocyte that assemble into a specialized cytoplasm called germ plasm. Those 
cells that will retain the germ plasm will adopt a germ cell fate. In the case of preformation, the 
germ cells form in response to specific signals from the surrounding environment [119]. 
Drosophila melanogaster is one of the best studied model organisms in which 
preformation is the mechanism that segregates the germline. As previously mentioned, the 
molecular factors required for germline specification start accumulating during mid oogenesis 
at the posterior pole of the oocyte where they assemble the germ plasm. Because the 
assembly occurs at the posterior of the oocyte, the Drosophila germ plasm is also called the 
pole plasm. During early embryogenesis, when cellularization occurs, the pole plasm is 
incorporated by a few cells forming at the posterior pole. These cells, the so-called “pole cells”, 
are the primordial germ cells (PGC) of Drosophila that later in development will form the 
germline [119]. 
Several experiments performed during the ‘60s and ‘70s were aimed at understanding the 
role of the pole plasm in Drosophila development. Irradiation of the posterior pole with UV light 
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was used to destroy pole plasm of embryos before cellularization. Flies generated from these 
embryos were sterile as a consequence of the reduced number of PGCs that formed [120]. On 
the other hand, transplantation of pole plasm from a non-irradiated embryo to the posterior of 
an UV irradiated one, restored PGC formation [121]. In addition, in now classical 
developmental biology experiments, it was shown that transplantation of pole plasm from a 
donor embryo to an ectopic position in a host embryo induced formation of cells that displayed 
characteristics of germ cells at the ectopic site [122]. These experiments demonstrated that 
pole plasm is sufficient for germline specification in Drosophila and also defined the cytological 
features of the pole plasm. Besides being assembled early during oogenesis, pole plasm 
contains mitochondria and large electron-dense structures called polar granules [122]. Today 
we know that polar granules are large RNPs. 
 
Figure 6. Oskar is both necessary and sufficient for abdomen and germ cell formation 
in Drosophila. In wild-type embryos, Osk accumulates at the posterior pole (B). As a consequence, 
germ cells form at the posterior (E) and abdominal structures are formed (H). When Osk is absent (A) 
no germ cells form in the embryo (D) and patterning of the abdomen fails (G). By using a transgene, it 
is possible to trigger Osk accumulation at the anterior pole, in addition to the canonical posterior 
accumulation (C). As a consequence, germ cells form both at the anterior and at the posterior (F) and 
an additional abdomen forms instead of the head (I). 
From Dr. Anne Ephrussi 
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After more than 20 years the germline determinant in Drosophila was shown to be 
encoded by osk. Embryos that lack osk fail to assemble a functional pole plasm at the posterior 
pole and as a consequence lack pole cells and abdominal structures (Fig. 6A, D and G) [123]. 
By using a transgenic construct in which the osk 3’UTR was replaced by the bcd 3’UTR, it was 
possible to engineer the accumulation of Osk protein at the anterior pole of the embryo (in 
addition to the normal posterior accumulation) (Fig. 6C). In this particular condition pole cells 
formed at both poles and embryos developed two abdomens in a perfect mirror image (Fig. 6F 
and I) [47]. This experiment demonstrated that osk is both necessary and sufficient for the 
assembly of a fully functional pole plasm, which in Drosophila is required for both germline 
specification and abdomen formation (Fig. 6). 
The mechanisms involved in anterior-posterior axis specification have been discussed in 
the previous paragraphs, therefore in the following paragraphs I will describe the mechanisms 
underlying germ cell fate specification. The pole plasm assembly activity of Osk relies on the 
ability of the protein to recruit other pole plasm components. One of these factors is the RNA 
helicase Vas, which is directly recruited to the posterior pole by Short Osk [109] [113] [115]. 
Several vas mutant alleles were identified in the last 30 years with strikingly different 
phenotypes. Some vas alleles lead to embryos that lack PGCs and abdominal structures, while 
others cause defects during early oogenesis linked to a failure in gurken translational activation 
[124] [125]. Vas function is crucial for posterior patterning and germline specification and in 
this context Vas might act as translational regulator of mRNAs such osk and nos. Indeed, in 
vas mutant ovaries Osk and Nos protein levels are reduced [55] [88]. The molecular 
mechanism underlying Vas activity in translational regulation of posterior localized mRNAs is 
not clear. It was proposed that a direct interaction between Vas and eIF5B is crucial for Gurken 
accumulation in the oocyte and might underlie a regulatory mechanism for other mRNAs [126]. 
However, a recent study did not detect a direct interaction between Vas and eIF5B, suggesting 
that Vas might recruit eIF5B indirectly [113]. 
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An additional important component of the pole plasm is the protein Tud. Embryos from tud 
mutant flies show posterior patterning defects and lack PGCs [127]. Tud recruitment to the 
pole plasm is mediated by Vls, a protein that interacts with both Tud and Osk [116]. Tud is a 
large protein that contains 11 copies of the Tud domain. Tud domains are involved in protein-
protein interactions and for binding require methylated arginine and lysine residues on the 
target proteins [128] [129]. Different Tud domains within the Tud protein sequence have been 
shown to be required for proper abdomen and germ cell formation, and it has been proposed 
that Tud functions as a scaffold protein, interacting with several targets within the pole plasm 
[128] [130]. Protein methylation at the posterior pole required for efficient Tud binding might be 
provided by Capsuleen, an arginine methyltransferase that interacts with Vls and is required 
for posterior patterning and germ cell formation [131] [132]. 
The mechanisms underlying the localization of nos mRNA and the activity of Nos as a 
morphogen during embryonic development were discussed above. However, in addition to its 
role in posterior patterning, nos is also required for germ cell formation. PGCs that lack Nos 
fail to migrate and to colonize the future gonads of the animal, possibly because gene 
expression that usually starts in the gonads, starts prematurely while the cells are migrating 
[133]. In the absence of Nos, PGCs express somatic genes, indicating that Nos function is 
required to maintain a germline fate [134]. Nos is also required to block mitosis of the PGCs 
before colonization of the gonads occurs. In this regard it has been proposed that Nos together 
with Pum blocks CycB mRNA translation in PGCs, thus downregulating cell proliferation [135] 
[136]. 
polar granule component (pgc) is another pole plasm component that acts in germline 
specification. pgc mRNA starts accumulating at the posterior pole during stage 11 of oogenesis 
and its localization depends on Osk [137]. pgc mutant embryos form PGCs normally but during 
embryogenesis these cells degenerate without reaching the future gonads of the animal 
causing sterility [138]. Initially identified as a non-coding RNA it has been shown that pgc 
transcripts encode a short peptide (71 amino acids) that acts to repress gene expression in 
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PGCs [138] [139]. RNA polymerase II transcriptional activity is linked to the phosphorylation 
state of the C-terminal domain (CTD) of the largest subunit. In Drosophila, the CTD of RNA 
polymerase II consists of 42 repeats of a heptapeptide motif that can be phosphorylated at 
different positions. Serine 5 (Ser5) phosphorylation is a hallmark of transcriptional initiation 
while phosphorylation of Serine 2 (Ser2) marks elongation. In Drosophila, high levels of 
phosphorylated Ser2 and Ser5 can be detected in somatic nuclei, while low levels of the same 
markers are present in nuclei of the PGCs. Transcriptional quiescence of PGCs appears to be 
linked to downregulation of RNA polymerase II-dependent transcription [140]. It has been 
shown that Pgc plays a fundamental role in inhibiting Ser2 phosphorylation in PGCs [138] 
[139]. In Drosophila Ser2 phosphorylation is catalyzed by the positive transcription elongation 
factor b (P-TEFb), a complex formed by Cdk9 and Cyclin T proteins. The fact that both Cdk9 
and Cyclin T directly interact with Pgc led to the proposal of a mechanism for Pgc activity, 
according to which Pgc by binding P-TEFb interferes with its recruitment to chromatin, thus 
suppressing zygotic transcription in PGCs [138]. 
Another mRNA that localizes at the posterior pole in an Osk-dependent manner is germ 
cell-less (gcl). gcl appears to be exclusively required for PGC formation and viability, as gcl 
mutant embryos have no patterning defects but show a strong reduction in the number of PGCs 
[141] [142]. Gcl protein can be detected already in the germarium, is present in the ooplasm, 
and associates with nuclear membranes in the nurse cells [143]. Starting in embryogenesis, 
Gcl accumulates at the posterior pole and remains restricted to the PGCs until their migration 
into the gonads [141]. It has been proposed that Bru activity is required for restricting Gcl 
activity to the posterior pole and that, by binding the gcl 3’UTR, Bru represses gcl translation 
in the ooplasm thus restricting the expression of Gcl protein [143]. Gcl exerts two different 
functions in PGC formation and maintenance: when PGCs form, Gcl activity controls 
centrosomal dynamics, which is essential for correct formation of the future germline [144]; 
additionally, Gcl acts to maintain the transcriptional quiescence of PGCs. Indeed, PGCs that 
lack Gcl activate transcription of several somatic genes [145]. 
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In conclusion, pole plasm assembly is crucial for posterior patterning and for establishing 
the future germline in Drosophila. Osk is the key factor involved in pole plasm assembly and 
most of the proteins and RNAs that accumulate at the posterior pole depend on the initial 
accumulation and activity of Osk protein. Even if we have accumulated considerable 
experimental information regarding Osk, the molecular mechanisms underlying its pole plasm 
inducing activity remains quite unclear. In this regard, it is interesting to note that many 
maternal mRNAs have been shown to localize at the posterior pole during oogenesis and early 
embryogenesis, and most of these localize either in an osk RNA- or Osk protein-dependent 
manner [146] [147]. Only recently it has been shown that Osk protein possesses an RNA-
binding activity. Further analysis of this feature might allow us to better understand the 
biological function of the germ plasm inducer Osk. 
 
1.7. Oskar associates with polyadenylated mRNAs in vivo 
It was recently demonstrated that Osk associates with polyadenylated mRNAs in 
Drosophila embryos. The first experimental evidence came from a work of Jeske and 
colleagues in 2015 [109]. In this study 0 to 2 hour old Drosophila embryos were subjected to 
an mRNA interactome capture strategy [148]. Using this experimental approach, wild-type 
embryos were irradiated with UV light, which induces the formation of covalent bonds between 
RNAs and proteins in direct contact. Lysates prepared from these embryos were incubated 
with magnetic beads coupled with oligo(dT) stretches that can anneal with the poly(A) tails of 
the mRNAs. In this way protein-mRNA complexes were purified and analyzed to identify 
protein factors associated with the transcriptome of the early embryo (Fig. 7A). Upon UV 
crosslinking and oligo(dT) capture, Osk protein, as well as the cytoplasmic poly(A)-binding 
protein (PABPC), a well-known RBP, was specifically recovered from the embryo lysates (Fig. 
7B). This experiment showed that Osk is able to associate with mRNAs in vivo, confirming in 
a physiological context the RNA-binding activity detected in vitro for the OSK domain [109]. 
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Figure 7. Oskar associates with polyadenylated mRNAs in vivo. (A). Interactome capture 
experimental workflow. 0 to 2 hour old Drosophila embryos are irradiated with UV light. After lysis, 
embryo extracts are incubated with magnetic beads conjugated to oligo(dT) stretches that anneal to the 
poly(A) tail of mRNAs. After stringent washing steps, the bound protein-mRNA complexes are eluted. 
(B). Western blot analysis of an interactome capture experiment on Drosophila embryos. Osk signal is 
specifically detected only after UV irradiation and oligo(dT) pull-down, as well as PABPC (used as a 
positive control). Actin, an abundant protein that does not bind RNA (used as a negative control), is not 
detected in the eluates. No Osk or PABPC signals are detected in the 2 negative control conditions: 
non-irradiated embryo extracts incubated with oligo(dT) beads and UV irradiated embryo extracts 
incubated with beads lacking oligo(dT) stretches. 
Adapted from [109]. 
Subsequently, in 2016 the association of Osk with mRNAs in 0 to 2 hour old embryos was 
confirmed by another research group. In this case, two different mRNA interactome capture 
methods were applied to identify on a proteome-wide level Drosophila RBPs. Among the 
numerous targets identified in that study was Osk protein [149]. 
Osk’s ability to bind polyadenylated RNAs in vivo suggests that the protein is a genuine 
RBP, even if it does not contain a canonical RBD. In this regard, several studies conducted in 
different biological contexts, in cell lines and in several organisms, indicated that proteins 
lacking canonical RBDs can bind RNAs in vivo [149] [150] [151] [152] [153] [154]. In the case 
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of Osk, RNA-binding might be crucial during pole plasm assembly. Osk might be involved in 
direct recruitment of some mRNAs to the posterior pole, it might regulate their translation, or it 
might be involved in regulating the stability of target transcripts. The identification of the 
transcripts bound by Osk in vivo and of the binding site(s) on the target mRNAs might provide 
useful information to understand the molecular mechanism by which Osk promotes pole plasm 
assembly and function. 
 
1.8. Methods for the study of protein-RNA interactions in vivo 
Gene expression processes can be regulated at different time points during the life of an 
mRNA, from transcription and processing in the nucleus, to translation and degradation in the 
cytoplasm. All the different steps and processes in the mRNA life cycle are precisely regulated 
by a large number of RBPs that dynamically associate with mRNAs at different locations in the 
cell [76]. 
A first step towards understanding the physiological role of a given RBP is the identification 
of the transcripts that are bound by the protein. Several methods both in vitro and in vivo are 
available as tools for answering this question. Although in vitro methodologies can provide 
useful information, techniques that allow the study of protein-RNA interactions in vivo are more 
informative. Indeed the ability to capture and detect an interaction that occurs in a specific 
biological context allows one to study protein-RNA interactions in their native physiological 
context. 
High throughput sequencing technologies have become more advanced and cheaper in 
the last twenty years [155]. These methods generate a large amount of information and have 
been used for studying different aspects of RNA biology. High throughput sequencing 
technologies have also been used to analyze protein-RNA interactions in vivo. It is possible 
with these methods to identify on a transcriptome-wide level the binding targets of a given 
RBP, and is possible to obtain positional information regarding where on the RNA the specific 
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interaction occurs [156]. Data produced in recent years have expanded our knowledge 
regarding numerous RBPs. Today we know that a specific factor within a cell can bind to a 
huge number of target mRNAs and regulate diverse aspects of their biology, ranging from 
nuclear events, such as splicing and transcriptional termination, to cytoplasmic events such as 
translation and decay. 
 
1.8.1. UV crosslinking of protein-RNA complexes 
The first experimental attempts to identify target mRNAs of a specific RBP were based on 
RNA immunoprecipitation (RIP) approaches. In this type of experiment, an RBP of interest 
bound to its target mRNAs was isolated using a specific antibody and the transcripts were 
identified by hybridization to a microarray (RIP-ChiP) [157]. The RIP-ChiP method presents 
several disadvantages. Indeed the method is prone to contaminations. Other proteins that can 
bind RNAs as well can co-precipitate with the RBP of interest, thus producing false positive 
results [158]. In addition, RNA targets might not reflect an in vivo association but might result 
from reassociation of the RBP with unspecific targets in the lysate. Furthermore, RIP-ChiP 
does not yield information regarding the binding site of the protein. 
In order to improve the specificity of these methodologies, protein-RNA crosslinking 
strategies were developed. Inducing the formation of covalent bonds between proteins and 
RNAs in vivo allows one to stabilize transient interactions that occur within a cell and facilitates 
the identification of the binding targets of RBPs in a physiological context. More than 30 years 
ago it was shown that UV light (from 250 to 270nm in wavelength) induces the formation of 
covalent bonds between proteins and RNAs. UV light is a zero-length crosslinking agent, and 
proteins and RNAs must be in direct contact in order to be crosslinked [159] [160]. These 
features make UV light the most useful crosslinking agent for protein-RNA interaction studies. 
Indeed, based on UV crosslinking, several methods have been developed for studying RBPs 
in vivo. 
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1.8.2. Transcriptome-wide approaches for studying protein-RNA 
interactions 
The first protocol that used UV crosslinking to identify the RNA targets of an RBP was 
developed in 2003 in the Darnell lab. The methodology is called crosslinking and 
immunoprecipitation (CLIP) and was successfully applied for the identification of RNAs bound 
by Nova protein in the mouse brain. In the protocol, protein-RNA complexes stabilized by UV 
light irradiation, are immunoprecipitated. The RNAs crosslinked to the protein of interest are 
extracted and reverse-transcribed, cDNAs are generated and amplified by polymerase chain 
reaction (PCR), and finally analyzed by Sanger sequencing [161]. In 2008, a new version of 
the protocol was developed to exploit next generation sequencing (NGS) technologies: the 
high throughput sequencing of RNA isolated by crosslinking and immunoprecipitation (HITS-
CLIP). In this method, RNA fragments crosslinked to the protein of interest are used as 
substrate for generating cDNA libraries suitable for NGS [162]. Coupling CLIP protocols with 
NGS allows one to generate a great amount of data that can be used to study protein-RNA 
interactions that occur in vivo, in detail on a transcriptome-wide level. Among the RBPs that 
have been studied by HITS-CLIP method there are: SRSF1, PTB, Fox2, Nova1, Nova2 and 
Argonaute 2 (Ago2) [163] [164] [165] [166] [167]. These methodologies also allow the 
identification of the binding site of the protein of interest on the target RNAs. This is achieved 
by analyzing deletions and mutations in the sequencing data. Indeed, it has been shown that 
the nucleotide(s) located at the sites of crosslinking are deleted or mutated during cDNA 
synthesis [156] [168]. 
CLIP methodologies use 254nm UV light to induce crosslinking. The crosslinking 
efficiency using this method is low, somewhere between 1% and 5% depending on the specific 
RBP [169]. In order to increase the efficiency of crosslinking, the Tuschl lab developed the 
photoactivable ribonucleoside-enhanced CLIP (PAR-CLIP) protocol. In this method cells are 
fed with the photoreactive nucleoside analog 4-thiouridine (4-SU) or 6-thioguanosine (6-SG), 
which are incorporated during transcription into RNA molecules. Upon 365nm UV light 
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irradiation, crosslinking events between proteins and RNAs occur; after immunoprecipitation 
of the RBP of interest, cDNA libraries are produced and subjected to NGS as described before. 
Is interesting to note that, upon crosslinking, the photoreactive nucleoside used in the PAR-
CLIP can lead to specific mutations in the cDNA that can later be used for the identification 
with high resolution of the binding site of a specific RBP. This method, which involves the use 
of nucleoside analogs and results in a higher crosslinking efficiency, allowing one to map the 
binding site of an RBP, is particularly suited to cell culture experiments. PAR-CLIP has been 
used to identify the RNA targets of several proteins including: Pumilio homologue 2 (PUM2), 
Quaking (QKI), the insulin-like growth factor 2 mRNA-binding protein 1-3 (IGF2BP1-3), Ago2, 
hnRNP LL and AU-rich element-binding factor 1 (AUF1) [156] [170] [171] [172] [173]. 
The finding that in CLIP experiments, reverse-transcription stops before the nucleotide 
crosslinked to the RBP, resulting in truncated cDNA libraries was the basis of a new CLIP 
methodology published in 2010. This method, developed in the Ule lab, is called individual 
nucleotide resolution CLIP (iCLIP) [174]. The iCLIP protocol will be described in detail in the 
following chapters. This methodology allows on one hand to identify on a transcriptome-wide 
level all the RNA targets of a specific RBP and in addition allows the identification of the binding 
sites on the target transcripts. In order to study RBP binding specificity and function in vivo, 
iCLIP represents one of the most powerful experimental approaches available so far. Several 
proteins have been studied by iCLIP including hnRNP C, T-cell intracellular antigen 1 (TIA1), 
TIA-like 1 (TIAL1), TAR DNA-binding protein 43 (TDP-43), hnRNP L, Aub, hnRNP A1 and 
Scaffold Attachment Factor B1 (SAFB1) [156] [174] [175] [176] [177] [178] [179] [180]. 
Crosslinking and immunoprecipitation strategies coupled with NGS are the state of the art 
methodologies available to study protein-RNA interactions in vivo. The successful application 
of these methods to the study of Osk-RNA interactions might allow to identify both the RNA 
interactome of Osk and the binding site(s) of the protein on its target transcripts. These 
information would allow me to investigate both the molecular mechanism and the physiological 
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relevance of Osk RNA-binding activity, in the context of pole plasm assembly during Drosophila 
development. 
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2. Aims of the project 
It was recently discovered that Osk protein associates with polyadenylated mRNAs in 
early Drosophila embryos (Fig. 7B) [109] [149]. Of the two globular domains harbored within 
Osk protein sequence, the C-terminal OSK domain shows RNA-binding activity in vitro [109]. 
Interestingly among the osk alleles that have been characterized over the years and that cause 
posterior patterning defects are two main classes of mutations: nonsense mutations harboring 
premature stop codons that lack the OSK domains, or missense point mutations that lie in the 
OSK domain itself [63] [114] [123]. Considering the RNA-binding activity of Osk, which most 
likely involves the C-terminal OSK domain, one can speculate that mutations that interfere with 
RNA binding strongly impair the biological function of Osk. 
The pole plasm inducing activity of Osk relies on its ability to recruit other factors, proteins 
and RNAs, that are required for both germ cell specification and posterior patterning. More 
than 20 years of studies have revealed that Osk colocalizes with several mRNAs in the pole 
plasm [146] [147]. In addition, the Long Osk protein isoform is required to ensure the correct 
posterior anchoring of osk mRNA [89]. However, we still lack experimental evidence of a direct 
interaction between Osk and any mRNA in the pole plasm. 
In order to understand in greater detail the molecular mechanism of action of Osk in vivo, 
it is important to identify which RNAs are directly bound by Osk and to study how and to what 
extent Osk RNA-binding activity affects its mRNA targets. The RNA-binding activity of Osk 
might underlie a possible regulatory function of different aspects of RNA biology, like 
localization and translational control, fundamental processes orchestrating pole plasm 
assembly and activity. 
In conclusion it is important to answer some key questions regarding the putative RNA-
binding activity of Osk protein in vivo: 
 Identify the Osk RNA bound interactome in vivo. 
 Identify Osk binding site(s) on its target RNAs. 
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 Generate transgenic flies harboring specific mutations in the target RNAs that 
interfere with Osk binding. 
 Analyze which biological aspects of the targets RNAs are controlled by Osk in vivo. 
 Study the physiological role of Osk RNA-binding activity in the context of posterior 
patterning and germ cell formation during early embryogenesis. 
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3. Results 
3.1. Oskar CLIP 
In order to identify the target mRNAs bound by Osk in vivo, I decided to apply the CLIP 
method [161] to study Osk-RNA interaction in Drosophila embryos. As described in the 
Introduction (Paragraph 1.8.1), UV light has been extensively used as a crosslinking agent for 
stabilizing protein-RNA interactions. UV light is a zero-length crosslinking agent that promotes 
the formation of covalent bonds between proteins and RNAs in direct contact [159] [160]. This 
feature is extremely useful for the identification of the direct RNA targets of an RBP because 
it reduces the likelihood of false positive results. These can be generated when using less 
stringent crosslinking procedures that allow covalent bond formation between the protein of 
interest and RNAs in close proximity even if not directly bound to one another. It has been 
shown that numerous mRNAs localize at the posterior pole of the Drosophila oocyte within the 
pole plasm where Osk protein accumulation occurs [146] [147]. It is therefore reasonable to 
speculate that some posteriorly localized mRNAs might be directly bound by Osk, while others 
might be indirectly recruited to the pole plasm by other factors. For this reason, UV crosslinking 
appeared to be the best strategy for capturing transient interactions between Osk and its target 
RNAs and avoiding capture of unspecific interactions that might merely reflect the 
accumulation of posteriorly localized mRNAs in the same subcellular compartment as Osk. 
A UV crosslinking protocol was previously established in our laboratory to perform 
interactome capture experiments on 0 to 2 hour old Drosophila embryos [154]. As previously 
discussed (Paragraph 1.7) this approach was used to identify proteins bound to 
polyadenylated mRNAs in vivo, and Osk was detected among the Drosophila’s RBPs (Fig. 7B) 
[109] [149]. 0 to 2 hour old embryos contain Osk protein and possess a functional pole plasm. 
Therefore this particular developmental stage represents a good starting point for trying to 
identify which mRNAs are bound by Osk in vivo. The first step required in order to perform an 
Osk CLIP experiment was to set up the conditions for a clean Osk immunoprecipitation (IP). 
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3.1.1. Optimization of Oskar Immunoprecipitation conditions 
During my first attempts to define optimal conditions for performing Osk IPs, I faced a 
major issue when trying to prepare embryo extracts under physiological conditions: after the 
centrifugation step necessary to remove debris and other particulate material from the soluble 
fraction, Osk protein was almost entirely present in the pellet fraction, rendering it inaccessible 
to IP (data not shown). This is most likely due to the fact that Osk is present in heavy RNPs 
that tend to sediment with the pellet fraction when lysates are prepared using conditions that 
do not promote RNP solubilization. 
The lysis conditions used in the interactome capture method were stringent enough to 
allow the recovery of a good amount of Osk protein in the soluble fraction (Fig. 7B). Indeed, 
this lysis buffer contains high salt (500mM LiCl) and high detergent (0.5% LiDS) concentrations 
[109] [148]. I used these conditions as a starting point for the Osk IP protocol optimization. 
Initially I tested several anti-Osk antibodies available in the lab and found that only a rabbit 
polyclonal antibody directed against the C-terminal half of Osk protein worked in the IPs [89]. 
By using this specific antibody and the lysis conditions from the interactome capture protocol, 
it was possible to IP Osk from embryo extracts, although the amount of protein recovered was 
low (Fig. 8). I tested several conditions, changing types and amounts of detergents in the lysis 
buffer, trying to find conditions that would yield the highest amount of Osk protein in solution, 
while allowing good antigen-antibody interaction. In this regard the addition of sodium 
deoxycholate (Na deoxycholate) to the embryo lysates (after preparation of the extracts) 
strongly improved the amount of protein collected in the IP. This was very striking in the case 
of the Long Osk isoform: indeed, Long Osk was barely detectable in the input and IP samples 
in the absence of Na deoxycholate, but was strongly enriched after addition of the detergent. 
The protocol was tested on both UV crosslinked and non-crosslinked extracts; this revealed 
that the treatment did not interfere with protein recovery (Fig. 8). 
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Figure 8: Comparison of Oskar IP conditions in presence or absence of Na 
deoxycholate. Drosophila embryos collected between 0 and 2 hours after egg laying were either 
treated (UV +) or not (UV -) with UV light before lysis. The extracts were diluted using lysis buffer 
containing (Na deoxycholate +) or not (Na deoxycholate -) 0.5% Na deoxycholate and subsequently 
incubated with protein G sepharose beads conjugated with an anti-Osk antibody (α-Oskar +) or no 
antibody (α-Oskar -). After washings, proteins were eluted in 2X NuPage LDS sample buffer and 
analyzed on western blot for: Osk, Vas and α-Tubulin. Lane 1: non-crosslinked input. Lane 6: UV 
crosslinked input. 
The IP conditions I established are stringent enough to avoid the co-IP of Vas, a well-
known interacting partner of Osk in vivo [113] [115] and α-Tubulin, a highly abundant protein. 
Vas is an RNA helicase and as such might represent a source of contamination in the CLIP 
experiment. No Vas signal was detected in either the UV crosslinked or non-crosslinked IP 
samples, confirming the stringency of the conditions used for the IP. For these experiments, a 
large amount of starting material was involved: indeed, for each sample I used 5ml of embryo 
lysate prepared from 0.5g of 0 to 2 hour old embryos. 
The possibility to IP Osk from embryo extracts in a clean manner represented a good 
starting point for the identification of RNAs bound in vivo using CLIP based methodologies. 
The fact that using Na deoxycholate increased Osk IP efficiency is interesting, as this particular 
detergent is used for solubilizing and isolating membrane associated proteins [181]. It has 
been reported that Long Osk associates with endosomes and other membranous structures 
within the pole plasm, and that Long Osk is involved in anchoring Short Osk to the posterior 
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pole of the oocyte [89]. In this regard Na deoxycholate, by solubilizing membranes, might help 
get Osk protein into solution, making it more accessible to antibodies in the IP. 
 
3.1.2. Oskar associates with nos, pgc and gcl mRNAs in vivo 
In order to identify RNAs bound by Osk in vivo, I adapted the CLIP method to Drosophila 
early embryos. In this experiment 0 to 2 hour old wild-type embryos were irradiated with UV 
light (254nm); as a control I used embryos that were not UV irradiated. After lysis and 
clarification of the lysates, 5ml of embryo extract (prepared from 0.5g of embryos) were 
incubated with beads conjugated with a specific anti-Osk antibody. After stringent washing 
steps, the proteins retained on the beads were digested by proteinase K, the RNAs extracted, 
reverse-transcribed and analyzed by quantitative real-time PCR (qPCR) (Fig. 9A). For both the 
UV crosslinked and non-crosslinked Osk IP, I performed a parallel IP in which I omitted the 
anti-Osk antibody (beads-only). The beads-only condition would allow me to measure 
background levels of RNA that co-IP with the beads in both UV crosslinked and non-
crosslinked conditions. 
Since Osk protein is produced and accumulates exclusively at the posterior pole, I 
hypothesized that Osk binding targets might include known posteriorly localized mRNAs. 
Therefore I took a candidate approach and tested the samples for enrichment of a set of 
mRNAs by performing qPCR analysis. I chose 7 posteriorly localized mRNAs: nos, orb, cycB, 
pgc, gcl, osk and Heat-shock protein 83 (Hsp83) mRNAs. As negative controls, I chose bcd, 
an anterior localized mRNA, and Actin42A (Act42A) mRNA, which is evenly distributed in the 
embryo [146] (Fig. 9B). Among the posteriorly localized mRNAs chosen as candidate targets, 
several genetic studies have shown that nos, cycB, pgc, gcl, osk and Hsp83 are dependent on 
Osk function for their localization at the posterior pole of the oocyte and embryo [49] [89] [137] 
[141] [182] [183]. 
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The results of the experiment are shown in Figure 9B. For each target mRNA tested, the 
level of enrichment in the Osk IP samples was normalized with respect to that of the beads-
only controls, in which the specific anti-Osk antibody was omitted. Among the mRNAs tested, 
I detected a significant UV- and Osk-dependent enrichment of nos, pgc and gcl mRNAs. The 
other posteriorly localized mRNAs, orb, cycB, osk and Hsp83, as well as the bcd and Act42A 
control mRNAs, were not significantly enriched upon UV crosslinking (Fig. 9B). 
 
Figure 9: Oskar associates with nos, pgc and gcl mRNAs in vivo. (A). Schematic 
representation of the Osk CLIP experimental procedure. Lysates are prepared from 0 to 2 hour old 
Drosophila embryos treated with UV light and Osk IP is performed. After stringent washing steps the 
proteins are digested by proteinase K treatment and RNAs are extracted. After reverse-transcription the 
cDNAs are analyzed by qPCR. (B). Enrichment levels of a set of mRNAs posteriorly localized in 
Drosophila embryos: nos, orb, cycB, pgc, gcl, Hsp83. bcd, an anteriorly localized mRNA and Act42A, 
an evenly distributed mRNA, were used as negative controls. For both UV crosslinked (UV +) and non-
crosslinked (UV -) conditions the enrichment levels in the Osk IP samples (α-Oskar +) were normalized 
respect to those in control samples in which the anti-Osk antibody was omitted (α-Oskar -). Bars 
54 
 
represent mean values ± standard deviation. p values were calculated using Student’s t test. (C). 
Western blot analysis of the Osk CLIP experiment. Proteins were eluted from 1% of the beads used in 
2X NuPage LDS sample buffer and analyzed on western blot for: Osk, Vas, α-Tubulin and Smg. (D). 
Relative expression levels of the mRNAs tested in B measured in the input embryo extracts. For the 
different transcripts the levels were normalized with respect to Actin42A mRNA. Bars represent mean 
values ± standard deviation. 
Adapted from [109]. 
The stringency of the conditions used in the IP prevented the co-IP of known RBPs such 
as Vas and Smg (Fig. 9C). Both proteins co-purify with Osk under physiological conditions and 
could have been a source of contamination in the experiment due to their RNA-binding activity 
[60] [113] [115]. In addition, I analyzed the relative expression level of each candidate mRNA 
in the input material, normalizing its amount with respect to the housekeeping Actin42A mRNA. 
This allowed me to compare the relative abundance of each transcript in the inputs with the 
enrichment measured for each of them in the CLIP experiment (Fig. 9D). This analysis showed 
that there was no correlation between the relative abundance of the mRNAs in the input and 
their enrichment in the CLIP. Altogether these data revealed that endogenous Osk protein 
associates with nos, pgc and gcl mRNAs in Drosophila early embryos [109]. 
The three mRNAs that were specifically enriched after Osk CLIP, nos, pgc and gcl, are 
involved in germline specification. As previously mentioned, in addition to encoding the 
abdominal determinant of the fly, nos mRNA is also required for germ cell specification. 
Specifically, Nos activity is required in PGCs, where it blocks mitosis and silences zygotic gene 
expression before the PGCs colonize the future gonads of the animal [48] [133] [134] [135] 
[136]. pgc and gcl gene products are required for proper germ cell formation in Drosophila 
[137] [138] [141]. Proteins produced by both genes were shown to be involved in transcriptional 
repression in PGCs, which is required to prevent their premature differentiation prior to 
reaching the somatic portion of the gonads in the early embryo [138] [145]. The molecular 
function of the three mRNAs identified in the Osk CLIP experiment is in line with the molecular 
function of Osk. Osk is required for both abdomen and germline formation and consistent with 
this function it can be UV crosslinked in vivo with mRNAs required for such biological functions. 
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In addition, it has been shown that all three mRNAs (nos, pgc and gcl mRNAs) require Osk 
activity for their accumulation at the posterior pole [49] [137] [141] and that Osk activity is 
required for translational activation of nos mRNA [59] [60]. In contrast, cycB, osk and Hsp83 
mRNAs, which accumulate at the posterior in an Osk-dependent manner [89] [182] [183], did 
not associate with Osk. Similarly, orb mRNA, whose posterior localization in the oocyte is osk-
independent (embryo data not available) [184] [185], was not enriched in the IPs (Fig. 9B).  
Altogether these data indicate that Osk binds nos, pgc and gcl transcripts in vivo. Although 
the ability to detect these three particular mRNAs in Osk CLIP experiments could be explained 
by their localization in the same subcellular compartment as Osk, this seems unlikely as other 
posteriorly localized mRNAs were not UV crosslinked to Osk. These experiments suggest that, 
within the crowded pole plasm, Osk associates specifically with mRNAs required for abdomen 
and germline formation, and not with other pole plasm mRNAs.  
It is possible that Osk might interact with additional mRNAs not tested in the experiment. 
Furthermore, Osk might be involved in regulating some of its target mRNAs, for instance 
promoting their translation or their posterior accumulation. By using a transcriptome-wide 
unbiased approach it would be possible to identify all the binding targets of Osk in vivo and in 
addition the binding site(s) of the protein on the target transcripts. This information would allow 
me to design perturbation experiments to address the biological significance of Osk RNA-
binding activity in vivo. 
 
3.2. Oskar iCLIP 
To identify and analyze in an unbiased manner the Osk RNA interactome in vivo I chose 
to apply the iCLIP methodology. As previously mentioned, iCLIP allows one to identify all the 
target mRNAs of a given RBP on a transcriptome-wide level and, additionally, yields 
information regarding the specific sites to which the protein of interest is bound [174]. In 
particular, the identification of the precise sequences or structures in target RNAs to which Osk 
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binds, would guide the design of site-specific mutations that would allow me to test whether 
Osk is a genuine RBP, as well as mechanistic analyses regarding the role of Osk RNA-binding 
activity in e.g. localization, translation and stability of the target mRNAs. 
 
3.2.1.  Overview of the Oskar iCLIP protocol 
The iCLIP protocol consists of the following sequence of complex biochemical reactions 
[186]. 
 in vivo UV crosslinking 
The iCLIP method relies on the ability to induce the formation of covalent bonds between 
proteins and RNAs upon UV light irradiation [159] [160]. I identified nos, pgc and gcl as Osk 
associated mRNAs in CLIP experiments performed on UV irradiated Drosophila embryos 
collected between 0 to 2 hours after egg laying (Fig. 9). For this reason I decided to perform 
the Osk iCLIP experiment using the same approach (Fig. 10, steps 1 and 2). 
 Osk IP 
The next step of the iCLIP protocol consists of the immunoprecipitation of Osk using a 
specific anti-Osk antibody (Fig. 10, step 3). Osk-RNA complexes are purified using the same 
conditions developed for the previously described Osk CLIP experiment (Fig. 9). The 
stringency of the IP protocol I developed prevents co-IP of known RBPs that interact with Osk 
such as Vas and Smg (Fig. 9C). 
 Partial RNA digestion 
A partial RNase I-mediated digestion step is performed to reduce the length of crosslinked 
RNAs, ideally in the range between 50 and 300 nucleotides (Fig. 10, step 4). 
 3’ end dephosphorylation 
After the RNase treatment, a residual phosphate group at the 3’ end of the RNA fragments 
must be removed, as L3App adapter ligation requires that the RNA substrates bear a terminal 
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3'-OH group. The dephosphorylation step is catalyzed by polynucleotide kinase (PNK) (Fig. 
10, step 5). 
 L3App adapter ligation 
A short (22 nucleotide long) DNA adapter (L3App adapter) is ligated at the 3’ end of the 
RNA fragments in a reaction catalyzed by a truncated version of T4 RNA ligase (T4 RNA ligase 
2 truncated) (Fig. 10, step 6). The L3App adapter bears two nucleotide modifications. At the 5’ 
end the adapter is pre-adenylated. Since T4 RNA ligase 2 truncated enzyme cannot catalyze 
the adenylation step required for the ligation [187], pre-adenylated L3App adapters are used 
as ligation substrates. A second modification at the 3’ end of the L3App adapter bears a 
dideoxycytidine nucleotide that lacks a 3’-OH group. This feature prevents the ligation of 
multiple adapters on the same RNA molecule. 
 RNA-L3App extraction 
After L3App adapter ligation, the RNPs are treated with proteinase K to remove the protein 
components (Fig. 10, step 7), and RNA-L3App products are extracted (Fig 10, step 8). It is 
important to note that proteinase K digestion always leaves a short peptide at the UV 
crosslinking site [188]. 
 Reverse-transcription 
Extracted RNAs are reverse-transcribed using primers complementary to the L3App 
adapter sequence (Fig. 10, step 9). The primers also contain short barcodes that allow one to 
distinguish the products of the different experimental conditions. The residual peptides 
attached to RNAs act as road blocks for enzymes (such as reverse-transcriptases) that move 
processively on the RNA templates. Consequently, cDNA synthesis stops one nucleotide 
before the site of protein crosslinking in the vast majority of the cases and this feature allows 
one to map the binding site of an RBP on its target transcript [174] [188]. 
 Circularization 
cDNA fragments are circularized by using a specific single stranded DNA ligase 
(CircLigase II) (Fig. 10, step 10). 
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 Linearization 
Following circularization, cDNAs are re-linearized using a DNA oligo that contains a 
BamHI cleavable site (Fig. 10, step 11). 
 PCR amplification and sequencing 
The resulting linear cDNAs are amplified by PCR to obtain libraries suitable for high 
throughput Solexa sequencing (Fig. 10, step 12). In the reads, the first nucleotide sequenced 
after the experiment-specific barcode corresponds to the nucleotide that precedes a UV 
crosslink on the RNA (Fig. 10), allowing one to identify with precision the site where an RBP is 
bound to the target RNA [174] [186].  
 Final considerations 
A revised and simplified version of the iCLIP method originally developed by Dr. Julian 
Konig (Institute of Molecular Biology, Mainz), was recently established and applied with 
success in our laboratory by Dr. Ales Obrdlik (unpublished data). The major differences 
between the two iCLIP protocols lie in the procedure for size selection during library 
preparation.  
In the classical iCLIP method, after L3App adapter ligation (Fig. 10, step 6), the RNA 
components of the RNP complexes are labeled with radioactive phosphate groups, separated 
on a polyacrylamide gel and blotted onto a nitrocellulose membrane. The radioactive signal 
allows one to detect the protein crosslinked to RNA fragments and cut out the portion of 
membrane bearing those of the desired length (between 50 and 300 nucleotides). These 
fragments are extracted and used as substrates for reverse-transcription. An additional 
extraction step is performed after reverse-transcription to select cDNA fragments of the desired 
size to be PCR amplified [186]. 
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Figure 10: Oskar iCLIP protocol overview. After UV crosslinking of Drosophila embryos, Osk protein 
is immunoprecipitated using anti-Osk specific antibodies. After stringent washing steps, a partial RNase 
I-mediated digestion is performed and a DNA adapter (L3App adapter) is ligated at the 3’ end of the 
RNA fragments covalently bound to the protein. Proteins are digested with proteinase K and RNAs 
extracted. The recovered RNAs are reverse-transcribed (R.T.), circularized, and then re-linearized by 
hybridizing with a DNA oligo encoding a BamHI recognition and cleavable site. Linear cDNA fragments 
are amplified by PCR. The obtained libraries are analyzed via Illumina sequencing. 
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In the protocol that was established in our lab, these extractions steps are omitted thus 
shortening considerably the duration of the experiment. Size selection of cDNA libraries is 
performed at the very end of the protocol: after PCR amplification, the libraries are run on a 
4% agarose gel and DNA fragments of the desired size are extracted and purified prior to 
sequencing. Considering the simplifications introduced in the iCLIP protocol by Dr. Obrdlik and 
the opportunity that I had to take advantage of his experience, I decided to apply the iCLIP 
method developed in our laboratory for studying Osk-RNA interaction in vivo. 
 
3.2.2. Oskar iCLIP preparative experiments 
The first step before starting with the library preparation process was to check the amount 
and quality of RNAs extracted after Osk CLIP. The experiment consisted of four samples. For 
both UV crosslinked and non-crosslinked conditions I performed an Osk-specific IP and a 
beads-only control without the anti-Osk antibody. The beads-only conditions would allow me 
to control for RNA stickiness to the matrix used in the experiment (protein G sepharose). The 
non-crosslinked Osk IP would allow me to control for RNAs that co-precipitate with Osk in 
absence of crosslinking, while the UV crosslinked Osk IP would allow me to measure which 
RNA species, upon UV light irradiation, are enriched compared to the control conditions. 
I performed the experimental procedure described in Figure 9A. To analyze the quality of 
the extracted material, after extraction and heat denaturation (70⁰C for 2’), I analyzed the RNAs 
on an Agilent Bioanalyzer 2100 instrument (Fig. 11). The profile of total RNA extracted from 
non-crosslinked and UV crosslinked embryo extracts respectively is shown in Figure 11 
(panels A and B). The two major peaks, which cluster at around 2000 nucleotides, represent 
18S and 28S ribosomal RNAs (rRNA). 
The profiles of the RNAs present in the input samples (Fig. 11A and B) appear different 
from total RNA extracted from other eukaryotic organisms, for instance human cell lines. In the 
latter, 18S rRNA migrates around 2000 nucleotides while 28S rRNA migrates around 4000 
61 
 
nucleotides. In Drosophila and in other insect species, the 28S rRNA is processed into two 
fragments of a size similar to that of 18S rRNA [189] [190]. Knowing this intrinsic feature of 
insect rRNAs allowed me to judge the quality of the total RNA extracted from the input material: 
in both cases (non-crosslinked and UV crosslinked), the overall quality of the RNA looked 
acceptable, with no evident signs of degradation (Fig. 11A and B). Therefore I considered that 
the protein-RNA complexes in the input material were protected from degradation, and that the 
extract preparation procedure was suitable for an Osk iCLIP experiment. 
 
Figure 11: Bioanalyzer profiles of RNA extracted from an Oskar CLIP experiment. (A and 
B). Total RNA extracted from non-crosslinked and UV crosslinked input embryo extracts. For both 
conditions 5ng of total RNA were loaded into the machine. The asterisks (*) indicate the 18S and 28S 
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rRNA species. (C, D, E and F). Total RNA extracted from: non-crosslinked beads-only, UV crosslinked 
beads-only, non-crosslinked Osk IP and UV crosslinked Osk IP samples respectively. After extraction, 
RNA pellets were resuspended in 10μl of H2O, 1μl has been loaded into the machine. On the Y axis, 
FU represents arbitrary fluorescent units measured by the instrument; on the X axis all samples were 
aligned respect to an RNA ladder (nt: nucleotides). 
I also analyzed the quality of RNA in the three Osk iCLIP experimental controls (Fig. 11C, 
D and E): non-crosslinked beads-only, UV crosslinked beads-only, and non-crosslinked Osk 
IP. All three samples from the controls appeared extremely clean: little or no rRNA was 
detected, nor were other RNA species (Fig. 11C, D and E). In contrast, the profile of RNA 
extracted under the UV crosslinked Osk IP condition showed a slight enrichment for RNA 
species ranging from 1500 to more than 4000 nucleotides in length (Fig. 11F). According to 
the measurements of the Bioanalyzer instrument, the amount of RNA recovered after Osk IP 
from extracts of UV crosslinked embryos, was ~1ng, approximately 10 times more than what 
was recovered in the three controls. 
The analysis of these results revealed both positive and negative aspects of the 
experiment. Among the positive aspects was the good quality of the input material, which 
showed no sign of RNA degradation. Also the cleanliness of the three control conditions 
represented a promising aspect of the experiment, as less background signal would help the 
identification of the binding targets of Osk. Of great concern, however, was the very small 
amount of RNA recovered after Osk IP from UV crosslinked embryo extracts, as iCLIP library 
preparation from ~1ng of total RNA is considered sub-optimal and at the limit of feasibility. I 
therefore attempted to scale up the IP protocol by a factor of 10. This, on one hand, helped to 
increase the amount of RNA recovered, but on the other hand increased the rRNA 
contamination in all four experimental conditions (data not shown). Therefore, all things 
considered, especially the reproducible enrichment of nos, pgc and gcl mRNAs I had measured 
by qPCR in my Osk CLIP pilot experiments (Fig. 9), and considering the high sensitivity of 
NGS detection methods that might circumvent the limitations of the experimental setup, I 
decided to apply those conditions and proceed to Osk iCLIP library preparation, in spite of the 
small amount of RNA in my samples.  
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A critical step in the preparation of iCLIP libraries is the definition of optimal conditions for 
the RNase I digestion step. As mentioned in the Paragraph 3.2.1, this is done by radioactive 
labeling of protein-RNA complexes following the IP and RNase digestion steps [186] [191]. 
Since the iCLIP protocol established in the lab does not include performing this step during the 
library preparation, it was important to include a preparative experiment to determine the 
amount of RNase needed to produce RNA fragments of the desired length. 
In this preparative experiment, I performed the Osk IP as previously described, on both 
UV crosslinked and non-crosslinked conditions. At the end of the IP, the beads were 
resuspended in 1ml of Washing Buffer 3 (see Materials and Methods), and 10μl of RNase I at 
increasing dilutions were added to different Osk IPs from UV crosslinked extracts. Samples 
were incubated 3’ at 37⁰C followed by three additional washing steps. Then protein-RNA 
complexes were labeled by PNK-mediated addition of radioactive 32P containing phosphate 
groups at the 5’ end of RNA fragments, separated by sodium dodecyl sulfate - polyacrylamide 
gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane. The 
membrane was first exposed to a phosphor imaging plate and subsequently used for Osk 
protein detection by western blot (Fig. 12). A particular pattern of radioactive signal was 
expected as a consequence of the decreasing RNase I amounts used in the experiment. When 
high concentrations of RNase I are used, RNA fragments crosslinked to Osk should be short 
and most of the radioactivity should concentrate at the same position as the protein, thus 
overlapping with the Osk signal on the western blot. Decreasing concentrations of RNase I 
result in spreading of the radioactive signal toward the upper part of the membrane, reflecting 
the increasing length of RNAs attached to Osk. 
Figure 12 shows the result of such an experiment. Comparison of the radioactive signal 
and the Osk protein signal on the western blot shows that, in the absence of UV crosslinking, 
Osk was not radioactively labeled (lanes 4 and 5). Conversely a faint radioactive signal that 
overlaps perfectly with Osk is detected in a crosslinking-dependent manner (lanes 8, 9, 10, 11 
and 12). In all 5 lanes, most of the radioactive signal is equally detected in the upper part of 
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the membrane, above the faint band overlapping with Osk, regardless of the amount of RNase 
I used in the assay (Fig. 12). This is unfortunately due to the incompatibility of RNase I with 
the Washing Buffer 3: in this buffer the activity of the enzyme was completely blocked. 
Nevertheless, the UV-dependent labeling of Osk suggested that the protein can be crosslinked 
to RNAs in vivo. I repeated this experiment several times using an RNase I compatible buffer, 
yet I was never able to detect radioactively labeled Osk-RNA complexes and as a 
consequence I was not able to identify the exact amount of RNase I to be used for achieving 
the partial RNA digestion required for iCLIP library preparation. 
 
Figure 12: Oskar IP and radioactive-dependent detection of Oskar-RNA complexes. Osk 
IP (α-Oskar +) was performed using extracts prepared from 0 to 2 hour old embryos either UV irradiated 
(UV +) or not (UV -). For both conditions a parallel IP omitting the anti-Osk antibody (α-Oskar -) has 
been performed. At the end of the IP, beads were resuspended in 1ml of Washing Buffer 3 and 10μl of 
RNase I (RNase +) at different dilutions were added. For samples 3, 5, 7 and 8 a 1:50 dilution was used, 
for samples 9, 10 and 11 1:500, 1:1000 and 1:2000 dilutions were added, respectively. Samples were 
incubated for 3’ at 37⁰C. In parallel the same samples were incubated without RNase I (RNase I -). RNA 
fragments were labeled with radioactive phosphate groups in a PNK-mediated reaction. Protein-RNA 
complexes were separated by SDS-PAGE and transferred to nitrocellulose membrane. The membrane 
was exposed to a phosphor imaging plate and subsequently analyzed by western blot for: Osk, Vas and 
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α-Tubulin. (*) IgG light chain. (**) RiboLock RNase inhibitor. (***) PNK. The red arrow indicates 
radioactively labeled Osk protein. 
The inability to reproducibly detect Osk-RNA complexes using the RNA labeling assay 
prevented me from defining the conditions to be used for the partial RNase I-mediated 
digestion in the iCLIP protocol. In addition, these negative results led me to question the ability 
of Osk to bind RNAs in vivo. Nevertheless, the results I had reproducibly obtained from the 
Osk CLIP experiment (Fig. 9) convinced me to attempt iCLIP library preparation. 
As a last preparatory experiment, I checked the stability of the interaction between Osk 
and the anti-Osk antibody throughout the entire protocol, up to RNA extraction. Indeed, it was 
possible that the different enzymatic reactions that have to be performed directly on beads, in 
the presence of relatively high concentrations of dithiothreitol (DTT) (10mM), polyethylene 
glycol (PEG) 400 (20%) and at relatively high temperature (37°C) [186], might interfere with 
the antigen-antibody interaction. By western blot analysis I showed that the Osk protein is 
retained on the beads until the end of the protocol (data not shown). 
 
3.2.3. Oskar iCLIP libraries preparation 
Knowing that the experimental conditions that I set up for the Osk CLIP (Fig. 9) work 
throughout the different steps of the iCLIP method, I proceeded to perform the entire Osk iCLIP 
experiment. As I was not able to identify the optimal RNase I amount required for correct 
trimming of RNA fragments crosslinked to Osk, I prepared libraries from samples treated with 
different RNase I concentrations. I was able to generate Osk iCLIP libraries by using an RNase 
I amount of 1*10-3U/μl. Figure 13 shows the results of the Osk iCLIP library preparation and 
analysis. 
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Figure 13: Oskar iCLIP libraries preparation. (A). 0 to 2 hour old embryos were either UV 
irradiated (UV +) or not (UV -) before lysis and extract preparation. For both conditions, an Osk specific 
IP (α-Oskar +) and a parallel IP omitting the anti-Osk antibody (α-Oskar -) were performed. After 
stringent washing steps 1% of the beads were subjected to protein elution. Protein samples were 
separated by SDS-PAGE and analyzed by western blot for: Osk, Vas and α-Tubulin. (B). iCLIP libraries 
prepared for all four experimental conditions were PCR amplified and analyzed on a 6% polyacrylamide 
native gel in TBE buffer. L: DNA ladder (C). iCLIP libraries amplified with 38 PCR cycles in B (lanes: 3, 
6, 9 and 12) were separated on a 4% agarose gel for extraction. L: DNA ladder (D). Bioanalyzer profiles 
of the PCR fragments extracted from C. L: DNA ladder. 
As previously described, at the end of the iCLIP protocol the cDNA libraries are amplified 
by PCR using specific primers that allow insertion of specific sequences required for Illumina 
sequencing. In order to assess the quality of the libraries, the PCR products were separated 
on a 6% native polyacrylamide gel. Panel B in Figure 13 shows the test PCR for the four 
experimental samples, each amplified using different PCR cycles (28, 33 and 38). A single 
sharp band migrating around 150 base pair (bp) (precisely 127bp) is present in all samples. In 
the two beads-only samples, the band is already detectable at 28 PCR cycles (Fig. 13B, lanes 
1, 2, 3, 7, 8, and 9) while in the two Osk IPs it starts to accumulate at 33 cycles (Fig. 13B, lanes 
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4, 5, 6, 10, 11 and 12). This band is produced by the unligated L3App adapter, as a 
consequence of the high amount of the oligo used during the ligation step (60 pmoles) that is 
not completely removed before RNA extraction. This product is commonly present in the 
libraries prepared using Dr. Obrdlik’s protocol and does not represent a major contamination, 
as it can be easily removed by gel extraction. An additional band can be detected in all samples 
running slightly above the 200bp band of the DNA ladder, starting from 33 PCR cycles in the 
beads-only samples (Fig. 13B, lanes 2, 3, 8 and 9) and from 38 cycles in the Osk IP samples 
(Fig. 13B, lanes 6 and 12). It is possible that this band is the result of multiple ligation events 
between different L3App adapter molecules. Although unlikely, this might happen when high 
amounts of free adapter molecules during the ligation step are present together with very small 
amounts of RNA substrate. This is likely to occur, especially in the three control samples, from 
which only a very low amount of RNA can be extracted (Fig. 11C, D and E), but it might also 
apply to the UV crosslinked Osk IP sample (Fig. 11F). Indeed, not all the L3App adapter 
molecules contain the two modifications described in the Paragraph 3.2.1: only 20% of them 
according to information provided by the manufacturer. As a consequence, those oligo that 
harbor a pre-adenylated 5’ end and do not contain a dideoxycytidine at the 3’ end might form 
concatamers as result of multiple ligation events. 
Interestingly, in the UV crosslinked Osk IP sample, after 38 PCR cycles one can detect a 
smeary signal starting above the band produced by the L3App adapter alone, up to the 400bp 
band of the DNA ladder (Fig. 13B, lane 12). This particular signal is absent in the control 
samples, possibly indicating the existence of cDNA produced from RNA fragments crosslinked 
to Osk. Even if this finding represented a positive indication that the experiment might be 
working, some major issues arose from the analysis of the experiment. 
The first concern regards the libraries produced from the control samples, which showed 
considerable background, putting the entire experiment at risk. The second problem was the 
high number of cycles required for the library amplification (38); this indicates that the starting 
amount of RNA was very low and therefore that the libraries were likely to be strongly PCR 
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biased, in other words, that many reads from the sequencing would be PCR duplicates 
generated by over-amplification of the same substrate. The third issue concerned the band 
running around 200bp. In principle, all the fragments running above the 127bp free adapter 
band might be the result of ligation of the L3App adapter to RNA fragments, and thus might be 
informative. The 127bp band can be removed during gel extraction and the rest of the library 
could be sequenced. But the presence of material corresponding to the second, 200bp band, 
which represented a ligation artifact, would most likely overload the sequencing instrument and 
reduce the number of reads from other fragments. 
In order to perform a deeper analysis of the libraries, I decide to proceed with gel extraction 
of the material. The PCR products were separated on a 4% agarose gel, so I cut out the PCR 
products running above the 127bp product, up to the 200bp band of the DNA ladder. It is 
interesting to see how differently the same libraries run on different gels (Fig. 13C). After 
extraction, the libraries were analyzed on an Agilent Bioanalyzer 2100 instrument that allows 
the quantification of the size of the products with high accuracy (Fig. 13D). From the 
Bioanalyzer traces, one can see that, in the three control samples, the average size of 
fragments was roughly 200bp (Fig. 13D, lanes 1, 2 and 3). In the UV crosslinked Osk IP 
sample, the average size of the library was ~230bp (Fig. 13D, lane 4). The difference in size 
of the libraries might reflect the presence of genuine ligation products in the UV crosslinked 
Osk IP condition that were absent in the controls. To understand the content of the libraries 
generated in the Osk iCLIP experiment, I decided to proceed with their sequencing. Although 
the quality of the libraries was clearly suboptimal, the sequencing would at least allow me to 
determine whether the three mRNAs I identified in the Osk CLIP using the candidate approach 
were present, which would constitute a starting point to further improve the protocol. 
 
3.2.4. Oskar iCLIP libraries analysis 
The four Osk iCLIP libraries were sequenced on a MySeq Illumina platform (single-end 
sequencing). First, I demultiplexed the raw data to separate the reads generated under the 
69 
 
different experimental conditions [192]. Each library contained between 3 and 4 million reads. 
I aligned the data against Drosophila genome using the TopHat2 tool [193], and PCR 
duplicates were removed [194]. Only a minor portion (~0.01%) of the reads was mapped to 
the Drosophila genome and all the reads mapped to two rRNA clusters on chromosomes 2 
and X. The great majority of the reads in all four conditions (~99.99%) contained sequences 
from the L3App adapter and PCR primers used for the final amplification of the libraries. These 
data suggest that the bands extracted from the four different experimental conditions most 
likely represent undesired products generated during preparation of the libraries. I was not able 
to confirm any of the target mRNAs identified in the candidate approach among the reads from 
any of the iCLIP samples prepared under any of the conditions; indeed no reads could be 
mapped to nos, pgc or gcl mRNAs. The analysis of the libraries showed a high level of PCR 
duplication, higher than 95% in all four conditions; this drastically reduced the number of unique 
mappable reads, to between 20 and 40 in each of the four libraries. 
These data confirmed that the Osk iCLIP experiment was not successful. The iCLIP 
method is one of the gold standard experimental approaches for studying protein-RNA 
interactions. Several explanations for the outcome of the experiment could be envisioned. One 
might be that Osk is simply not an RBP, and that the enrichment of nos, pgc and gcl mRNAs 
measured in the Osk CLIP experiment (Fig. 9) was due to the co-IP of other RBPs together 
with Osk. Even if, by western blot analysis, the stringent washing conditions of the method 
destroyed the interaction of Osk with Vas and Smg, I cannot exclude that the interaction of 
Osk with other RBPs was similarly affected. Alternatively, it is possible that although present 
in residual amounts below the sensitivity threshold of western blot detection, some Vas and 
Smg crosslinked to their target RNAs might have co-IPed with Osk. 
 
3.3. Oskar CLIP from denatured embryo extracts 
If Osk is not a genuine RBP, then the UV-dependent enrichment of nos, pgc and gcl upon 
Osk IP might be due to residual interactions of Osk with some proteins that directly contact 
70 
 
these mRNAs. To see if this might be the case, I sought to increase the stringency of the Osk 
IP protocol and established a method for Osk IP from denatured embryo extracts. This protocol 
consists of lysing 0 to 2 hour old embryos, UV irradiated or not, in a buffer containing 8M urea. 
After lysis, the extracts are diluted 10 fold, to reduce the urea concentration to 0.8M. 
Afterwards, an Osk specific IP is performed overnight (16 hours) at 8⁰C. A 0.8M concentration 
of urea and high salt and detergent concentrations are maintained during the first washing 
steps after the IP. The denaturing conditions used during embryo lysis should denature Osk 
and thus prevent its association with factors that might otherwise mediate the co-IP of specific 
mRNAs; blocking even residual interactions with other factors might allow me to IP Osk protein 
exclusively. Under such conditions, I should not be able to measure any specific RNA 
enrichment upon UV crosslinking if Osk was not directly crosslinked to mRNAs. 
Fortunately, the Osk specific antibody I was using functions in denatured embryo extracts. 
This allowed me to specifically IP Osk from both UV crosslinked and non-crosslinked extracts, 
as can be seen by the specific depletion of Osk protein from the input material (Fig. 14A). 
Furthermore, Vas did not co-purify with Osk, and its level did not change after IP in the input 
material used in the experiment. As previously described, after RNA extraction from the IPs 
and after reverse transcription, a qPCR analysis of candidate RNAs was performed as a first 
measure of the success of the experiment. Therefore, I tested some of the targets tested in 
the first Osk CLIP experiment: nos, pgc, gcl, osk, bcd and Act42A mRNAs. 
The results of the qPCR analysis are shown in Figure 14B. With the new experimental 
conditions, nos, pgc and gcl mRNAs were again significantly enriched in a UV- and Osk-
dependent manner. osk mRNA, as well as the negative control mRNAs bcd and Act42A were 
not enriched in the precipitated material. The fold enrichment of pgc (~18 fold) was similar to 
that in the Osk CLIP experiment shown in Figure 9B. However, gcl was only ~3 fold enriched, 
compared with the ~6 fold I had obtained previously (Fig. 9B). Strikingly, the level of nos 
enrichment dropped from ~25 fold (Fig. 9B) to ~4 fold using the new experimental conditions 
(Fig. 14B). 
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Figure 14: Oskar CLIP in denatured embryo extracts. (A). 0 to 2 hour old Drosophila embryos 
were treated (UV +) or not (UV -) with UV light. The lysis was performed in denaturing lysis buffer 
containing 8M urea. After dilution and clarification, 5ml aliquots (0.5g of embryos) of the extracts from 
both conditions were incubated with beads conjugated with an anti-Osk antibody (α-Oskar +) or with 
unconjugated beads (α-Oskar -). IP incubation was performed overnight (16 hours) at 8⁰C. After 
washing, 1% of the total protein content of the beads (IP) was analyzed by western blot for: Osk, Vas 
and α-Tubulin. The four lanes from the right show the protein content of the flow through (FT) after IP 
incubation. (B). qPCR analysis of the RNAs extracted after Osk CLIP. nos, pgc gcl, osk, bcd and Act42A 
mRNAs were analyzed. For both UV crosslinked and non-crosslinked conditions, the level of enrichment 
of the different targets measured in the Osk IP (α-Oskar +) was normalized to the level measured in the 
beads-only condition (α-Oskar -). Bars represent mean values ± standard deviation. p values were 
calculated using Student’s t test. (C). Relative abundance of the target mRNAs in B measured in the 
input extracts. The levels were normalized to that of the housekeeping Act42A mRNA. Bars represent 
mean values ± standard deviation. 
These data demonstrate that Osk can be UV crosslinked to nos, pgc and gcl mRNAs in 
vivo. pgc seems potentially a direct target of Osk, since the level of pgc RNA enrichment upon 
UV crosslinking and Osk IP didn’t change when protein-RNA complexes were denatured after 
UV irradiation. gcl was just slightly enriched in the experiment in Figure 9B and in the new 
experimental conditions its enrichment was decreased. Although the enrichment of gcl is 
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statistically significant, the interaction of Osk with this mRNA appears weak, suggesting that it 
might be unspecific. The results obtained for nos mRNA opens new questions regarding its 
possible direct interaction with Osk. If nos was the most enriched target in the previous Osk 
CLIP experiment (Fig. 9B), in the new conditions its level of enrichment was very close to that 
of gcl. The drop in enrichment might indicate that, in the previous experimental conditions, the 
majority of nos mRNA was not directly crosslinked to Osk, but that an additional protein 
crosslinked to nos was co-IPed together with Osk. Protein denaturation during extract 
preparation might prevent Osk from interacting with the protein(s) that directly bind nos 
transcripts. 
 
3.3.1. Conclusions and next steps towards Oskar target RNAs 
identification 
The Osk CLIP experiment performed in denatured embryo extracts showed that Osk can 
be UV crosslinked to specific mRNAs in vivo. pgc appears to be a genuine target of the protein 
in vivo, while in case of nos other factors might be involved in regulating or stabilizing the Osk-
nos interaction. Unfortunately, because the UV crosslinking step is performed on intact 
embryos, these data did not allow me to conclude that Osk is a genuine RBP. Knowing where 
Osk is crosslinked within its putative target mRNAs would provide key information for 
understanding if Osk is an RBP. If Osk is a genuine RBP, it might recognize specific motifs or 
secondary structure elements in mRNAs. This would allow me to design mutations in these 
elements that might disrupt the interaction with Osk. In the event that the Osk RNA-binding 
activity is totally unspecific, the UV crosslinking of some posteriorly localized mRNAs to Osk 
might simply reflect the close proximity of the protein with these particular transcripts within the 
pole plasm. 
The fact that Osk can be UV crosslinked in vivo to nos, pgc and gcl mRNAs (Fig. 14) 
suggests that iCLIP method can be applied to Osk. It appears that the lack of information 
obtained from the Osk iCLIP libraries shown in Figure 13 was not due to the absence of RNAs 
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crosslinked to the protein. Other steps of the protocol might have caused the poor outcome of 
the experiment. In particular, the three enzymatic steps performed before RNA extraction, 
partial RNA digestion, 3’ end dephosphorylation and L3App adapter ligation, appear to be 
crucial steps in the preparation of libraries of good quality. In fact, when performing the 
experiment, I was not able to truly control the partial RNA digestion step, and it is possible that 
over-digestion of the RNA in the samples might have caused the poor results. Moreover. I did 
not assess the efficiency of the dephosphorylation and the L3App ligation steps. Considering 
the small amount of starting material in the experiment (Fig. 11), a low efficiency of any or all 
these steps would compromise the overall quality of the libraries and of the whole experiment.  
After discussion with colleagues, with this in mind I decided to analyze in detail each of 
the three enzymatic steps in the iCLIP protocol, in order to check their efficiency and optimize 
them. The following steps in the protocol, reverse transcription, circularization and 
linearization, were all to be performed using standard conditions provided by the 
manufacturers of the different enzymes and commercial kits utilized, hence they were not the 
primary focus of the following optimizations. 
 
3.4. Oskar iCLIP optimization 
The Osk CLIP experiment performed in denatured embryo extracts showed that Osk can 
be directly crosslinked to pgc mRNA, and to a lesser extent to nos and gcl mRNAs in vivo (Fig. 
14). This finding represent the starting point for trying to apply the iCLIP method to Osk protein. 
The iCLIP protocol is complex and involves several key enzymatic steps (Fig. 10), therefore it 
was possible that the unsuccessful results I had obtained so far might be due to improperly 
optimized reaction conditions. I therefore decided to focus on the optimization of the three 
enzymatic steps performed before RNA extraction: partial RNA digestion, 3’ end 
dephosphorylation and L3App adapter ligation. The analysis of these reactions and their 
optimization would ideally lead to an optimized protocol, appropriate for studying the 
interactions of Osk with RNAs in vivo. 
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3.4.1. Partial digestion by RNases 
The iCLIP protocol involves partial digestion of RNAs crosslinked to the protein of interest 
using RNases, to obtain fragments ranging between 50 and 300 nucleotides in size. The 
amount of RNases that is required to obtain such fragments can be determined in preparative 
experiments. In such experiments, after treating the samples with different amounts of a 
specific RNase, RNA fragments are radioactively labeled. Protein-RNA complexes are then 
separated by SDS-PAGE, blotted on a nitrocellulose membrane and, by analyzing the 
radioactive signal from the blot, it is possible to identify the right amount of enzyme to be used 
in the reaction [186] [191]. I performed the RNA labeling assay after Osk CLIP performed in 
denatured embryo extracts but I was not able to detect any signal from Osk-RNA complexes 
(data not shown). The negative outcome of the experiment prevented me from defining the 
amount of RNase I to be used during partial RNA digestion step in the iCLIP protocol. 
As an alternative approach, I decided to perform the partial RNase-mediated digestion 
directly on the input extracts, during the Osk IP. My aim was to find conditions that would allow 
me to partially digest the total RNA content of the extracts and produce fragments of an 
average length around 200-300 nucleotides. Since the RNase I used in my first Osk iCLIP 
experiment (Fig. 13) is inhibited in the lysis buffer used for embryo extract preparation (data 
not shown), I used a mix of RNase A and T1. In the test experiment, 1ml aliquots of embryo 
extracts were incubated in the presence of increasing amounts of RNase A and T1. As 
ultimately I wanted to perform the RNase-mediated digestion step while the Osk IP was 
ongoing, the RNase optimizations involved incubating the reactions for 3 hours at 8⁰C (the 
conditions under which the IPs are performed). At the end of the incubation, I extracted the 
RNA and analyzed it on an Agilent Bioanalyzer 2100 (Fig. 15A). 
The results of the test experiment are shown in Figure 15A. In the untreated sample (lane 
1), the total RNA appears intact, with no sign of degradation. The two prominent bands running 
slightly below the 2000 nucleotide band of the RNA ladder are the 28S and 18S rRNAs [189] 
[190]. Addition of increasing amounts of RNase A and T1 to the extracts resulted in digestion 
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of the total RNA into progressively smaller fragments (lanes from 2 to 11). Examination of the 
different samples undergoing the controlled digestion revealed that, as the rRNA bands lost 
intensity, additional bands appeared lower on the gel. Whereas the rRNAs bands were totally 
gone in the presence of RNase A and T1 at a concentration of 4*10-5U/μl (lane 5), with 4*10-
3U/μl or higher, the total RNA extracted was fully degraded (lanes 9, 10 and 11). Reactions 
performed at a concentration of 8*10-5U/μl of RNase A and T1 (lane 6) seemed to produce 
RNA fragments of the most optimal size: the RNA fragments spread from the bottom of the 
lane to the 1000 nucleotide band of the RNA ladder, and the majority of the signal accumulated 
below the 500-nucleotide band of the ladder, reflecting fragments in a size-range optimal for 
an iCLIP experiment. It is important to realize that the fact that the only bands clearly visible in 
the RNA trace in lane 1 (Fig. 15A) correspond to rRNAs does not necessarily mean that the 
digestion products accumulating after RNase A- and T1-mediated digestion are solely derived 
from rRNAs. Bioanalyzer traces are produced by the instrument and represented as images 
resembling a gel. The white background color of each lane is arbitrarily set by the instrument 
after sample reading. In this case, the rRNA signal is particularly intense and therefore masks 
any additional RNA traces running above and/or below these bands. In order to control for 
possible mRNA over-digestion, I reverse-transcribed 1μg of total RNA from samples 1 and 6. 
Then I measured by qPCR the relative abundance of nos, pgc and gcl mRNAs, comparing the 
untreated and RNase treated samples. All three mRNAs could be detected after partial RNase 
A and T1 digestion, but at lower levels compared with the control (data not shown). This 
indicated that the RNase treatment didn’t over-digest the mRNAs in the embryo extracts. 
Altogether, these data suggested that performing the RNase A- and T1-mediated RNA 
digestion step during Osk IP from the input extracts might allow better control of this particular 
step in the iCLIP protocol. The RNA fragments generated appear to be of an optimal size for 
iCLIP library preparation, the samples do not look over-digested, and the target mRNAs 
identified by candidate approach, nos, pgc and gcl, are detectable in the extracts after partial 
RNA digestion. An additional positive aspect of this method is that it allows easy checking the 
degree of RNA fragmentation prior to library preparation. Indeed, at the end of the IP and 
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RNase treatment, total RNA can be extracted from the different aliquots of embryo extract used 
and analyzed to assess the outcome of the RNase-mediated digestion step before proceeding 
with the experiment. 
 
Figure 15: RNase A and T1 partial RNA digestion. (A). RNA digestion test using increasing 
amounts of RNase A and T1. 1ml aliquots of Drosophila embryo extracts prepared in denaturing 
conditions were incubated 3 hours at 8⁰C in presence of increasing amounts of RNase A and T1. After 
incubation, total RNA was extracted and analyzed on an Agilent Bioanalyzer 2100 instrument. RNase 
A and T1 concentrations used in the assay: sample 2, 4*10-6U/μl; sample 3, 8*10-6U/μl; sample 4, 1.6*10-
5U/μl; sample 5, 4*10-5U/μl; sample 6, 8*10-5U/μl; sample 7, 4*10-4U/μl; sample 8, 8*10-4U/μl; sample 9, 
4*10-3U/μl; sample 10, 8*10-3U/μl; sample 11, 4*10-2U/μl. For each sample 50ng of total RNA were 
loaded into the instrument. L: RNA ladder (B). Bioanalyzer traces of RNAs extracted from two Osk CLIP 
experiments. Drosophila embryos, either UV crosslinked (UV +) or non-crosslinked (UV -) were lysed in 
lysis buffer containing 8M urea. After dilution, 5ml aliquots of the extracts were incubated with protein G 
sepharose beads conjugated with an anti-Osk antibody (α-Oskar +) or only with beads (α-Oskar -). The 
samples from the two Osk CLIP experiments were incubated overnight (16 hours) at 8⁰C. One set of 
samples was supplemented with RNase A+T1 mix (final concentration 8*10-5U/μl) 3 hours before the 
end of the incubation time (RNase A+T1 +), while the other was not (RNase A+T1 -). After several 
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washes, proteins were digested and the RNAs extracted. The extracted RNAs were analyzed on an 
Agilent Bioanalyzer 2100 instrument. For non-crosslinked and UV crosslinked input embryo extracts 
(lanes 1 and 2), 5ng of total RNA were loaded into the machine. The RNA samples extracted from the 
two Osk CLIP experiments (from lane 3 to 10) were resuspended in 5μl of H2O and 1μl was loaded into 
the machine. L: RNA ladder. 
As an additional test, I evaluated the RNase A- and T1-mediated digestion in a standard 
Osk CLIP experiment, repeating the experiment shown in Figure 14, and performing two 
parallel sets of Osk IPs in denatured embryo extracts. In one case the samples were not 
treated with RNase A and T1, whereas in the other, RNase A and T1 (8*10-5U/μl) were added 
during the last 3 hours of IP incubation. After several washes, the proteins were removed by 
enzymatic digestion, and RNAs were extracted and analyzed on the Agilent Bioanalyzer 2100 
instrument (Fig. 15B). As can be seen in Figure 15B, the untreated samples were quite strongly 
contaminated with rRNAs, probably due to the huge abundance of these RNA species in the 
input extracts, which  tend to stick to the protein G sepharose beads used (Fig. 15B, lanes 3, 
4, 5 and 6). In contrast, the four RNase treated samples (Fig. 15B, lanes 7, 8, 9 and 10) 
contained fragments of a size distribution similar to those obtained under the conditions 
determined as most optimal in the optimization experiment (Fig. 15A, lane 6). This 
demonstrated the reproducibility of the partial RNA digestion step. The amount of RNA 
extracted from the different IP samples in both RNase treated and untreated condition ranged 
between 1 and 3ng and might be considered at the limit for feasibility of iCLIP library 
preparation. To additionally analyze the applicability of the RNase A and T1 treatment in the 
Osk iCLIP, I repeated the experiment described in Figure 15B and after RNA extraction and 
reverse-transcription I performed the qPCR analysis showed in Figure 14. In such 
experiments, nos, pgc and gcl mRNAs were significantly enriched after UV crosslinking and 
Osk IP in both RNase treated and untreated conditions (data not shown), indicating that the 
conditions that I identified for the partial RNA digestion step can be applied during iCLIP library 
preparation. 
The abundant rRNA content in the samples in Figure 15B was not present using the IP 
condition established for the first Osk iCLIP experiment (Fig. 11) and was going to represent a 
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major contamination during iCLIP libraries preparation. Nevertheless, the Osk CLIP protocol 
in denatured embryo extracts still allowed detection of the UV- and Osk-dependent enrichment 
of nos, pgc and gcl mRNAs (Fig. 14) and reduced the likelihood of co-IP for proteins that 
interact with Osk. With this protocol I was more confident that the enriched mRNAs truly reflect 
crosslinking events that occurred in vivo between Osk and its putative mRNA targets. For this 
reason, I decided that, when preparing iCLIP libraries in the future, I would perform the Osk IP 
on denatured embryo extracts. The high number of reads generated in such an experiment 
might allow bioinformatic filtering out the signal from rRNAs, and analysis of the remaining 
reads for identification of the targets and definition of the binding site(s) of Osk protein. 
 
3.4.2. 3’ end dephosphorylation 
After RNase-mediated digestion, the remaining RNA fragments bear a phosphate group 
at their 3’ end. However, T4 RNA ligase 2 truncated-mediated L3App adapter ligation requires 
that the RNA substrates harbor an -OH group at the 3’ end, making necessary the removal of 
the residual phosphate groups. This reaction is catalyzed by the PNK enzyme. I set out to test 
the efficiency and possibly optimize this essential step of my experiment. 
To test the efficiency of PNK-mediated dephosphorylation in my reactions, I took an 
indirect experimental approach. In this method, two RNA oligos of identical sequence are used 
as substrates of the dephosphorylation reaction. The oligos differ in that one bears a 3’-OH 
group (oligo 1), whereas the second bears a 3’ phosphate group (oligo 1-P) (Fig. 16A).  
The oligos I chose were 40 nucleotides long and contained a central sequence (28 
nucleotide) from the Renilla reniformis luciferase gene, flanked by 6 nucleotide-long random 
stretches. The randomized sequences flanking the core of the oligo would reduce the likelihood 
of double strand formation between the 5’ and 3’ ends of the same molecule, ensuring that the 
reaction mix contained single stranded 3’ ends accessible to enzymes. 
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To test the efficiency of the dephosphorylation reaction, I first incubated increasing 
amounts of RNA substrate in the reactions, from 8*10-4 to 2 pmoles. I set up three different 
reactions for each substrate concentration: a negative control, the experiment itself, and a 
positive control. In the negative control sample, I incubated the phosphorylated oligo (oligo 1-
P) in the iCLIP dephosphorylation reaction buffer but did not add the PNK enzyme; in the 
experimental sample, I incubated the phosphorylated oligo (oligo 1-P) in the presence of PNK, 
thus mimicking the experimental conditions of the iCLIP protocol; in the positive control sample 
I incubated the unphosphorylated oligo (oligo 1) without any PNK (Fig. 16A). All the reactions 
were performed under the same conditions as the iCLIP protocol [186], in the presence of the 
same amount of protein G sepharose beads as for Osk IP, at 37⁰C for 30’. 
The experiment was designed such that, in the experimental sample, PNK activity would 
be expected to remove the phosphate group from the phosphorylated oligo, producing a 3’-
OH substrate required for the following ligation step. In contrast, in the negative and positive 
control samples, the chosen oligos should not be modified. Consequently, while in the 
subsequent ligation step, the unphosphorylated oligo of the positive control would be a suitable 
substrate for adapter ligation, the phosphorylated oligo of negative control sample would not 
(Fig. 16A). Since in reality not all the phosphorylated oligo molecules contain a phosphate 
group at their 3’ end (as indicated by the manufacturer) and ligation products would most likely 
be produced also in the negative control, this control would determine the expected 
background level of ligation for a given amount of oligo used in the assay. Conversely, in the 
positive control, all the unphosphorylated oligo can be used as substrate for the ligation step, 
hence this condition can serve to determine the maximum dephosphorylation efficiency in the 
reactions for a given amount of oligo. Finally, the experimental sample should result in an 
amount of product somewhere in between the two controls. 
After the dephosphorylation step, I performed the L3App ligation using T4 RNA ligase 2 
truncated. Next I reverse-transcribed the ligation products using the iCLIP primers, which 
anneal to the L3App adapter sequence. Finally, I analyzed the cDNAs by PCR and separated 
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the products on an agarose gel (Fig. 16A). The size of the specific PCR products generated in 
the experiment were expected to be 89bp long. 
As shown in Figure 16B, with the smallest amounts of RNA oligo substrate (8*10-4 and 
8*10-3 pmoles), no background signal was detected in the negative control. With higher 
amounts of substrate (0.08, 0.4 and 2 pmoles) the intensity of the specific PCR product in the 
negative control conditions increased proportionally with the amount of substrate used. 
However, in all cases, the intensity of the band in the negative control was lower than that of 
both the positive control and the experimental condition performed with the same amount of 
oligo (Fig. 16B). 
 
Figure 16: PNK-mediated 3’ end dephosphorylation efficiency test. (A). Schematic 
representation of the experimental procedure. Two oligos of identical sequence are used in the 
experiment: oligo 1-P contains a phosphate group at the 3 ’end while oligo 1 does not. For a given 
amount of oligo three reactions were performed. In the negative and positive control samples, oligo 1-P 
and oligo 1 respectively, were incubated without PNK. In the experimental sample, oligo 1-P was 
incubated with PNK. The reactions were performed on protein G sepharose beads in iCLIP 
dephosphorylation reaction buffer and were incubated at 37⁰C for 30’. At the end of the incubation the 
RNA oligos were extracted and L3App adapter ligation was performed using T4 RNA ligase 2 truncated 
enzyme. After an additional step of oligo purification, reverse-transcription was performed using primers 
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that anneal to the adapter sequence. cDNAs were analyzed by PCR using a primer that anneals to the 
sequence of the primer used in the reverse-transcription step and a primer that anneals to the RNA oligo 
sequence. (B). Agarose gel showing the PCR products from a dephosphorylation efficiency test 
experiment performed using different amounts of RNA oligo substrate. (C). Densitometric analysis of 
the gel shown in B. For each experimental point, values from the negative control conditions were 
subtracted from the experimental and positive control conditions. Values obtained from positive controls 
were used to define 100% dephosphorylation efficiency for each experimental point. Bars represent 
mean values ± standard deviation. 
To quantify the efficiency of the dephosphorylation reactions, I performed a densitometric 
analysis of the signal from the agarose gel (Fig. 16B). The graph shows the results of this 
analysis (Fig. 16C). For each experimental condition, I subtracted the values measured in the 
negative control from those in the experimental and positive control samples. For each oligo 
amount tested, I considered the values in the positive control samples as representing the 
maximum level of efficiency (100% dephosphorylation). This analysis showed that, for all the 
different RNA substrate amounts tested in the assay, the efficiency of dephosphorylation was 
nearly 100% (Fig. 16C). 
This experiment indicated that PNK-mediated dephosphorylation of the RNA substrate 
was not the limiting step in the iCLIP protocol. Therefore, the low quality of the libraries 
prepared in my Osk iCLIP experiment (Fig. 13) was probably not due to inefficient 3’ end 
dephosphorylation. 
 
3.4.3. L3App adapter ligation onto RNA 
3.4.3.1. L3App adapter ligation efficiency in iCLIP conditions 
Ligation of the L3App adapter to the 3’ end of RNA fragments crosslinked to Osk is the 
last enzymatic reaction performed on beads in the Osk iCLIP protocol [186]. I set up an 
experimental procedure to analyze the efficiency of this reaction under the iCLIP conditions. 
As a first step, I labelled different amounts of the same RNA oligo (oligo 1) used in the 
dephosphorylation efficiency test at the 5’ end with radioactivity, by PNK-mediated addition of 
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a 32P containing phosphate group. After RNA extraction, I incubated the oligo with T4 RNA 
ligase 2 truncated enzyme (200U) and a molar excess of L3App adapter (60 pmoles) in the 
iCLIP ligation reaction buffer. In this assay, I used increasing amounts of RNA substrate, from 
8*10-4 pmoles to 2 pmoles. The reactions were performed in the presence of the same amount 
of protein G sepharose beads as in Osk IP and were incubated overnight (16 hours) at 16⁰C, 
in accord with the iCLIP protocol [186]. At the end of the incubation period, I extracted the RNA 
oligos and separated them on a 10% polyacrylamide denaturing gel that I subsequently 
exposed to a phosphor imaging plate to detect the radioactive signal. By densitometric 
analysis, I calculated the percentage of ligation from the ratio between the signal of the ligation 
product versus the total signal in the experiment (ligation product plus free RNA substrate). 
The results of the L3App ligation efficiency test performed in iCLIP conditions are shown 
in Figure 17A and B. The lower band represents the unligated RNA substrate, while the band 
just above represents the ligation product. In all samples, the majority of the RNA substrate 
was not ligated, revealing that the ligation reaction was inefficient. In the samples containing 
the highest amount of oligo (Fig. 17A, lanes 6 and 7), an additional band (*) is present above 
the first ligation product. This band is most likely the product of two ligation events involving 
the same RNA substrate. As mentioned previously, the L3App adapter contains two 
modifications: the 5’ end is pre-adenylated and the 3’ end is blocked by a dideoxycytidine. As 
in the case of the oligo 1-P (previous paragraph), not all the oligos are modified, and in this 
case only 20% of the L3App molecules contain both modifications. Therefore, ligation of an 
RNA substrate molecule to an adapter lacking the 3’ end modification can occur. In this case, 
the ligation product will contain a 3’ -OH group that can undergo a second ligation event. Such 
additional products can be detected on the gel when high amounts of RNA substrate are used, 
as more ligation products lacking the 3’ end modification are present in the reaction.  
As can be seen in the graph in Figure 17B, the ligation efficiency under iCLIP conditions 
was low, ranging from ~2% (8*10-4 pmoles RNA substrate) up to ~12% (2 pmoles) (Fig. 17B). 
The results of these tests revealed the low efficiency of the reaction and that L3App ligation 
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was the limiting step in my iCLIP experiment. As the total amount of RNA co-precipitated with 
Osk using CLIP was ~1ng, it is possible that the conditions of the iCLIP were similar to those 
in the samples shown in lanes 4 and 5 of Figure 17A and B. The percentage of ligation in these 
conditions was ~5% and ~8% respectively, possibly explaining why the Osk iCLIP experiment 
failed (Fig. 13). 
 
Figure 17: L3App ligation test experiments. (A). Ligation test experiment performed using iCLIP 
conditions. Increasing amounts of radioactively labeled RNA oligo (oligo 1) substrate were incubated 
with L3App adapter (60 pmoles) in presence of T4 RNA ligase 2 truncated (200U) and protein G 
sepharose beads. The reactions were performed in iCLIP ligation reaction buffer and were incubated 
overnight (16 hours) at 16⁰C. Following RNA extraction, reaction products were separated on a 10% 
denaturing polyacrylamide gel. Samples 5, 6 and 7 were diluted in order to load the same amount of 
RNA oligos used in sample 4. The gel was exposed to a phosphor imaging plate for 1 hour and overnight 
(O.N.). Reaction products from two ligation events on the same RNA molecules are indicated by the *. 
O: radioactively labeled free RNA oligo. (B). Densitometric analysis of the gel shown in A. Bars represent 
mean values ± standard deviation. (C). Comparison of ligation efficiency in different reaction buffers 
(samples 3 and 4: iCLIP ligation reaction buffer; samples 5 and 6: commercial ligation buffer; samples 
7 and 8: eCLIP ligation buffer). For all samples 8*10-3 pmoles of RNA substrate were incubated with T4 
RNA ligase 2 truncated (200U) in presence of L3App adapter (60 pmoles) and protein G sepharose 
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beads. For the three different buffer tested two incubation conditions were analyzed: 2 hours at 25⁰C or 
16 hours at 16⁰C. O: radioactively labeled free RNA oligo. (D). Densitometric analysis of the gel showed 
in C. Bars represent mean values ± standard deviation. 
 
3.4.3.2. Effect of buffer composition and incubation 
temperature 
As the L3App ligation was clearly a limiting step in the iCLIP method I was employing, I 
decided to optimize the reaction and identify conditions that would increase its efficiency. I 
started by analyzing the effect of different buffer compositions and different times and 
temperatures of incubation. All reactions were performed in the presence of protein G 
sepharose beads and a constant amount of T4 RNA ligase 2 truncated (200U). Additionally, I 
chose to perform the test using 8*10-3 pmoles of RNA oligo substrate, as in addition to the low 
ligation efficiency (~5%), this amount of oligo substrate had produced a clear signal on a 
phosphor imaging plate after 1 hour of exposure (Fig. 17A). Hence these particular conditions 
seemed a good starting point for optimization of the ligation step. 
I first tested three different buffers: the iCLIP ligation reaction buffer, a commercial ligation 
buffer (T4 RNA ligase reaction buffer), and the enhanced CLIP (eCLIP) ligation buffer. The 
iCLIP ligation was the one I was aiming to optimize [186]. The commercial buffer is the 
standard buffer that is commercially provided with the enzyme. The eCLIP ligation buffer was 
used in a recently published protocol similar to iCLIP [195]. The main difference between the 
three buffers lies in the presence of PEG8000, rather than of PEG400, and of dimethyl 
sulfoxide (DMSO) in the commercial and eCLIP buffers. It has been shown that addition of 
PEG8000 and DMSO increases T4 RNA ligase-dependent ligation [196]. Therefore, I wanted 
to determine whether the presence of these components in the eCLIP and commercial ligation 
buffers might improve the efficiency of ligation of my L3App adapter and oligo substrates. 
In addition to the different buffers I also tested two incubation conditions: overnight (16 
hours) at 16⁰C (as stated in the iCLIP protocol) and a shorter (2 hours) incubation at 25⁰C (as 
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recommended by the T4 RNA ligase 2 truncated manufacturer). The overnight ligation 
introduced a desirable break in the lengthy iCLIP protocol. Although 16⁰C is a temperature 
lower than the optimal one for the enzyme, it should minimize RNA degradation and the long 
incubation (16 hours) should allow a sufficient level of ligation to be achieved. I also tested if a 
shorter incubation time at the optimal temperature of 25⁰C might improve the outcome of the 
reaction. 
The densitometric analysis of the data confirmed that overnight ligation in the iCLIP ligation 
reaction buffer leads to low percentage of ligation (~5%) (Fig. 17C and D, lane 4). Increasing 
the incubation temperature did not produce a higher level of ligation (Fig. 17C and D, lane 3). 
In both assay conditions, the majority of the RNA substrate was not ligated in the iCLIP ligation 
reaction buffer (Fig. 17C, lanes 3 and 4). In contrast, use of the commercial and eCLIP ligation 
buffers both led to a strong increase in the percentage of ligation. In both cases, overnight 
incubation at 16⁰C produced better results compared to the other reaction conditions (Fig. 17C 
and D, compare lanes 5 vs 6, and 7 vs 8). Specifically, overnight ligation in the eCLIP ligation 
buffer resulted in an average of ~38% ligation (Fig. 17D, lane 8) and, in the commercial ligation 
buffer, of ~45% ligation of the oligo (Fig. 17D, lane 6). 
These data show that addition of PEG8000 and DMSO to the ligation buffer increased the 
ligation reaction efficiency almost 10 fold. The presence of DTT (1mM) in the commercial 
ligation buffer seems to result in better ligation than what was obtained using the eCLIP ligation 
buffer, which does not contain any DTT. In view of this, I decided to use the commercial ligation 
buffer to test additional parameters that might increase L3App ligation efficiency in the Osk 
iCLIP protocol. 
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3.4.3.3. Effect of increasing amounts of T4 RNA ligase 2 
truncated enzyme 
I next tested how increasing the amount of T4 RNA ligase 2 truncated in the reaction might 
influence L3App ligation efficiency. In this experiment, I incubated a fixed amount of RNA oligo 
substrate (8*10-3 pmoles) with increasing amounts of T4 RNA ligase 2 truncated (200U up to 
1200U), in the presence of protein G sepharose beads, in the commercial ligation buffer. As 
with the previous experiment, I compared two incubation conditions: 2 hours at 25⁰C and 
overnight (16 hours) at 16⁰C. 
 
Figure 18: Optimized reaction conditions for L3App ligation. (A). Ligation test experiment 
performed using increasing amounts of T4 RNA ligase 2 truncated. 8*10-3 pmoles of radioactively 
labeled RNA oligo 1 were incubated in commercial ligation buffer in presence of increasing amounts of 
T4 RNA ligase 2 truncated (from 200U to 1200U), L3App adapter (60 pmoles) and protein G sepharose 
beads. Reactions were incubated 2 hours at 25⁰C or 16 hours at 16⁰C. Products of ligation were 
separated on a 10% denaturing polyacrylamide gel subsequently exposed to a phosphor imaging plate 
for detection. O: radioactively labeled free RNA oligo. (B). Densitometric analysis of the gel showed in 
A. Bars represent mean values ± standard deviation. (C). Ligation test experiment performed using 
increasing amounts of RNA oligo 1 substrate using optimized reaction conditions from the experiment 
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showed in panels A and B (sample 10). Increasing amounts of radioactively labeled RNA substrate, 
ranging from 8*10-4 pmoles to 2 pmoles were incubated in commercial ligation buffer in presence of 
1000U of T4 RNA ligase 2 truncated, 60 pmoles of L3App adapter and protein G sepharose beads. After 
16 hours of incubation at 16⁰C the products of the reactions were separated on a 10% denaturing 
polyacrylamide gel (samples 6, 7, 8 and 9 were diluted in order to load the same amount of RNA oligos 
used in sample 5). The gel was exposed to a phosphor imaging plate for 1 hour and overnight (O.N.). 
Reaction products from two ligation events on the same RNA molecules are indicated by the *. O: 
radioactively labeled free RNA oligo. (D). Densitometric analysis of the gel showed in panel C. Bars 
represent mean values ± standard deviation. 
This experiment revealed that incubating the reaction overnight at 16⁰C resulted in a 
higher ligation efficiency than for 2 hours at 25⁰C (Fig. 18A, compare lanes 3 vs 4 and 5 vs 6). 
This finding is best illustrated by the graph (Fig. 18B), which shows that, regardless of the 
amount of enzyme used, 2 hours of incubation at 25⁰C always produced a lower percentage 
of ligation. Increasing amounts of T4 RNA ligase 2 truncated in the reaction mix positively 
affected the ligation efficiency. When only considering the data from the reactions incubated 
for 16 hours, the percentage of ligation increased from ~41% when 200U of enzyme were 
used, to ~56% in the presence of 1000U of enzyme. Amounts of T4 RNA ligase 2 truncated 
higher than 1000U in the reaction, did not further increase the efficiency of ligation (Fig. 18B). 
These data confirm that the best L3App adapter ligation results are achieved when the 
reaction is incubated for 16 hours at 16⁰C, as was shown in the previous experiment (Fig. 17C 
and D) and show that increasing the amount of enzyme used in the reaction (up to 1000U) 
further improves reaction efficiency. These new reaction conditions represent an important 
improvement to the ligation conditions proposed by the standard iCLIP protocol. I decided 
therefore to use these ligation conditions when performing the final optimization experiments 
(Fig. 18A and B, lane 10). 
 
3.4.3.4. Effect of different amounts of RNA substrate 
The final experiment I performed to optimize L3App ligation was to test the effect of 
different amounts of RNA substrate on the efficiency of ligation using the optimized 
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experimental conditions (Fig. 18A and B, lane 10). The results of the experiment are depicted 
as a graph (Fig. 18D). For the entire range of substrate amounts tested, ligation efficiency was 
greater than 50% and considerably higher than that achieved using the original iCLIP ligation 
conditions (Fig. 17B), ranging from ~52% with the smallest amount of oligo substrate (8*10-4 
pmoles) to close to 70% of ligation when 2 pmoles of RNA substrate were included in the 
reaction (Fig. 18D). 
In conclusion, I identified the ligation of the L3App adapter to the RNA substrate as the 
limiting step in the iCLIP protocol. By testing different reaction buffers, incubation conditions 
and amounts of T4 RNA ligase 2 truncated, I managed to optimize the ligation step in the iCLIP 
protocol, achieving between 50% and 70% of ligation over a wide range of amounts of RNA 
substrate. The optimization of the ligation step in the iCLIP protocol might help to increase the 
quality of the libraries produced from the Osk iCLIP experiment possibly allowing me to identify 
where Osk is crosslinked to its target transcripts in vivo. 
 
3.5. The Oskar iCLIP protocol optimized 
With the experiments shown in the previous paragraphs, I was able to set up and optimize 
the three enzymatic steps: partial RNA digestion (Fig. 15), 3’ end dephosphorylation (Fig. 16) 
and L3App adapter ligation (Fig. 17 and 18), all performed before RNA extraction in the iCLIP 
protocol (Fig. 10). The optimized iCLIP protocol that I set up might help me to increase the 
overall quality of the libraries produced from an Osk iCLIP experiment. A successful library 
preparation and analysis might eventually help to identify all the RNAs bound by Osk in vivo 
and the deposition site(s) of Osk on its target transcripts. I therefore decided to proceed and 
carry out the full experiment. 
 
 
89 
 
3.5.1. Preparation of an optimized Oskar iCLIP 
For the optimized Osk iCLIP experiment, I began by preparing 5ml of denatured extracts 
from embryos that had either been, or not been, subjected to UV crosslinking. I incubated the 
extracts with protein G sepharose beads conjugated with an anti-Osk antibody or, as a control, 
I performed a parallel IP using beads lacking the antibody. I incubated the samples overnight 
(16 hours), supplementing the reactions with 8*10-5U/μl of RNase A and T1 for the last 3 hours 
of IP incubation. After several washing steps, 1% of the beads used for each sample were 
subjected to protein extraction and western blot analysis to monitor the IP efficiency. The 
results of the Osk IP are shown in Figure 19A. Western blotting revealed that Osk protein was 
specifically precipitated from both UV crosslinked and non-crosslinked samples, and that was 
strongly depleted from the extracts following the IP. As previously, the IP washing conditions 
were stringent enough to avoid co-IP of Vas, a well-known Osk interactor [113] [115], and of 
α-Tubulin, a very abundant cytoplasmic protein (Fig. 19A). 
To check integrity of the RNA in the input material and RNA fragmentation pattern after 
partial digestion with RNases, following the IP incubation I extracted the RNA for analysis on 
an Agilent Bioanalyzer 2100 instrument. The Bioanalyzer traces from the inputs (UV 
crosslinked and non-crosslinked) showed that the RNA in the starting material was intact (Fig 
19B, lanes 1 and 2). The Bioanalyzer traces of the RNA extracted after RNase A- and T1-
mediated digestion showed the level of RNA fragmentation. The four profiles were very similar, 
indicating an optimal level of digestion of all the samples in the experiment (Fig. 19B, lanes 3, 
4, 5 and 6).  
Knowing that both the Osk IP and the partial digestion by RNases worked as expected, I 
proceeded with the iCLIP protocol (Fig. 10), using the optimized ligation conditions that I 
previously identified. At the end of the protocol, I performed a test PCR, with 28 and 30 cycles 
for library amplification, and analyzed the products on a 6% native polyacrylamide gel in TBE 
buffer (Fig. 19C). This analysis showed that with 28 PCR cycles the signals from the four 
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libraries was not sufficiently strong to appreciate and analyze the differences between the 
samples (Fig. 19C, lanes 1, 3, 5 and 7). 
 
Figure 19: Oskar iCLIP libraries prepared according to the optimized protocol. (A). 
Western blot analysis of the Osk IP step. Drosophila embryos collected between 0 and 2 hours after 
egg laying were irradiated (UV +) or not (UV -) with UV light. Lysis was performed in lysis buffer 
supplemented with 8M urea. After extract dilution and clarification, 5ml aliquots (0.5g of embryos) were 
incubated with protein G sepharose beads conjugated with an anti-Osk antibody (α-Oskar +) or, in a 
parallel control experiment, only with beads (α-Oskar -). After stringent washing steps, 1% of beads from 
each sample were subjected to protein elution, SDS-PAGE and western blot analysis for: Osk, Vas and 
α-Tubulin. FT: flow through. (B). RNase A and T1 partial RNA digestion. During the last 3 hours of IP 
incubation, the extracts were supplemented with 8*10-5U/μl of RNase A and T1. After reaction 
completion, total RNA was extracted from the extracts used for Osk IP (FT). RNAs have been analyzed 
on an Agilent Bioanalyzer 2100. L: RNA ladder. (C). Test PCR for Osk iCLIP libraries. Final libraries 
were amplified by PCR using different cycles (28 and 30) and separated on a 6% native polyacrylamide 
gel in TBE buffer. L: DNA ladder. (D). Osk iCLIP library analysis on agarose gel. PCR amplified Osk 
iCLIP libraries (30 PCR cycles) were separated on a 4% agarose gel in TBE buffer for extraction. L: 
DNA ladder. 
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In contrast, the signals produced after 30 PCR cycles allow analysis of the libraries (Fig. 
19C, lanes 2, 4, 6 and 8). As with the previous Osk iCLIP experiment (Fig. 13B), all four libraries 
present a sharp band (127bp) towards the bottom of the gel. This band was produced by 
residual unligated L3App adapter molecules that were not removed before RNA extraction. All 
the DNA fragments migrating above this band should in principle represent single ligation 
events, and therefore should contain useful information. A second sharp band of ~260bp is 
also detected in all four samples. This band was also present in the previous Osk iCLIP 
libraries (Fig. 13B), but in this case did not seem to be the major product present in the libraries. 
Furthermore, after 30 PCR cycles, the two libraries from the non-crosslinked samples looks 
very similar: in both the beads-only and the Osk IP samples, the signal spreads from the 127bp 
band to ~260bp band, and no additional product in the upper part of the gel is visible (Fig. 19C, 
lanes 2 and 4). The library produced from the UV crosslinked beads-only sample shows the 
least signal between the 127bp and ~260bp bands, and no other PCR products are visible 
above these two bands (Fig. 19C, lane 6). Interestingly, this particular library looks emptier 
than the one produced from the non-crosslinked beads-only condition. There are at least two 
possible explanations for this result: some material from the UV-crosslinked beads-only 
sample might have been lost during the procedure or, for unknown reasons, during the washing 
steps performed on this sample, background RNA fragments and unligated L3App adapter 
molecules might have been removed more efficiently than in the other conditions. Finally, 
library prepared from the UV crosslinked Osk IP sample looked different from the others. The 
smearing signal above the 127bp band was stronger than in the other libraries and, 
interestingly, this library contained an additional smearing signal in the upper part of the gel, 
between 300bp and 700bp of the DNA ladder (Fig. 19C, lane 8). This feature is completely 
absent in the libraries from the three control conditions, which might indicate the presence of 
longer cDNA molecules produced from RNA fragments crosslinked to Osk. 
A positive feature of the optimized method of iCLIP library preparation is the number of 
PCR cycles required to detect their content. In the original iCLIP experiment, 38 PCR cycles 
were needed to detect a smeared signal in the UV crosslinked Osk IP sample (Fig. 13B, lane 
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12). The optimized protocol required 8 fewer cycles, which indicates that the cDNA input in the 
PCR reaction was 1000 times greater than in the previous iCLIP experiment. One possible 
reason for this difference is the much higher RNA background signal in the samples prepared 
using the Osk IP protocol from denatured embryo extracts (Fig. 15B). Another possible reason 
is the improved efficiency of the ligation step (Fig. 18C and D). With the optimized ligation 
conditions, more than 1 out of 2 RNA molecules is attached to an iCLIP adapter, in a ligation 
reaction that is ~10 times more efficient than in the standard iCLIP protocol (Fig. 17A and B). 
Although at this stage of the experiment I could not distinguish which of the two factors was 
responsible for the fewer PCR cycles needed, the presence of a stronger signal in the UV 
crosslinked Osk IP library and the fewer PCR amplification cycles required to detect it, indicate 
that more RNA fragments were used as substrates in the optimized iCLIP experiment. 
Importantly, this means that the new iCLIP libraries might be less PCR biased than the original 
ones. 
In order to analyze the four new libraries in greater detail, I decided to proceed with the 
experiment. After PCR amplification, I separated the libraries on a 4% agarose gel (Fig. 19D) 
and extracted and purified all the DNA fragments running above the 127bp band. PCR 
fragments from the different samples show a similar distribution to those generated in the test 
PCR (Fig. 19C). In the non-crosslinked condition, the beads-only sample appears slightly 
“cleaner” than the Osk IP. In both cases, the signal spreads above the 127bp band 
representing the unligated L3App adapter, towards the upper part of the gel (Fig. 19D, lanes 
1 and 2). The lane containing the UV crosslinked beads-only sample is almost empty compared 
with the others (Fig. 19D, lane 3). The library prepared from UV crosslinked Osk IP sample 
shows a stronger signal spreading above the 127bp band (Fig. 19D, lane 4). Curiously, the 
band running at ~260bp on the test PCR polyacrylamide gel is not detected on the agarose 
gel (Fig. 19D). 
I next analyzed the Osk iCLIP libraries from the four samples on an Agilent Bioanalyzer 
2100 instrument to determine with higher accuracy the size of the PCR products (Fig. 20). In 
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all four, the 127bp band was removed during gel excision, and only ~260bp band is detectable. 
The two samples from the non-crosslinked condition show very similar profiles: in addition to 
the ~260bp band, which is the strongest PCR product in the samples, other PCR fragments 
are mostly distributed between the 150bp and 300bp bands of the DNA ladder. Additional 
fragments can be detected above 300bp (up to 500bp), but at very low levels (Fig. 20A and 
B). 
 
Figure 20: cDNA fragments distribution in Oskar iCLIP libraries. After PCR amplification and gel 
extraction, DNA fragments in the different Osk iCLIP libraries were analyzed on an Agilent Bioanalyzer 
2100 instrument. (A, B, C and D). Analysis of single Osk iCLIP libraries from the four different 
experimental conditions used. (E). Analysis of the four libraries produced in the Osk iCLIP experiment 
pooled and concentrated. On the Y axis, FU represents arbitrary fluorescent units measured by the 
instrument; on the X axis all samples were aligned respect to a DNA ladder (bp: base pairs). 
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The library from the UV crosslinked beads-only sample contained very little material.  DNA 
fragments are visible between 150bp and 300bp, but no additional signals are detected in 
addition to the ~260bp band (Fig. 20C). The UV crosslinked Osk IP specific library had the 
highest DNA content. Most of the DNA fragments are visible between 150bp and 300bp, and 
some additional material accumulates up to 600bp (Fig. 20D). It was encouraging to note that 
this library contained more material between 300bp and 600bp than the libraries from the 
control conditions. This was a positive indication that might indicate the presence of DNA 
fragments produced from RNA molecules UV crosslinked to Osk. 
It seemed likely that the ~260bp band in the four Osk iCLIP libraries was a contaminant 
and would not produce any informative data. Indeed, a similar band was present in the previous 
iCLIP libraries (Fig. 13B) and sequencing analysis of those libraries suggested it was an artifact 
produced by the L3App adapter. Although in the optimized Osk iCLIP libraries the similarly 
dominant band was of slightly higher molecular weight, it seemed probable that sequencing of 
this band would not produce any mappable reads. I considered avoiding this band during gel 
extraction step, but decided against it, for two reasons. First, during the gel extraction step, the 
removal of a specific PCR product is not 100% efficient, as demonstrated by the residual 
presence of the 127bp L3App adapter product at ~130bp, which is visible on the Bioanalyzer 
trace of the individual iCLIP libraries (Fig. 20). Second, excising the ~260bp band would result 
in the loss of PCR fragments overlapping with, as well as those migrating just below and above 
the abundant contaminating band during gel electrophoresis. 
After considering the positive and negative points of the experiment, I decided to proceed 
and have the Osk iCLIP libraries, produced with the optimized protocol, sequenced. The four 
libraries, after PCR amplification and gel extraction, were pooled together and sent for 
sequencing. The Bioanalyzer profile of this library preparation is showed in Figure 20E.  
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3.5.2.  Analysis of the Oskar iCLIP libraries 
Osk iCLIP libraries produced using the optimized protocol previously described were 
sequenced on a HighSeq 2000 instrument (Illumina; single-end sequencing). I demultiplexed 
the raw data [192], aligned the reads against the Drosophila genome using the TopHat2 tool 
[193], and finally I removed PCR duplicates [194]. 
 
total 
accepted 
reads 
alignment 
rate 
total 
aligned 
reads 
PCR 
duplication 
rate 
unique 
reads 
mapped 
non-crosslinked 
beads-only 
5887649 46.1% 2716758 99.87% 3532 
non-crosslinked 
Osk IP 
44558054 59.8% 26667372 99.97% 8000 
UV crosslinked 
beads-only 
32267440 63.4% 20449096 99.95% 10225 
UV crosslinked 
Osk IP 
31458786 47.3% 14868341 99.92% 11895 
Table 1: Statistical analysis of the optimized Oskar iCLIP libraries 
The analysis of the data shown in Table 1 revealed a different library size for the different 
experimental conditions. The library from the non-crosslinked beads-only sample was the 
smallest (~6 millions of reads), whereas the non-crosslinked Osk IP library was the largest, 
with ~44 millions of reads. The libraries from the UV crosslinked condition were of a 
comparable size, with ~32 and ~31 millions of reads in the beads-only and the Osk IP samples, 
respectively. The percentage of reads successfully aligned in Drosophila genome ranged 
between 46% and 63% depending on the sample. In all four libraries, the reads that could not 
be aligned mainly contained L3App adapter sequences, probably derived from the ~260bp 
contaminating band present in all four experimental samples. Unfortunately, all four libraries 
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showed an extremely high PCR duplication rate (close to 99.9%) that strongly reduced, to just 
a few thousand, the number of unique reads aligned in each sample (Table 1). 
To further analyze the results, I focused on the three mRNA targets identified by candidate 
approach in the Osk CLIP experiment (Fig. 9 and Fig. 14). I hoped that, even if the experiment 
was not optimal due to the high rate of PCR duplication in the libraries, it might be still possible 
to confirm the UV- and Osk-dependent enrichment of nos, pgc and gcl mRNAs and to infer 
information regarding the position of Osk binding on those RNAs. 
 
Figure 21: Osk iCLIP libraries alignment. Osk iCLIP libraries were sequenced on Illumina 
HighSeq 2000 instrument. After data processing the reads from the different libraries were aligned 
against Drosophila genome. Final data were visualized with Integrative Genomics Viewer software [197] 
[198]. The alignment results for three genes are showed: (A) nos, (B) pgc (C) gcl. In the schematic 
representation of the genomic sequences, green boxes represent 5’UTRs, blue boxes represent the 
coding regions, purple boxes represent 3’UTRs and black lines represent introns. In B, both splicing 
isoforms of pgc (pgc-RA and pgc-RC) are shown. 
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The results of sequence alignment for nos mRNA are shown in Figure 21A. In general, 
fewer reads could be mapped to nos mRNA in the non-crosslinked than in the UV crosslinked 
condition, and the vast majority of the reads mapped to the nos 3’UTR. The major cluster of 
reads in the 3’UTR is present in both UV crosslinked beads-only and Osk IP libraries with the 
same intensity. A smaller cluster of reads is present at the same position also in the non-
crosslinked Osk IP sample. In the UV crosslinked Osk IP library, in addition to the major cluster 
of reads from the 3’UTR, several smaller clusters map to the 3’UTR and the 5’UTR of the nos 
sequence. Even if some of these are absent in the control samples (Fig. 21A), the clusters in 
the UV crosslinked Osk IP library contain too few reads (between 2 and 5) to be considered 
putative Osk deposition sites, and to conclude that nos mRNA was enriched in the UV 
crosslinked and Osk IP experimental sample. 
A similar analysis was carried out for pgc mRNA (Fig. 21B). In this case, the number of 
reads aligned to pgc transcripts in the different conditions was generally lower than nos mRNA. 
Similar to nos, most of the reads map to the pgc 3’UTR and a few more to the 5’UTR. As in 
the case of nos, due to the low number of mappable reads, it was not possible to confirm the 
UV- and Osk-dependent enrichment of the pgc transcript and it was not possible to recognize 
putative deposition sites of Osk protein on the RNA (Fig. 21B). 
The results for gcl mRNA were very poor. Only three reads could be mapped to gcl in the 
four iCLIP libraries and none from the UV crosslinked Osk IP sample (Fig. 21C). Therefore, 
was not possible to confirm gcl RNA as a binding partner of Osk protein in vivo. The other 
reads present in the iCLIP libraries mapped randomly throughout the Drosophila genome, 
without a specific enrichment for particular mRNAs other than rRNAs. 
 
3.6. nos and pgc 3’UTRs are enriched in Oskar CLIP experiments 
The results of the Osk iCLIP experiment shown in Figure 21 did not allow me to confirm 
Osk association with nos, pgc and gcl mRNAs. Given that in the case of nos and gcl mRNAs, 
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the majority of the reads mapped to the 3’UTR of both transcripts, I decided to try a different 
CLIP-based approach to investigate which regions of nos and pgc mRNAs might be bound by 
Osk. 
To this end, I performed an Osk CLIP experiment on denatured embryo extracts, as 
described in the Paragraph 3.3. After RNA extraction and reverse-transcription using random 
hexamer primers, I analyzed the cDNAs by qPCR using primers that amplify short DNA 
fragments covering different regions of nos and pgc mRNAs. Most of the primers used in the 
experiment were designed to anneal in the 3’UTR of nos and pgc sequences (Fig. 22A and 
D), as the highest number of unique mappable reads in the Osk iCLIP libraries mapped in 
these positions (Fig. 21A and B). 
The results of the experiment for nos mRNA are shown in Figure 22B and C. All the 
fragments tested were significantly enriched upon UV crosslinking and Osk IP, but to different 
degrees. Interestingly, the two fragments located at the 3’ end of nos 3’UTR (nos3’UTR7 and 
nos3’UTR8) were the most enriched (Fig. 22B). 
One can speculate that, if the efficiency of reverse-transcription along the target mRNA 
were identical, all fragments produced under the UV crosslinked Osk IP condition should be 
enriched to the same degree. In reality, a number of factors might influence reverse-
transcription such as nucleotide sequence, secondary structure or selective degradation of 
some mRNAs [199]. As a consequence, some fragments might be over or underrepresented 
in the pool of cDNA produced in the reaction. In order to control for the efficiency of reverse-
transcription along nos mRNA, I measured the relative abundance of the different nos 
fragments, normalized with respect to the housekeeping protein encoding Act42A mRNA, in 
the input extracts. The graph in Figure 22C shows the results of the analysis. The first six 
fragments of nos mRNA (nos5’UTR, nosEx2, nos3’UTR2, nos3’UTR3, nos3’UTR5 and 
nos3’UTR6) were all expressed at similar levels, and were between 2 and 4 fold more 
abundant than Act42A mRNA. Conversely, two fragments that mapped to the 3’ end of nos 
3’UTR (nos3’UTR7 and nos3’UTR8) appeared underrepresented compared to the others. This 
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result was probably the consequence of the random hexamer primers used for reverse-
transcription. Indeed, random hexamer primers anneal inefficiently to poly(A) stretches, 
resulting in underrepresentation of cDNA fragments covering mRNA regions close to the 
poly(A) tail. 
 
Figure 22: nos and pgc 3’UTRs are enriched in Oskar CLIP. Osk CLIP experiments were 
performed as described in Paragraph 3.3. The cDNAs were analyzed by qPCR for the enrichment of 
different fragments of both nos and pgc mRNAs. (A and D). Schematic representation of nos and pgc 
genomic regions. The two splicing isoforms of pgc (pgc-RA and pgc-RC) are shown. Green boxes 
represents 5’UTRs, blue boxes represent coding regions, purple boxes represent 3’UTRs and black 
lines represent introns. The red lines below the gene structure represent the DNA fragments amplified 
by qPCR. Black arrows represent the position of PCR primers used for amplification of the two 5’UTR 
variants of pgc (two isoform specific forward primers and a single reverse primer). (B and E). qPCR 
analysis of Osk CLIP experiment for nos and pgc mRNAs. For both UV crosslinked and non-crosslink 
conditions, the level of enrichment for the different fragments of nos and pgc measured in the Osk IP 
was normalized to the level of the beads-only control. Bars represent mean values ± standard deviation. 
p values were calculated using Student’s t test. (C and F). Relative abundance of nos and pgc fragments 
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tested in B and E, measured in the input extracts. The levels were normalized compared to the 
housekeeping Act42A mRNA. Bars represent mean values ± standard deviation. 
Taken together, the low relative abundance of nos3’UTR7 and nos3’UTR8 fragments in 
the input samples and the high degree of enrichment of those same fragments in the Osk CLIP 
experiment might indicate that nos3’UTR7 and nos3’UTR8 fragments were specifically 
enriched, in a UV- and Osk-dependent manner. One can therefore speculate that Osk might 
bind in vivo to the nos mRNA, at a position close to the poly(A) tail of the transcript. Indeed, if 
this were the case, this region of nos would preferentially co-precipitate with Osk upon UV 
crosslinking, whereas fragments located far from the crosslinking site(s) might be 
“preferentially” lost during the experiment procedure due to RNA degradation, which cannot 
be completely abolished. 
pcg mRNA was analyzed in a similar manner and the results are shown in Figure 22E and 
F. All pgc fragments analyzed in the Osk CLIP experiment were significantly enriched in the 
UV crosslinked Osk IP condition and, similarly to nos, the fragment closest to the poly(A) tail 
(pgc3’UTR4) was the most enriched (Fig. 22E). Analysis of the relative abundance of the pgc 
fragments in the input material revealed that pgc3’UTR4 was underrepresented compared to 
the others. As in the case of nos mRNA, one can speculate that Osk binds to pgc mRNA at a 
position near the poly(A) tail. 
An additional pgc fragment is underrepresented in the input material: pgc5UTRA (Fig. 
22F). There are two splicing isoforms of pgc mRNA, pgc-RA and pgc-RC, that possess 
different 5’UTRs (Fig. 22D). The qPCR analysis shown in Figure 22F revealed that the two 
isoforms are expressed at different levels in 0 to 2 hour old Drosophila embryos: pgc-RC is 
roughly 100 times more abundant than pgc-RA. Both isoforms are enriched in the Osk CLIP 
experiment in a UV- and Osk-dependent manner and, reflecting their relative abundance in the 
input, pgc-RC is enriched to a higher level than is pgc-RA (Fig. 22E). However, considering 
the different expression levels of the two pgc isoforms in the input material, and taking into 
account the data from the optimized Osk iCLIP experiment, in which no reads could be mapped 
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to the pgc-RA 5’UTR (Fig. 21B), I would not conclude that Osk binds to the 5’UTR of the pgc-
RA isoform. 
In conclusion, the Osk CLIP experiments shown in Figure 22 indicate that fragments close 
to the poly(A) tail of nos and pgc mRNAs are specifically enriched in a UV- and Osk-dependent 
manner. Unfortunately these results were not confirmed in the optimized Osk iCLIP 
experiment. Lacking additional experimental evidences in support of the results of the Osk 
CLIP experiments showed in Figure 22, I can only speculate that Osk might associates close 
to the poly(A) tail of nos and pgc mRNAs in vivo. These data, even if not fully conclusive, might 
represent a good starting point to further investigate Osk deposition site(s) on nos and pgc 
transcripts.  
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4. Discussion and Conclusions 
The accumulation of Osk protein at the posterior pole of the Drosophila oocyte triggers 
assembly of the germ plasm of the animal. The pole plasm contains all the molecular factors, 
both proteins and RNAs, required for both germ cell formation and posterior patterning (Fig. 6) 
[47] [88]. The pole plasm inducing activity of Osk relies on its ability to recruit in a step wise 
process other pole plasm components. Among the pole plasm components, it has been shown 
that Osk directly interacts with Vas, Vls and Lasp proteins [113] [115] [116] [117] and that Osk 
activity is necessary for the posterior localization of several mRNAs such as nos, cycB, pgc, 
gcl, osk and Hsp83 [49] [89] [137] [141] [182] [183]. 
Despite the large amount of information produced in more than 20 years of research, the 
molecular mechanism underling the pole plasm inducing activity of Osk is still not fully 
understood. Recently, two independent studies demonstrated that Osk associates with 
polyadenylated mRNAs in Drosophila embryos and indicated that Osk’s RNA-binding activity 
might be exerted, at least in part, by the C-terminal OSK domain [109] [149]. The ability to 
interact with RNA might represent a crucial feature during pole plasm assembly. Osk might 
directly recruit some mRNAs at the posterior pole or it might exert regulatory functions in post-
transcriptional processes such as mRNA stabilization and translation. 
In order to investigate the RNA-binding activity of Osk, I applied the CLIP methodology 
[161], using UV light as a crosslinking agent to stabilize Osk-RNA interactions in vivo. I set up 
stringent Osk IP conditions in 0 to 2 hour old embryos (Fig. 8) and performed Osk CLIP 
experiments that I analyzed in a candidate approach, in which I tested by qPCR the UV- and 
Osk-dependent enrichment of a set of posteriorly localized mRNAs in Drosophila early embryo. 
Among the targets analyzed, I detected a significant enrichment of three mRNAs: nos, pgc and 
gcl (Fig. 9) [109], all three of which are involved in abdomen and/or germ cell formation. nos is 
not only a morphogen that acts in abdominal patterning, but is also required during PGC 
formation to inhibit somatic gene expression and mitosis [48] [133] [134] [135] [136]. pgc and 
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gcl are both required to maintain transcriptional quiescence of PGCs during early 
embryogenesis [138] [139] [145].  
The data I obtained showing that Osk associates with nos, pgc and gcl mRNAs in vivo 
suggest that, by direct interaction, Osk might be involved in regulating its target mRNAs. It is 
noteworthy that Osk activity is required to activate nos mRNA translation at the posterior [59] 
[60]. It is tempting to speculate that, in the case of nos mRNA, Osk might interact directly with 
nos in such a manner as to promote its translation at the posterior pole. Only a small number 
of mRNAs were tested in the candidate approach, hence it is possible that Osk additionally 
associates with other posteriorly localized transcripts that were not analyzed. 
To further characterize Osk’s RNA-binding activity I decided to apply the iCLIP protocol, 
an unbiased transcriptome-wide method that should allow one to identify all the binding targets 
of a specific RBP, as well as the precise sites of protein binding on the mRNAs [174] (Fig. 13). 
Unfortunately, the Osk iCLIP experiment was not successful and I was not able to confirm any 
of the mRNAs identified in the Osk CLIP experiment. 
Considering that the iCLIP approach has been used to study several RBPs in vivo [174] 
[175] [176] [177] [178] [179] [180], the negative results of the Osk iCLIP experiment that I 
performed might indicate that Osk is not a genuine RBP. The enrichment of nos, pgc and gcl 
mRNAs in the Osk CLIP experiment (Fig. 9) might be due to the residual interaction of Osk 
with other RBPs in the embryo extracts, rather than to crosslinking events occurring between 
Osk and these transcripts. Although the stringency of the IP conditions used in the experiment 
were such that I did not detect the co-IP of Vas and Smg (Fig. 9C and Fig. 13A), two proteins 
that have been shown to interact with Osk directly [60] [113] [115], I cannot exclude that 
residual amounts of these or other RBPs crosslinked to their target RNAs, below the detection 
limit of the western blot assay, co-IPed with Osk nevertheless. 
To rule out that the UV- and Osk-dependent enrichment of nos, pgc and gcl mRNAs might 
be caused by residual interactions between Osk and other proteins associated with these 
mRNAs, I increased the stringency of the IP conditions by performing the Osk IP on denatured 
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embryo extracts (Fig. 14A). The denaturation applied during the Drosophila embryo extract 
preparation should consequently prevent interaction between Osk and other proteins, and 
allow me to exclusively IP Osk. The results of the Osk CLIP experiment from denatured embryo 
extracts show that nos, pgc and gcl mRNAs are enriched in a UV- and Osk-dependent manner 
(Fig. 14B). This demonstrates that Osk is UV crosslinked to nos, pgc and gcl mRNAs in 0 to 2 
hour old Drosophila embryos. In the case of pgc mRNA, I measured a similar level of 
enrichment upon UV crosslinking and Osk IP from non-denatured and denatured experimental 
conditions (compare Fig. 9B and 14B). This suggests that pgc might be a direct binding target 
of Osk protein in vivo. In contrast, the low level of enrichment measured for gcl mRNA, even if 
statistically significant, might indicate an unspecific interaction with Osk (Fig. 14B). The 
enrichment of nos mRNA measured in denaturing conditions (Fig. 14B) was significantly lower 
than from the Osk CLIP experiment shown in Figure 9B. This might indicate that, in the non-
denaturing Osk CLIP experiment, nos mRNA was not directly crosslinked to Osk but was 
crosslinked to some other protein(s) co-precipitating with Osk. 
Although the Osk CLIP experiment performed on denatured embryo extracts showed that 
Osk can be UV crosslinked in vivo to pgc mRNA and to a lesser extent to nos and gcl mRNAs 
(Fig. 14), I cannot conclude that Osk is a genuine RBP. The reason for this is that the UV 
crosslinking step is performed on intact embryos in which Osk, localized within the pole plasm, 
is in close proximity to other pole plasm components. The interaction between Osk and other 
RBPs bound to their own target mRNAs might bring these mRNA molecules close enough to 
Osk for crosslinking to the protein upon UV light irradiation. The identification of putative Osk 
binding site(s) on the target mRNAs would allow me to test whether the RNA-binding activity 
of Osk detected in vivo is truly significant. As a genuine RBP, Osk might recognize specific 
sequence motif(s) or secondary structure element(s) within the target mRNA sequences. Once 
these are identified, I would design specific mutations that should abolish Osk recognition, 
either confirming or disproving the RNA-binding activity of the protein. 
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Since the unsuccessful result of the Osk iCLIP experiment shown in Figure 13 was not 
due to the lack of mRNAs crosslinked to the protein, other steps in iCLIP library preparation 
(Fig. 10) might be responsible for the negative results of the experiment. In particular, the 
enzymatic reactions performed before the RNA extraction step, namely partial RNA digestion, 
3’ end dephosphorylation and L3App adapter ligation, are crucial for generating a library of 
good quality. Considering the suboptimal amount of starting material used in the experiment 
(Fig. 11), insufficiently controlled and optimized reactions might negatively impact on iCLIP 
library preparation. I therefore decided to focus on the optimization of these enzymatic 
reactions. 
I first established new conditions for the partial RNA digestion step. The new reaction 
conditions allowed me to reproducibly achieve optimal levels of RNA fragmentation and in 
general they allowed me to better control this step of the iCLIP protocol (Fig. 15). 
Next, I analyzed the efficiency of the 3’ end dephosphorylation step performed using the 
iCLIP protocol conditions. The data obtained suggested that this reaction was not a limiting 
step in the protocol, as PNK-mediated dephosphorylation worked efficiently under the original 
iCLIP experimental conditions (Fig. 16). 
Finally, my analysis of the L3App adapter ligation step revealed that this reaction was the 
limiting step in the original iCLIP protocol (Fig. 17A and B). By testing several reaction buffer 
compositions (Fig. 17C and D) and different amounts of enzyme (Fig. 18A and B), I 
successfully increased the L3App adapter ligation efficiency over a wide range of RNA 
substrate amounts (Fig. 18C and D). 
Once the iCLIP conditions were optimized, I repeated the Osk iCLIP experiment from 
denatured embryo extracts using my new protocol (Fig. 19). The iCLIP libraries produced using 
the optimized conditions contained 1000 time more cDNA material than the previous non-
optimized Osk iCLIP experiment (compare Fig. 19C and Fig. 13B). Two factors might account 
for this: the higher efficiency of the optimized L3App ligation step (Fig.18) and the higher RNA 
level present in all four experimental conditions in the Osk CLIP assay from denatured embryo 
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extracts (Fig. 15B). Interestingly, in the optimized Osk iCLIP experiment, the library produced 
from the UV crosslinked and Osk IP sample contained more DNA material compared to the 
three control conditions (Fig. 19C, D and Fig. 20). 
The analysis of the sequencing data revealed that the optimized iCLIP protocol improved 
the overall quality of the libraries. The percentage of reads aligned to the Drosophila genome 
ranged between 46% and 63%, depending on the specific experimental condition. 
Unfortunately the PCR duplication rate of the libraries was high (99.9%), strongly reducing the 
number of unique mappable reads (Table 1). Indeed, analysis of the alignment results for nos, 
pgc and gcl mRNAs revealed the negative outcome of the experiment. In the case of nos and 
pgc, the few reads aligned on the transcripts mainly clustered in the 3’UTR of the mRNAs. 
Unfortunately, the low number of mappable reads and the absence of striking differences 
between the experimental and the control conditions did not allow me to confirm a UV- and 
Osk-dependent enrichment of nos and pgc mRNAs, precluding identification of putative Osk 
binding sites (Fig. 21A and B). The results for gcl mRNA were very poor, and from the UV 
crosslinked Osk IP condition no reads could be mapped to gcl (Fig. 21C). 
The negative outcome of the optimized Osk iCLIP experiment might be due to two different 
technical issues. On the one hand, an important negative contribution might be due to those 
steps of the protocol that I did not optimize, such as reverse-transcription, circularization and 
linearization (Fig. 10). It is possible that low efficiency of at least one of these steps might have 
negatively influenced the experiment. However, it is important to keep in mind that the same 
experimental conditions, including low efficiency ligation conditions were successfully applied 
by others studying different RBPs in vivo [174] [175] [176] [177] [178] [179] [180]. On the other 
hand, the suboptimal amount of RNA that co-IPed with Osk (Fig. 15B) might have been the 
major limitation of the experiment. In this regard, one should note that in one study, in vitro 
experiments are presented that would suggest that Osk has a low binding affinity for RNAs (in 
the low micromolar range) [109]. 
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Considering the number of unique reads that I was able to map in the optimized Osk iCLIP 
experiment (a few thousand) (Table 1), it might be necessary to scale up the protocol at least 
100 times to produce datasets rich enough to be informative. In the Osk iCLIP experiment, 
0.5g of Drosophila embryos were used as the starting material for preparation of each sample. 
Therefore the amount of embryos (hundreds of grams), buffers, enzymes and other reagents 
required for such a scaled up experiment probably exceeds a rational ratio between cost and 
benefit, and another strategy should be envisioned. 
My data suggest that the iCLIP protocol cannot be applied to the study of Osk-RNA 
interaction in vivo. Other approaches, easier from a technical point of view, such as a 
commercial kits designed for cDNA library preparation from low amounts of RNA, might be 
used to analyze the RNA interactome bound to Osk in vivo. Although they would constitute a 
first step, none of these experimental strategies provides the high resolution required to identify 
the binding site(s) of the protein on its target mRNAs. Even if the optimized iCLIP protocol I 
established did not allow me to carry out a full analysis of Osk-RNA interactions, it should be 
applicable for the study of other RBPs in Drosophila or other model organisms. 
The finding that in the optimized Osk iCLIP experiment the majority of the reads mapped 
to nos and pgc mRNAs were clustered in the 3’UTR of both transcripts led me to try a different 
CLIP-based approach to narrow down which part of those mRNAs might be crosslinked to Osk 
in vivo. After performing an Osk CLIP experiment from denatured embryo extracts, as shown 
in Figure 14, I analyzed the extracted RNAs by qPCR using primers to amplify short stretches 
of nucleotides spanning the length of the nos and pgc mRNA sequences. The results of these 
experiments showed that, for both nos and pgc mRNAs, the 3’UTR fragments close to the 
poly(A) tail were more enriched in a UV- and Osk-dependent manner than were the other 
fragments tested (Fig. 22B and E). Although these data indicate a possible preference of Osk 
for association with the nos and pgc 3’UTRs, at this stage there are no additional data to 
support this hypothesis. 
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In conclusion, in this study I provided the first experimental evidence regarding the 
interaction between Osk and three mRNAs (nos, pgc and gcl mRNAs) localized at the posterior 
pole of live Drosophila embryos (Fig. 9) [109]. By performing the same experiment using 
denatured embryo extracts, I showed that, upon UV light irradiation, Osk is directly crosslinked 
to nos, pgc and gcl mRNAs, suggesting that Osk-RNA interaction might be mediated by an 
intrinsic RNA-binding activity of the protein (Fig. 14). To further study Osk-RNA interaction in 
vivo, I applied the iCLIP protocol, an unbiased transcriptome-wide strategy. After a first 
negative outcome of the experiment, I focused on optimization of three major steps in iCLIP 
library preparation: partial RNA digestion, 3’ end dephosphorylation and L3App adapter 
ligation. My efficiency test experiment showed that the 3’ end dephosphorylation reaction is 
not the limiting step in the iCLIP protocol (Fig. 16). Conversely the L3App adapter ligation step, 
due to low reaction efficiency, was suboptimal for the library preparation process (Fig. 17A and 
B). By changing the reaction conditions, I managed to increase the efficiency of this step (Fig. 
17C, D and Fig. 18). In spite of this improvement, performance of the Osk iCLIP experiment 
using the optimized protocol nevertheless again resulted in a negative outcome (Fig. 21). 
Finally, by using a different, CLIP-based approach, I showed that nos and pgc 3’UTR 
fragments close to the poly(A) tail of both transcripts are preferentially enriched upon UV 
irradiation and Osk IP (Fig. 22). These data might indicate an interaction of Osk with these 
particular regions of nos and pgc mRNAs. 
Although I found that Osk associates in vivo with nos, pgc and gcl mRNAs, the next steps 
into the project will require knowing precisely where on the target mRNAs Osk is bound. This 
information would allow me to design specific mutations to abolish Osk interaction with a 
specific mRNA and analyze the biological relevance of the Osk RNA-binding activity I detected. 
It would be possible to address whether and which mRNA post-transcriptional processes Osk 
might influence, such as localization, translation or stability. In addition, knowledge of the 
precise Osk binding sequences in the mRNAs would make it possible to study how the 
protein’s RNA-binding activity influences posterior patterning, germ cell formation and germ 
cells viability. 
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5. Materials and methods 
5.1. UV crosslinking in Drosophila embryos in vivo 
UV crosslinked and non-crosslinked embryo extracts were prepared from Drosophila 
melanogaster Oregon R wild-type animals. Embryos were collected between 0 and 2 hours 
after egg laying on 1% agar and 30% apple juice plates supplemented with yeast paste, 
dechorionated in a 50% sodium hypochlorite solution for 4’ and extensively washed with water. 
Dechorionated embryos were resuspended in 15ml of Embryo Washing Buffer (120mM NaCl; 
0.04% Triton-X100), spread on 600cm2 cell culture plates and irradiated with UV light (254nm; 
1J*cm-2) on ice in a Stratalinker 2400 (Stratagene) instrument; non-crosslinked control 
embryos were left on ice. 
 
5.2. Embryo extracts preparation 
UV crosslinked and non-crosslinked embryos were collected and resuspended in 1 
volume (1g in 1ml) of specific Lysis Buffer (see below). 
 
5.2.1. Non-denatured embryo extracts 
Embryos were resuspended in Lysis Buffer 1 (LB1) (20mM Tris-HCl pH 7.5; 500mM LiCl; 
0.5% LiDS; 1mM EDTA; 1mM DTT) [148] supplemented with complete EDTA-free proteinase 
inhibitor cocktail (Roche) and RiboLock RNase inhibitor (Thermo Scientific), then lysed using 
a 15ml Douncer homogenizer (Wheaton). The extracts were centrifuged 10’ at 3500g at 4⁰C, 
the supernatants collected were frozen in liquid N2 and stored at -80⁰C for later use. After 
thawing, extracts were centrifuged 4’ at 16000g and the supernatant were diluted 1:10 (1g in 
10ml) in LB1 [148] supplemented with complete EDTA-free proteinase inhibitor cocktail 
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(Roche) and RiboLock RNase inhibitor (Thermo Scientific). 5ml aliquots (0.5g of embryos) 
were prepared and stored on ice. 
 
5.2.2. Non-denatured embryo extracts supplemented with Na 
deoxycholate 
Embryo lysis was performed as described in 5.2.1. After thawing and centrifugation (4’ at 
16000g) the supernatants were diluted 1:10 (1g in 10ml) in Lysis Buffer 2 (LB2) (20mM Tris-
HCl pH 7.5; 500mM LiCl; 0.5% LiDS; 0.5% Na deoxycholate; 1mM EDTA; 1mM DTT) 
supplemented with complete EDTA-free proteinase inhibitor cocktail (Roche) and RiboLock 
RNase inhibitor (Thermo Scientific). 5ml aliquots (0.5g of embryos) were prepared and stored 
on ice. 
 
5.2.3. Denatured embryo extracts 
After collection (see 5.1), embryos were resuspended in Lysis Buffer Urea (LBU) (20mM 
Tris-HCl pH 7.5; 500mM LiCl; 0.5% LiDS; 8M urea; 1mM EDTA; 1mM DTT) supplemented 
with complete EDTA-free proteinase inhibitor cocktail (Roche) and RiboLock RNase inhibitor 
(Thermo Scientific). Lysis was performed in a 15ml Douncer homogenizer (Wheaton). The 
extracts were centrifuged 10’ at 16000g at 4⁰C and the supernatants collected were diluted 
1:10 (1g in 10ml) using LB2. 5ml aliquots (0.5g of embryos) of the extracts were prepared, 
frozen in liquid N2 and stored at -80⁰C. 
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5.3. CLIP 
5.3.1. Immunoprecipitation 
Different IP conditions were used in the experiments presented in this work and described 
in the next paragraphs. For each IP, 20μl of protein G sepharose beads (GE Healthcare) were 
used. 
 
5.3.1.1. Immunoprecipitation from non-denatured embryo 
extracts 
Beads were washed 3 times for 5’ on a rotating wheel in the cold (8⁰C) with Coupling 
Buffer (CB) (20mM Tris-HCl pH 7.5; 150mM NaCl; 0.5mM EDTA; 0.2% Nonidet P-40). 50μl of 
anti-Osk antibody [89] were added to beads together with 450μl of CB and the samples were 
incubated overnight on a rotating wheel in the cold (8⁰C). Beads-only control samples were 
incubated in absence of the antibody. Beads were washed 3 times with LB1 [148] 
supplemented with complete EDTA-free proteinase inhibitor cocktail (Roche) and RiboLock 
RNase inhibitor (Thermo Scientific), for 5’ in the cold (8⁰C) and were added to 5ml aliquots of 
embryo extract prepared according to 5.2.1. Before beads addition, two aliquots of 50μl each 
were collected from the extracts to analyze proteins and RNAs in the input. IPs were incubated 
1 hour at room temperature on a rotating wheel. After incubation, the beads were washed 3 
times (1ml) with LB1 [148], 3 times with (1ml) Washing Buffer 1 (WB1) (20mM Tris-HCl pH 7.5; 
500mM LiCl; 0.1% LiDS; 1mM EDTA; 1mM DTT) [148] and 3 times (1ml) with Washing Buffer 
3 (WB3) (20mM Tris-HCl pH 7.5; 150mM LiCl; 0.1% LiDS; 1mM EDTA; 1mM DTT). All buffers 
were supplemented with complete EDTA-free proteinase inhibitor cocktail (Roche) and 
RiboLock RNase inhibitor (Thermo Scientific), and all the washes were performed for 10’ on a 
rotating wheel in the cold (8⁰C). For the experiment in Figure 8 (lanes 2, 3, 7 and 8), beads 
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were resuspended in 20μl of 2X NuPage LDS sample buffer (Thermo Scientific) and incubated 
10’ at 95⁰C for protein elution. 
 
5.3.1.2. Immunoprecipitation from non-denatured embryo 
extracts supplemented with Na deoxycholate 
Beads preparation and antibody coupling were performed as described in 5.3.1.1. Beads 
were washed 3 times with LB2, supplemented with complete EDTA-free proteinase inhibitor 
cocktail (Roche) and RiboLock RNase inhibitor (Thermo Scientific), for 5’ in the cold (8⁰C), 
then were added to 5ml aliquots of embryo extracts prepared as described in 5.2.2. Before 
beads addition, two aliquots of 50μl each were collected for the analysis of proteins and RNAs 
in the input. IP incubation was performed as described in 5.3.1.1. Beads were washed 3 times 
(1ml) with LB2, 3 times (1ml) with Washing Buffer 2 (WB2) (20mM Tris-HCl pH 7.5; 500mM 
LiCl; 0.1% LiDS; 0.1% Na deoxycholate; 1mM EDTA; 1mM DTT) and 3 times (1ml) with WB3. 
All buffers were supplemented with complete EDTA-free proteinase inhibitor cocktail (Roche) 
and RiboLock RNase inhibitor (Thermo Scientific) and all the washings were performed for 10’ 
on a rotating wheel in the cold (8⁰C). For the experiment in Figure 8 (lanes 4, 5, 9 and 10) 
beads were resuspended in 20μl of 2X NuPage LDS sample buffer (Thermo Scientific) and 
incubated 10’ at 95⁰C for protein elution. For experiments in Figures 9 and 13, 1% of the beads 
were resuspended in 10μl of 2X NuPage LDS Sample Buffer (Thermo Scientific) for western 
blot analysis. 
 
5.3.1.3. Immunoprecipitation from denatured embryo extracts 
Beads were prepared and coupled to anti-Osk antibody as described in 5.3.1.1. Beads 
were washed 3 times with LB2 supplemented with complete EDTA-free proteinase inhibitor 
cocktail (Roche) and RiboLock RNase inhibitor (Thermo Scientific), for 5’ in the cold (8⁰C). 
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After washings, the beads were added to embryo extracts prepared as described in 5.2.3. 50μl 
aliquots were collected from the extracts before bead addition for protein and RNAs analysis. 
IPs were incubated overnight (16 hours) on a rotating wheel in the cold (8⁰C). Beads were 
washed 3 times (1ml) with Washing Buffer Urea 1 (WBU1) (20mM Tris-HCl pH 7.5; 500mM 
LiCl; 0.5% LiDS; 0.8M urea; 1mM EDTA; 1mM DTT), 3 times (1ml) with Washing Buffer Urea 
2 (WBU2) (20mM Tris-HCl pH 7.5; 500mM LiCl; 0.1% LiDS; 0.8M urea; 1mM EDTA; 1mM 
DTT) and 3 times (1ml) with Washing Buffer 4 (WB4) (20mM Hepes pH 7.8; 125mM NaCl; 
0.1% Nonidet P-40). All buffers were supplemented with complete EDTA-free proteinase 
inhibitor cocktail (Roche) and RiboLock RNase inhibitor (Thermo Scientific) and all the 
washings were performed for 10’ on a rotating wheel in the cold (8⁰C). 1% of the beads were 
resuspended in 10μl of 2X NuPage LDS Sample Buffer (Thermo Scientific) for protein elution 
and western blot analysis (Fig.14 and Fig. 19). 
 
5.3.2. RNA extraction 
At the end of the Osk IP processes described in 5.3.1.2 and 5.3.1.3, beads were 
resuspended in 100μl of Proteinase K Buffer (PKB) (10mM Tris-HCl pH 7.5, 150mM NaCl; 
0.2% SDS; 10mM EDTA; 0.5mM DTT; 5mM CaCl2) [148], supplemented with 80μg of 
Proteinase K (Promega) and incubated 1 hour at 50⁰C in a Thermomixer C (Eppendorf). RNA 
extraction was performed using TRIzol LS reagent (Invitrogen) according to the manufacturer’s 
protocol and extracted RNAs were resuspended in 6μl diethyl pyrocarbonate (DEPC) treated 
H2O. 50μl aliquots from input extracts were supplemented with 40μg of Proteinase K 
(Promega) and incubated 1 hour at 50⁰C. RNA was extracted using TRIzol LS (Invitrogen), 
treated with Turbo DNase (Invitrogen) according to manufacturer’s instructions and again 
extracted using Phenol/Chloroform/isoamyl alcohol (AppliChem). The RNA was ethanol 
precipitated overnight at -20⁰C in presence of 0.3M Na acetate (pH 5.0) and 15μg of GlycoBlue 
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(Invitrogen). The RNA was resuspended in 50μl DEPC treated H2O and RNA concentration 
was measured using a NanoDrop 8000 instrument (Thermo Scientific). 
 
5.3.3. Reverse-transcription 
Reverse-transcription was performed using a SuperScript III First-Strand Synthesis 
SuperMix kit (Invitrogen) using random hexamer primers, following the manufacturer’s 
instructions. 1μg of total RNA extracted from UV crosslinked and non-crosslinked inputs were 
used for cDNA synthesis, whereas all the RNA extracted from the IP samples was used in the 
reaction. 
 
5.3.4. Quantitative real-time PCR 
qPCR analysis was performed on a StepOnePlus Real-Time PCR System (Applied 
Biosystems). Each reaction was prepared in 11μl total volume containing: 1.1μl cDNA; 0.33μl 
primers mix (10μM); 5.5μl 2X SYBR Green PCR Master Mix (Applied Biosystems); 4.07μl 
DEPC treated H2O. 10μl of the mix were used for the PCRs. The PCRs were performed using 
the following conditions: 
10’ at 95⁰C - {15’’ at 95⁰C - 15’’ at (see Table 2) - 1’ at 60⁰C}. 
45 total PCR cycles (steps between {---}). 
Results were visualized with StepOne software v2.3 (Applied Biosystems) and analyzed 
using the ΔΔCt method. All primers were purchased from Eurofins Genomics. 
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Primer name Sequence 5’-3’ Ann. T Figure 
nos2 RT Fw AATCTCGGCGTGGGAATGGG 55⁰C 9, 14 
nos2 RT Rev GGGCACAGCACTCGGTTAAAG 55⁰C 9, 14 
orb1 RT Fw CGAGATTAGGACCACGAAGTTCAC 55⁰C 9 
orb1 RT Rev CTCTGCGACTTGGAGTTGCG 55⁰C 9 
CycB2 RT Fw CGAGGACGAGCACCATACG 55⁰C 9 
CycB2 RT Rev GCGAGTAGAAGGTCAGAGTGG 55⁰C 9 
pgc2 RT Fw GAAGACAGCTCCTGCGAGGG 55⁰C 9, 14 
pgc2 RT Rev CATCTATCCGCGATGACCGGC 55⁰C 9, 14 
gcl2 RT Fw CGGCACATTCACAACCACTG 55⁰C 9, 14 
gcl2 RT Rev CCAGGCTCAAGCAACATACG 55⁰C 9, 14 
osk4 RT Fw GCGGAGTCGAACTGGTGCTACC 55⁰C 9, 14 
osk4 RT Rev GTGGGCGTCATTTCGTGGCG 55⁰C 9, 14 
Hsp83-1 RT Fw ATACACAATTTACTTGCGTTTC 55⁰C 9 
Hsp83-1 RT Rev CGACAACTGCTCTTGAATG 55⁰C 9 
bcd1 RT Fw TGCTATGCCAAAGTGTCTG 55⁰C 9, 14 
bcd1 RT Rev TGCTCTTCTTAGTGATGTAAATAG 55⁰C 9, 14 
Act42A1 RT Fw GGCTGGGCGTGGTCGTTC 55⁰C 9, 14, 22 
Act42A1 RT Rev AAGTGTTGTGCGCCTGCTCCC 55⁰C 9, 14, 22 
nos5UTR Fw GAATTGCCGTACGCTTCGCAG 55⁰C 22 
nos5UTR Rev GGGTTAAAATCGTGACGCAGAGGC 55⁰C 22 
nosEx2 Fw CATCA CAACAGCAGGGGCTG 55⁰C 22 
nosEx2 Rev GTAGTTGTTCAGCCAGTGGGTGG 55⁰C 22 
nos3UTR2 Fw ACTTGTTCAATCGTCGTGGC 55⁰C 22 
nos3UTR2 Rev GACCAGTTGCAGACCAATTCC 55⁰C 22 
nos3UTR3 Fw CGTAAAATGTTCGCTTGCGG 55⁰C 22 
nos3UTR3 Rev CAGTTCGAAATTCAAAGTGTTCC 55⁰C 22 
nos3UTR5 Fw GACATTCCGCACTTTTTG 50⁰C 22 
nos3UTR5 Rev GAAATGAATACTTGCGATACATG 50⁰C 22 
nos3UTR6 Fw CATGTATCGCAAGTATTCATTTC 50⁰C 22 
nos3UTR6 Rev GAAAAATTGATCAATGGTAAAC 50⁰C 22 
nos3UTR7 Fw GTTTACCATTGATCAATTTTTC 55⁰C 22 
nos3UTR7 Rev CATTTTCAGAATATGTGTACAC 55⁰C 22 
nos3UTR8 Fw GTGTACACATATTCTGAAAATG 50⁰C 22 
nos3UTR8 Rev CCTTAAATTGTAACCATTTC 50⁰C 22 
pgc5UTRA2 Fw GTGGAAGCCAGGTGCATCTG 55⁰C 22 
pgc5UTRC2 Fw CAAGAGAACAAGTTGAGCGTGGC 55⁰C 22 
pgc5UTR Rev TCGCACATTTTCGGGTCTTC 55⁰C 22 
pgcORF Fw GAAGACAGCTCCTGCGAGGG 55⁰C 22 
pgcORF Rev GCAACTCCTCGCGCACTTGATG 55⁰C 22 
pgc3UTR2 Fw GCCACATGAGTGGAACATCGTG 55⁰C 22 
pgc3UTR2 Rev CATACGATCGCCTCTGAAGGCTG 55⁰C 22 
pgc3UTR3 Fw GTCCGTGTATTCAAATGTTTGC 55⁰C 22 
pgc3UR3 Rev GACAACCATATGCGATTGATTGG 55⁰C 22 
pgc3UTR4 Fw GTATTCAAGAACAAGTAGGGAAG 55⁰C 22 
pgc3UTR4 Rev GAACGATTGCGAATCGAAAATA 55⁰C 22 
Table 2: List of primers used for qPCR analysis 
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5.4. Radioactive labeling of protein-RNA complexes 
Osk IP was performed as described in 5.3.1.2. At the end of the washing steps, beads 
were resuspended in 1ml of WB3. 10μl of a series of dilutions (1:50, 1:500, 1:1000 and 1:2000) 
of a 100U/μl stock of RNase I (Invitrogen) were added to the samples (see Fig. 12 for details). 
In parallel, control samples were not treated with RNase I. The samples were incubated 3’ at 
37⁰C at 1100rpm in a Thermomixer C (Eppendorf) instrument and subsequently washed 2 
times (1ml) with 1X PNK Reaction Buffer B (50mM Tris-HCl pH 6.4; 18mM MgCl2; 5mM DTT; 
0.1mM spermidine; 0.1mM ADP) (Thermo Scientific). After washings, beads were 
supplemented with 20μl of T4 PNK Reaction Mix: 2μl 10X PNK Reaction Buffer B (Thermo 
Scientific); 2μl T4 PNK (10U/μl) (Thermo Scientific); 1μl RiboLock RNase inhibitor (Thermo 
Scientific); 1μl gamma 32P ATP (10mCi/ml) (Hartmann Analytic); 14μl DEPC treated H2O. 
Reactions were incubated 30’ at 37⁰C at 1100rpm in a Thermomixer C (Eppendorf). At the end 
of the incubation, beads were resuspended in 10μl of 2X NuPage LDS Sample Buffer (Thermo 
Scientific) and incubated 10’ at 75⁰C. Proteins were analyzed by SDS-PAGE and western blot 
as described in 5.10. 
 
5.5. iCLIP 
Osk IP was performed as described in 5.3.1.2 except for the last washing step, which was 
performed using WB4 (1ml, 3 times). All buffers were supplemented with complete EDTA-free 
proteinase inhibitor cocktail (Roche), RiboLock RNase inhibitor (Thermo Scientific) and 
0.02mg/ml of heparin (Sigma Aldrich). At the end of the washing steps, beads were 
resuspended in 1ml of WB4 (without heparin) and 10μl of a 1:1000 dilution of RNase I (stock 
100U/μl) (Invitrogen) were added. Samples were incubated 3’ at 37⁰C at 1100rpm in a 
Thermomixer C (Eppendorf) and subsequently washed 2 times with 1ml of WB4 
(supplemented with 0.02mg/ml of heparin) and 2 times with 1ml of WB4 (without heparin). The 
washings were performed for 5’ on a rotating wheel in the cold (8⁰C). Beads were equilibrated 
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2 times in 1ml of Dephosphorylation Buffer for Equilibration (DBE) (70mM Tris-HCl pH 6.5; 
10mM MgCl2; 5mM DTT) [186] then supplemented with 40μl of Dephosphorylation Reaction 
mix: 38μl Dephosphorylation Reaction Buffer (DRB) (74.1mM Tris-HCl pH 6.5; 10.6mM MgCl2; 
5mM DTT); 1μl T4 PNK (10U/μl) (Thermo Scientific); 1μl RiboLock RNase inhibitor (Thermo 
Scientific). Samples were incubated 30’ at 37⁰C at 1100rpm in a Thermomixer C (Eppendorf) 
and subsequently washed 2 times with 1ml of WB4 (supplemented with 0.02 mg/ml of heparin) 
and 2 times with 1ml of WB4 (not supplemented with heparin). The washings were performed 
for 5’ on a rotating wheel in the cold (8⁰C). Beads were equilibrated 2 times with 1ml of Ligation 
Buffer for Equilibration (LBE) (50mM Tris-HCl pH 7.5; 10mM MgCl2; 10mM DTT) [186] then 
supplemented with 40μl of Ligation Reaction mix: 27μl Ligation Reaction Buffer (75.3mM Tris-
HCl pH 7.5; 15mM MgCl2; 15mM DTT); 1μl T4 RNA ligase 2 truncated (200U/μl) (New England 
BioLabs); 3μl L3App adapter (20μM) (Sigma Aldrich); 1μl RiboLock RNase inhibitor (Thermo 
Scientific); 8μl PEG400 (20% final concentration) (Sigma Aldrich). Reactions were incubated 
overnight (16 hours) at 16⁰C at 1100rpm in a Thermomixer C (Eppendorf) then washed 2 times 
with 1ml of WB4 (supplemented with 0.02mg/ml of heparin) and 2 times with 1ml of WB4 
(without heparin). The washings were performed for 5’ on a rotating wheel in the cold (8⁰C). 
Beads were resuspended in 400μl of PKB [148], supplemented with 200μg of Proteinase K 
(Promega) and incubated 1 hour at 50⁰C at 1100rpm in a Thermomixer C (Eppendorf). RNA-
L3App were extracted using Phenol/Chloroform/isoamyl alcohol (AppliChem). Products were 
ethanol precipitated overnight at -20⁰C in presence of 0.3M Na acetate (pH 5.0) and 15μg of 
GlycoBlue (Invitrogen) then resuspended in 6μl DEPC treated H2O. For reverse-transcription, 
samples were transferred to 0.2ml PCR tubes and were supplemented with: 1μl Annealing 
Buffer (from Invitrogen SuperScript III First-Strand Synthesis SuperMix kit); 1μl RT primers mix 
(see Table 3). Samples were incubated in a C1000 Touch Thermal Cycler (Biorad): 5’ at 70⁰C 
- 5’ at 25⁰C; followed by addition of: 10μl 2X Reaction Mix; 2μl Superscript III (both from 
Invitrogen SuperScript III First-Strand Synthesis SuperMix kit). Samples were additionally 
incubated: 20’ at 25⁰C - 30’ at 42⁰C - 50’ at 50⁰C - 3’ at 90⁰C then cooled on ice. cDNA 
fragments were purified using QIAquick PCR Purification Kit (Qiagen) following the 
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manufacturer’s instructions and were eluted in 20μl of DEPC treated H2O. Samples were 
transferred to 0.2ml PCR tubes and were supplemented with 20μl of 2X Circularization mix: 
4μl 10X CircLigase II Reaction Buffer (Epicentre); 0.4μl MnCl2 (50mM) (Epicentre); 0.6μl 
CircLigase II ssDNA Ligase (100U/μl) (Epicentre); 15μl DEPC treated H2O. Samples were 
incubated in a C1000 Touch Thermal Cycler (Biorad): 1 hour at 60⁰C and subsequently 
supplemented with 17μl of Oligo Annealing mix: 6μl NEBuffer 4 (New England BioLabs); 1.5μl 
Cut Oligo (10μM) (Sigma Aldrich); 9.5μl DEPC treated H2O. Reactions were additionally 
incubated 4’ at 85⁰C, then slowly cooled down (T decreased 1⁰C/10’’) to 25⁰C. After addition 
of 3μl of BamHI HF (20U/μl) (New England BioLabs), samples were incubated 30’ at 37⁰C. 
Reaction products were purified using QIAquick PCR Purification Kit (Qiagen) following the 
manufacturer’s instructions and were eluted in 20μl of DEPC treated H2O. 
Oligo name Sequence 5’-3’ Sample 
L3App 
adapter 
App/AGATCGGAAGAGCGGTTCAG/ddC all 
RT10Clip nnGACCnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC 
non-crosslinked       
beads-only 
RT13Clip nnTCCGnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC 
RT4Clip nnAGGTnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC non-crosslinked           
Osk IP 
RT8Clip nnCATTnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC 
RT2Clip nnACAAnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC 
Uv crosslinked         
beads-only RT7Clip nnCTAAnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC 
RT3Clip nnATTGnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC UV crosslinked 
Osk IP RT9Clip nnGCCAnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC 
Cut Oligo GTTCAGGATCCACGACGCTCTTC all 
Table 3: List of oligos used in the Oskar iCLIP experiment 
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5.6. RNase A- and T1-mediated digestion 
1ml aliquots of embryo extracts prepared as described in 5.2.3 were incubated 3 hours on 
a rotating wheel in the cold (8⁰C), in presence of different amounts of a mix of RNase A (from 
bovine pancreas) (Sigma Aldrich) and RNase T1 (from Aspergillus oryzae) (Sigma Aldrich). 
Stock mix concentration: 4U/μl (see Fig. 15 for the amounts of RNase A and T1 used). After 
digestion RNA was extracted as described in 5.3.2. 
 
5.7. Dephosphorylation efficiency test 
For each sample, 20μl of protein G sepharose beads (GE Healthcare) were used. Beads 
were washed 2 times for 5’ on a rotating wheel in the cold (8⁰C), with 1ml of CB then 
equilibrated 2 times with 1ml of DBE [186]. Beads were supplemented with 40μl of different 
reaction mixes according to the experimental condition. Experiment: 37μl DRB; 1μl oligo 1-P 
(diluted according to the final amount required in the experiment, see Fig. 16) (Integrated DNA 
Technologies); 1μl T4 PNK (10U/μl) (Thermo Scientific); 1μl RiboLock RNase inhibitor 
(Thermo Scientific). Positive Control: 38μl DRB; 1μl oligo 1 (diluted according to the final 
amount required in the experiment, see Fig. 16) (Integrated DNA Technologies); 1μl RiboLock 
RNase inhibitor (Thermo Scientific). Negative Control: 38μl DRB; 1μl oligo 1-P (diluted 
according to the final amount required in the experiment, see Fig. 16) (Integrated DNA 
Technologies); 1μl RiboLock RNase inhibitor (Thermo Scientific). For oligo sequences see 
Table 4. Beads were incubated 30’ at 37⁰C at 1100rpm in a Thermomixer C (Eppendorf), RNA 
was extracted using TRIzol LS reagent (Invitrogen) according to the manufacturer’s protocol 
and resuspended in 5μl DEPC treated H2O. L3App adapter (Sigma Aldrich) ligation was 
performed using T4 RNA ligase 2 truncated (New England BioLabs) and products were purified 
using QIAquick PCR Purification Kit (Qiagen) following the manufacturer’s instructions (eluted 
in 6μl DEPC treated H2O). Reverse-transcription using RT Clip primers 3 and 9 (see Table 3) 
122 
 
was performed as described in 5.5; cDNAs were purified using QIAquick PCR Purification Kit 
(Qiagen) following the manufacturer’s instructions and were eluted in 20μl DEPC treated H2O. 
 
Oligo name Sequence 5’-3’ 
oligo 1 NNNNNNGGCCUCGUGAAAUCCCGUUAGUAAAAGGNNNNNN 
oligo 1-P NNNNNNGGCCUCGUGAAAUCCCGUUAGUAAAAGGNNNNNN-P 
Table 4: List of oligos used in the dephosphorylation efficiency test experiments 
 
5.8. L3App adapter ligation efficiency test 
Different amounts of oligo 1 (Integrated DNA Technologies) (see Table 4) were 
radioactively labeled at the 5’ end. 20μl labeling reaction composition: 2μl 10X PNK Reaction 
Buffer A (Thermo Scientific); 1μl oligo 1 (Integrated DNA Technologies) (diluted according to 
the final amount required in the experiment, see Fig. 17, Fig. 18 and Table 4); 1μl T4 PNK 
(10U/μl) (Thermo Scientific); 1μl RiboLock RNase inhibitor (Thermo Scientific); 1μl gamma 32P 
ATP (10mCi/ml) (Hartmann Analytic); 14μl DEPC treated H2O. Reactions were incubated 30’ 
at 37⁰C in a 2720 Thermal Cycler (Applied Biosystems), then RNA was extracted using TRIzol 
LS reagent (Invitrogen) following the manufacturer’s instructions and was resuspended in 4μl 
DEPC treated H2O. 20μl of protein G sepharose beads (GE Healthcare) were used for each 
reaction and were initially washed 2 times for 5’ on a rotating wheel in the cold (8⁰C) with 1ml 
of CB. Equilibration was performed using different buffers, according to the specific 
experimental conditions. For iCLIP conditions (Fig. 17): 2 times with 1ml of LBE [186]. For 
Commercial conditions (Fig. 17 and Fig. 18): 2 times with 1ml of 1X T4 RNA Ligase Reaction 
Buffer (50mM Tris-HCl pH 7.5; 10mM MgCl2; 1mM DTT) (New England BioLabs). For eCLIP 
conditions (Fig. 17): 2 times with 1ml of 1X eCLIP Ligation Buffer (50mM Tris-HCl pH 7.5; 
10mM MgCl2) [195]. Ligation reactions were performed in 40μl total volume with different 
composition according to specific experiments. iCLIP condition (Fig. 17): 23μl Ligation 
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Reaction Buffer; 1μl T4 RNA ligase 2 truncated (200U/μl) (New England BioLabs); 3μl L3App 
adapter (20μM) (Sigma Aldrich); 1μl RiboLock RNase inhibitor (Thermo Scientific); 8μl 
PEG400 (20% final concentration) (Sigma Aldrich); 4μl radioactive labeled oligo 1. Commercial 
condition (Fig. 17 and Fig. 18): 4μl 10X T4 RNA Ligase Reaction Buffer (New England 
BioLabs); Xμl T4 RNA ligase 2 truncated (200U/μl) (according to experimental conditions, see 
Fig. 17C, Fig. 18A and C) (New England BioLabs); 3μl L3App adapter (20μM) (Sigma Aldrich); 
1μl RiboLock RNase inhibitor (Thermo Scientific); 14.4μl 50% PEG8000 (18% final 
concentration) (New England BioLabs); 1.3μl 100% DMSO (3.2% final concentration) 
(AppliChem); 4μl radioactive labeled oligo 1; Xμl DEPC treated H2O to 40μl final volume. eCLIP 
conditions (Fig. 17): 4μl 10X eCLIP Ligation Buffer [195]; 1μl T4 RNA ligase 2 truncated 
(200U/μl) (New England BioLabs); 3μl L3App adapter (20μM) (Sigma Aldrich); 1μl RiboLock 
RNase inhibitor (Thermo Scientific); 14.4μl 50% PEG8000 (18% final concentration) (New 
England BioLabs); 1.3μl 100% DMSO (3.2% final concentration) (AppliChem); 4μl radioactive 
labeled oligo 1; 13.3μl DEPC treated H2O. In the control reactions (no L3App adapter and no 
T4 RNA Ligase 2), the reaction volume of the omitted component was replaced by DEPC 
treated H2O. Samples were incubated overnight (16 hours) at 16⁰C at 1100rpm or 2 hours at 
25⁰C at 1100rpm in a Thermomixer C (Eppendorf). RNA oligos were extracted using TRIzol 
LS reagent (Invitrogen) following the manufacturer’s instructions, resuspended in 5μl DEPC 
treated H2O and supplemented with 5μl 2X RNA Loading Dye (New England BioLabs). 
 
5.9. Optimized iCLIP 
Osk IP was performed as described in 5.3.1.3. During the last 3 hours of IP incubation, 
the extracts were supplemented with 8*10-5U/μl of RNase A and T1 mix (Sigma Aldrich) and 
incubated on a rotating wheel in the cold (8⁰C). All buffers were supplemented with complete 
EDTA-free proteinase inhibitor cocktail (Roche), RiboLock RNase inhibitor (Thermo Scientific). 
WBU1 and WBU2 were also supplemented with 0.02mg/ml of heparin (Sigma Aldrich). Beads 
were equilibrated 2 times in 1ml of DBE [186] then supplemented with 40μl of 
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Dephosphorylation Reaction mix: 38μl DRB; 1μl T4 PNK (10U/μl) (Thermo Scientific); 1μl 
RiboLock RNase inhibitor (Thermo Scientific). Samples were incubated 30’ at 37⁰C at 1100rpm 
in a Thermomixer C (Eppendorf) then washed 2 times with 1ml of WBU2 and 2 times with 1ml 
of WB4. The washings were performed 10’ on a rotating wheel in the cold (8⁰C). Beads were 
equilibrated 2 times with 1ml of 1X T4 RNA Ligase Reaction Buffer (New England BioLabs) 
then were supplemented with 40μl of Commercial Ligation mix: 4μl 10X T4 RNA Ligase 
Reaction Buffer (New England BioLabs); 5μl T4 RNA ligase 2 truncated (200U/μl) (New 
England BioLabs); 3μl L3App adapter (20μM) (Sigma Aldrich); 1μl RiboLock RNase inhibitor 
(Thermo Scientific); 14.4μl 50% PEG8000 (18% final concentration) (New England BioLabs); 
1.3μl 100% DMSO (3.2% final concentration) (AppliChem); 11.3μl DEPC treated H2O. 
Samples were incubated overnight (16 hours) at 16⁰C at 1100rpm in a Thermomixer C 
(Eppendorf) then washed 2 times with 1ml of WBU2 and 2 times with 1ml of WB4 (10’ on a 
rotating wheel in the cold at 8⁰C). The other steps of the protocol were performed as described 
in 5.5. For the RT Clip primers used for reverse-transcription see Table 5. 
Oligo 
name 
Sequence 5’-3’ Sample 
RT2Clip nnACAAnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC 
non-crosslinked      
beads-only 
RT7Clip nnCTAAnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC 
RT3Clip nnATTGnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC non-crosslinked           
Osk IP RT9Clip nnGCCAnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC 
RT4Clip nnAGGTnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC 
UV crosslinked         
beads-only RT8Clip nnCATTnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC 
RT10Clip nnGACCnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC UV crosslinked 
Osk IP RT13Clip nnTCCGnnnAGATCGGAAGAGCGTCGTGgatcCTGAACCGC 
Table 5: List of oligos used in the optimized Oskar iCLIP experiment 
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5.10. SDS-PAGE and western blot 
Protein samples collected as described in 5.3.1.1, 5.3.1.2 and 5.3.1.3 were separated on 
NuPAGE 4-12% polyacrylamide Bis-Tris gels (Invitrogen). Gels were run in 1X NuPAGE 
MOPS SDS Running Buffer (Invitrogen) using an XCell SureLock Mini-Cell Electrophoresis 
System (Thermo Scientific), for 1 hour at 180V constant electric current. Gels were blotted on 
Protran Pure Nitrocellulose membranes (Perkin Elmer) using a PerfectBlue Semi-Dry-Blotter 
Sedec (VWR Peqlab) for 1 hour at 14V and 2mA*cm-2 in 1X Towbin SDS Buffer (25mM Tris; 
192mM Glycine; 0.1% SDS; 20% Methanol; pH 8.3). In the case of the experiment described 
in 5.4 (Fig. 12), the gels were blotted on Protran Pure Nitrocellulose membranes (Perkin Elmer) 
using a Mini Trans-Blot Cell (Biorad) wet-blotting system, for 1 hour at 130V constant electrical 
current in 1X Towbin SDS Buffer. For western blots, membranes were blocked in 5% milk 
(Frema) solution in TNT Buffer (20mM Tris-HCl pH 7.5; 150mM NaCl; 0.05% Tween-20), 
incubated overnight with primary antibodies and 1h with secondary antibodies. All antibody 
incubations were performed in 5% milk (Frema) solution in TNT Buffer in the cold (8⁰C). The 
washing steps after both primary and secondary antibody incubations were performed in TNT 
Buffer at room temperature. For information regarding the antibodies used see Table 6. Protein 
detection was performed using Western Lightning Plus-ECL (Perkin Elmer) and Amersham 
Hyperfilm ECL (GE Healthcare) films developed using an RP X-Omat Processor, model M6B 
(Kodak). Developed films were scanned using a Perfection V750 Pro (Epson) scanner. 
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Primary Antibodies 
Name Dilution Source 
anti-Oskar (rabbit) 1:2000 [89] 
anti-Vasa (rat) 1:2000 [125] 
anti-α-Tubulin (mouse) 1:10000 Sigma Aldrich 
anti-Smaug (rabbit) 1:500 gift from Dr. E. Whale 
Secondary Antibodies 
Name Dilution Source 
anti-rabbit light chain 
specific 
1:100000 Merck 
anti-rabbit whole antibody 1:2000 GE Healthcare 
anti-rat whole antibody 1:10000 GE Healthcare 
anti-mouse whole antibody 1:10000 GE Healthcare 
Table 6: List of antibodies used for western blot analysis 
 
5.11. PCR 
Test PCRs for iCLIP libraries generated as described in 5.5 (Fig. 13) and 5.9 (Fig. 19) 
were performed in 8μl volumes: 4μl 2X Phusion Flash High-Fidelity PCR Master Mix (Thermo 
Scientific); 0.2μl P3/P5 primers mix (10μM each) (Sigma Aldrich) (see Table 7); 1μl cDNA 
template; 2.8μl DEPC treated H2O. The reactions were incubated: 
20’’ at 98⁰C - {3’’ at 98⁰C - 10’’ at 65⁰C - 15’’ at 72⁰C} - 1’ at 72⁰C. 
For PCR cycles number (steps between {---}) see Figure 13 and 19. 
Final PCRs for iCLIP library generation were performed in a 20μl volume: 10μl 2X Phusion 
Flash High-Fidelity PCR Master Mix (Thermo Scientific); 1μl P3/P5 primers mix (10μM each) 
(Sigma Aldrich); 4μl cDNA template; 5μl DEPC treated H2O. Reaction incubation conditions 
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were the same as described above, except for the number of PCR cycles: Figure 13, 36 cycles; 
Figure 19, 28 cycles. For the PCR of the dephosphorylation efficiency test experiment 
described in 6.7 (Fig. 16), reactions were performed in 10μl volumes: 5μl 2X Phusion Flash 
High-Fidelity PCR Master Mix (Thermo Scientific); 0.5μl iCLIP PCR test (forward primer) 
(10μM) (Eurofins Genomics) (see Table 7); 0.5μl P3 (reverse primer) (10μM) (Sigma Aldrich); 
1μl cDNA template; 3μl DEPC treated H2O. The reactions were incubated: 
1’ at 98⁰C - {10’’ at 98⁰C - 10’’ at 60⁰C - 5’’ at 72⁰C} - 1’ at 72⁰C. 
30 PCR cycles (steps between {---}) were performed. All PCR reactions were performed 
in a C1000 Touch Thermal Cycler (Biorad). 
Primer name Sequence 5’-3’ 
P3 
CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTG
AACCGCTCTTCCGATCT 
P5 
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGAC
GCTCTTCCGATCT 
iCLIP PCR test 1 GGCCTCGTGAAATCCCGT 
Table 7: List of primers used for PCR analysis 
 
5.12. RNA and DNA gels 
Test PCRs from iCLIP experiments described in 5.5 (Fig. 13B) and 5.9 (Fig. 19C) were 
supplemented with 6X Gel Loading Dye Blue (New England BioLabs) to a final 1X 
concentration. Samples were separated on 6% polyacrylamide Novex TBE gels (Invitrogen). 
Gels were run in 0.5X TBE buffer (45mM Tris-borate pH ~8.3; 1mM EDTA) using an XCell 
SureLock Mini-Cell Electrophoresis System (Thermo Scientific), for 40’ at 60V constant electric 
current. The gels were stained in 0.5X TBE containing HD Green Plus DNA Stain (Intas) diluted 
1:20000. Final PCRs for iCLIP libraries (Fig. 13C and Fig. 19D) were supplemented with 6X 
Gel Loading Dye Blue (New England BioLabs) to a final 1X concentration. Samples were 
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separated on 4% MetaPhor Agarose (Lonza) gel in 0.5X TBE buffer. The gels were run in 0.5X 
TBE buffer, for 3.5 hours at 50V constant electric current, in the cold (8⁰C). Gels were stained 
with SYBR Gold Nucleic Acid Gel Stain (Invitrogen) diluted 1:10000. PCRs from the 
dephosphorylation efficiency test experiment described in 5.7 (Fig. 16) were supplemented 
with 6X Gel Loading Dye Blue (New England BioLabs) to a final 1X concentration. The 
reactions were separated on a 2% agarose (Sigma Aldrich) in 0.5X TBE buffer. Gels were run 
in 0.5X TBE buffer for 1 hour at 60V constant electric current. The gels were stained using HD 
Green Plus DNA Stain (Intas) diluted 1:20000. All DNA gels were visualized on a Quantum 
ST4 instrument (Vilber) using the Quantum-Capt software (Vilber). Reaction products of L3App 
adapter ligation efficiency test experiment described in 5.8 (Fig. 17 and Fig. 18) were separated 
on 10% polyacrylamide Novex TBE-Urea Gels (Invitrogen). Gels were pre-run in 0.5X TBE 
buffer using an XCell SureLock Mini-Cell Electrophoresis System (Thermo Scientific), for 1 
hour at 180V constant electric current. After loading the gels were run 1 hour using the same 
conditions. 
 
5.13. DNA extraction from gel 
iCLIP libraries prepared as described in 5.5 (Fig. 13C) and 5.9 (Fig. 19D) and separated 
on 4% MetaPhor Agarose (Lonza) gels were extracted using QIAquick Gel Extraction Kit 
(Qiagen) following the manufacturer’s instructions. The purified libraries were eluted in 20μl of 
Buffer EB (10mM Tris-HCl pH 8.5) (Qiagen). 
 
5.14. RNA and DNA analysis 
RNA and DNA samples were analyzed on a Bioanalyzer 2100 instrument (Agilent). RNA 
samples from experiments described in 5.3.1.2 (Fig. 11) and 5.3.1.3 (Fig. 15B) were analyzed 
on RNA 6000 Pico Chips (Agilent). RNA samples from experiments described in 5.6 (Fig. 15A) 
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and 5.9 (Fig. 19B) were analyzed on RNA 6000 Nano Chips (Agilent). DNA libraries from 
experiments described in 5.5 (Fig. 13D) and 5.9 (Fig. 20) were analyzed on High Sensitivity 
DNA Chips (Agilent). The results were visualized using 2100 Expert software (Agilent). 
 
5.15. Radioactivity detection 
Nitrocellulose membranes from experiments described in 5.4 (Fig. 12) were exposed 
overnight to a BAS-SR 2040 Imaging plate (Fujifilm). Gels from experiments described in 5.8 
(Fig. 17 and Fig. 18) were exposed 1 hour and overnight to a BAS-MS 2040 Imaging plate 
(Fujifilm). The plates were analyzed on a Typhoon FLA 7000 laser scanner (Fujifilm), using the 
FLA 7000 software (Fujifilm). 
 
5.16. NGS sequencing 
iCLIP libraries prepared as described in 5.5 (Fig. 13) were sequenced on a MiSeq platform 
(Illumina). iCLIP libraries prepared as described in 5.9 (Fig. 19 and Fig. 20) were sequenced 
on a HiSeq 2000 platform (Illumina). In both cases, single-end sequencing was performed by 
the EMBL Genomics Core Facility. 
 
5.16.1. Data analysis pipeline 
Raw data from iCLIP library sequencing were analyzed using bioinformatic tools available 
on the EMBL Galaxy server (Genome Biology Unit Computational Support). Data were 
demultiplexed using the Je-Demultiplex tool [192]. Data were subsequently processed using 
FASTQ Groomer tool [200]. Reads were aligned against the Drosophila genome (release 3) 
[201] using the TopHat2 tool [193]. PCR duplicates were removed using rmdup application 
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from SAMTools toolkit [194]. Data were visualized using Integrative Genomics Viewer software 
[197] [198]. 
 
5.17. Software 
All graphs and statistical analyses presented in this work were generated using Excel 2013 
software (Microsoft). All images were processed using ImageJ (USA National Institutes of 
Health) and Photoshop CS6 (Adobe) software. Figure assembly was performed using 
Illustrator CS6 (Adobe) software. 
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